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Motor neurone disease (MND) is a neurodegenerative disease with reported incidence  
between 1.68 and 2.08 per 100,000 (A Chio et al., 2013; Marin et al., 2017) and prevalence of 
5.40 per 100,000 (A Chio et al., 2013). The defining symptoms of MND are loss of voluntary 
control of muscle movement, spasticity and hyperreflexia due to degeneration of upper motor 
neurons, and flaccidity, atrophy and fasciculations due to degeneration of lower motor 
neurons. These symptoms can affect the muscles of deglutition, resulting in oropharyngeal 
dysphagia. Patients with MND are not often offered dysphagia treatment due to a historical 
belief that exercise would result in muscular fatigue and increased rate of degeneration 
(Plowman, 2015). However, recent research demonstrates that low to moderate intensity 
exercise may be beneficial for patients with MND (Carreras et al., 2010; Plowman, 2015). 
Additional research is necessary to determine appropriate treatment modalities to improve 
swallowing outcomes in this population. The research presented in this thesis investigated the 
effects of skill training on swallowing and quality of life outcomes in patients with MND. 
This programme of research involves a methodological study investigating quantification of 
fatigue during exercise of bulbar muscles and two exploratory studies that investigated the 
effects of skill training for swallowing.  
Study one investigated the potential for using surface electromyography (sEMG) as a method 
of quantifying fatigue of bulbar muscles during a lingual pressure endurance task. It is known 
that as muscles become fatigued, additional motor units are recruited, firing frequency 
increases and discharges are synchronised for sustained power generation (Chang, Chablat, 
Bennis, & Ma, 2016). However, it is unknown whether the smoothed data from sEMG of the 
submental muscles can be used during a lingual pressure task to indicate degree of muscular 
fatigue. Twenty-four healthy participants completed a lingual endurance task with sEMG 
placed over the submental muscles. Results demonstrated fatigue over the task, represented 
by a gradual decline in endurance time. However, there was no significant difference in 
average sEMG output across sessions, indicating that sEMG of the submental muscles, as 
used in this study, is not an appropriate method of quantifying fatigue during a lingual 
pressure task.   
The second and third studies were exploratory studies that first assessed the feasibility of a 
skill training protocol in patients with MND and then assessed the effect of the treatment on 
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biomechanical, functional and quality of life outcomes. The aim of the pilot study was to 
determine whether further research was possible within the New Zealand context and to 
refine the methodology of the treatment study. Five participants underwent a four-week skill 
training protocol with a four-week no contact periods pre-treatment (baseline) and post-
treatment (retention). The skill training protocol consisted of 80 swallows per session using 
the Biofeedback in Strength and Skill Training (BiSSKiT) software. BiSSkiT uses surface 
electromyography (sEMG) for visualisation of muscle activity to enhance conscious control 
of swallowing. There were no drop outs and all participants were able to follow instructions 
to complete the treatment task. Following treatment, an improvement in functional 
swallowing was observed for the patients with mild to moderate dysphagia. This 
improvement was demonstrated through increased volume swallowed per second, increased 
swallowing efficiency and decreased time per swallow when consuming 150 mL of water in 
the Timed Water Swallow Test (TWST). These findings indicated that further research was 
warranted.  
The treatment study followed the pilot study and investigated additional outcome measures 
including biomechanical changes to swallowing. For the treatment study, 27 patients with 
MND were recruited. From these participants, 19 completed two weeks of daily skill training 
using the BiSSkiT software with a two-week baseline and two-week retention period. Quality 
of life was measured through the Swallowing Quality of Life Questionnaire (Swal-QOL), 
functional swallowing assessed through the TWST and the Test of Masticating and 
Swallowing Solids (TOMASS). Additionally, instrumental assessments (ultrasound [US], 
videofluoroscopy [VF] and high resolution impedance manometry [HRIM]) were included to 
assess swallowing biomechanics. Following treatment, timing (p < .01) and amplitude (p = 
.04) errors during the skilled task decreased, total symptom frequency measured by the Swal-
QOL improved (p = .02) and oropharyngeal transit time decreased for puree (p = .01) but 
increased for water (p = .02). Hyoid displacement on VF increased over the retention period 
but not the treatment period for water (p = .04) and puree (p = .01). Although there was 
evidence of improvements in quality of life and swallowing biomechanics, there were no 
significant differences observed in functional swallowing outcomes. This research 
demonstrates that participants with MND are able to participate in swallowing skill training 
and improve at the task with no evidence of adverse effects. Changes in quality of life and 
swallowing biomechanics were observed following two weeks of treatment; however, there 
was no transfer to functional tasks. This suggests two weeks of treatment is not sufficient for 
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functional improvement but may have facilitated maintenance of function and highlights the 
need for future research.  
Skill training is a developing area of treatment for dysphagia. This research was the first to 
investigate the use of skill training to improve pharyngeal swallowing for patients with MND. 
Results from these studies add to the emerging literature that demonstrates the need for 
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Dysphagia is a common symptom associated with MND (A. Chen & Garrett, 2005; Kühnlein 
et al., 2008; Onesti et al., 2017). Oropharyngeal dysphagia can result in malnutrition and 
aspiration pneumonia, which can lead to death (Corcia et al., 2008; Yang et al., 2011). 
Dysphagia is also one of the biggest contributors to reduced quality of life (Paris et al., 2013). 
Patients with MND often do not complete exercises to improve dysphagia due to a historic 
belief that exercise results in fatigue of muscles and leads to a hastened rate of decline. 
However, recent evidence demonstrates that mild-moderate intensity exercise may be 
beneficial for maintaining strength and functional ability in patients with MND; this includes 
exercise of bulbar muscles (Carreras et al., 2010; Plowman, 2015; Plowman et al., 2019). 
Swallowing is a task that is performed at submaximal strength and adverse effects such as 
nasal redirection and a reduction in hyoid excursion have been associated with strength 
training (Bülow, Olsson, & Ekberg, 1999; Garcia, Hakel, & Lazarus, 2004). There is the need 
for further investigation to identify appropriate treatment options for managing dysphagia in 
this population. Skill training has been investigated in the limb literature for decades but is a 
recent addition to dysphagia management. The aim of skill training is to enhance 
neuroplasticity and cortical control of muscle movements. This research programme 
investigates fatigue of bulbar muscles during endurance tasks and the potential of skill 
training to improve swallowing and quality of life outcomes for patients with MND. 
Part I is a comprehensive literature review. A summary of the physiology and neural control 
of normal swallowing is provided in chapter two. Chapter three discusses MND, including 
the pathophysiology associated with dysphagia and the effects of dysphagia on health 
outcomes and quality of life. Routine intervention in MND is discussed in chapter four and 
chapter five discusses dysphagia assessment. Current methods for managing dysphagia and 
emerging evidence for potential treatment options are discussed in chapter six along with the 
strengths and limitations of treatment approaches. Chapter seven provides a summary of the 
evidence.  
Part II presents the experimental studies. Chapter eight summarises the objectives and 
hypotheses for the studies that are discussed in this thesis. The first is a methodological study, 
discussed in chapter nine. This study investigates the use of clinically replicable measures of 
surface electromyography (sEMG) for quantifying fatigue of bulbar muscles during a series 
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of lingual presses. This study is somewhat peripheral but related to the overall theme of the 
thesis, as fatigue is a limiting factor in many treatment options for patients with MND. 
Quantification of fatigue may help to ensure that patients are completing exercises at a level 
that allows them to receive maximum benefit without reaching an intensity that results in 
detrimental muscle fatigue. The study was designed as a community engagement protocol to 
introduce two high school students to research.  
Chapter 10 describes an exploratory investigation into the use skill training to improve 
swallowing and quality life outcomes in patients with MND. This includes two exploratory 
studies that were inspired by a lack of treatment options for dysphagia offered to patients 
with MND and the limitations associated with strength training. This section consists of a 
pilot study investigating the feasibility and safety of using skill training for this patient 
population and a treatment study that investigated changes in functional, biomechanical and 
quality of life outcomes associated with skill training. These studies are important steps in 
assessing potential treatment options to improve dysphagia outcomes for patients with this 
degenerative neurological disease. Chapter 11 provides the concluding remarks from this 
thesis, and discussed how the research programme has contributed to the current literature in 














2. Normal swallowing 
Swallowing is a complex biomechanical process that involves the coordinated recruitment of 
31 pairs of muscles (Dodds, Stewart, & Logemann, 1990). This highly coordinated sequence 
of muscle contractions is vital for adequate nutritional intake and pulmonary safety. Safety 
and efficiency are not dependent on motor movements alone; sensory feedback is integrated 
at all stages of swallowing to ensure precision of movement and to allow the process to adapt 
to differences in bolus density, viscosity and size. 
2.1 Phases of swallowing 
Swallowing is often broken down into phases based on visual analysis of bolus position and 
physiological response. There is a large amount of overlap between the interdependent phases 
(Martin-Harris, Michel, & Castell, 2005), making the boundaries of each distinct phase open 
for interpretation. For the purposes of this document, swallowing will be described in four 
discrete stages: the pre-oral, oral, pharyngeal and oesophageal phases, as described by 
Daniels and Huckabee (2014). An overview of normal swallowing is provided; however, it is 
important to consider that there is a large amount of variation encompassed in normal 
swallowing behaviour. Differences in swallowing have been demonstrated in relation to age 
and sex, as well as a large amount of variation both within and between individuals (Robbins, 
Hamilton, Lof, & Kempster, 1992). 
2.2 Pre-oral phase of swallowing 
The process of swallowing begins prior to placing a bolus in the oral cavity, as sensory 
receptors from the optic and olfactory cranial nerves activate the cerebral cortex (Ebihara et 
al., 2006). This pre-oral stimulation allows an individual to prepare for a bolus, and modifies 
subsequent swallowing by increasing the rate of saliva production by the sublingual, 
submandibular and parotid glands (Noh, Im, & Kim, 2017; Pedersen, Sørensen, Proctor, 
Carpenter, & Ekström, 2018). Saliva is important during swallowing as it increases taste, 
facilitates bolus formation and begins the digestive process of starches and lipids (Pedersen, 
Bardow, Jensen, & Nauntofte, 2002). Additionally, pre-oral olfactory and optic stimulation 
can result in increased appetite and reduced latency of the onset of pharyngeal swallowing, 




2.2.1 Oral phase of swallowing 
The oral phase begins once a bolus is placed within the oral cavity. During this phase, oral 
containment of the bolus is crucial. Multiple muscles are recruited to contain the bolus both 
anteriorly and posteriorly. Anterior bolus containment is important to prevent bolus loss 
through the lips. This is achieved through contraction of the orbicularis oris muscle, which 
ensures that there is adequate labial seal (Daniels & Huckabee, 2014). Glossopalatal 
approximation is necessary to prevent the bolus from spilling into the pharynx prior to the 
initiation of swallowing (J. Cichero, 2006; Daniels & Huckabee, 2014). Premature spillage of 
the bolus into the pharynx can result in pre-swallow aspiration if airway closure is not 
complete. 
During the oral phase of swallowing, a cohesive bolus is formed by breaking down food into 
small particles and mixing it with saliva from the submandibular, sublingual and parotid 
glands. The intrinsic lingual muscles move the bolus around the mouth and between the teeth, 
such that mastication can prepare a solid bolus for swallowing. Jaw opening occurs through 
contraction of the anterior belly of the digastric, mylohyoid and geniohyoid muscles, in 
conjunction with relaxation of muscles required to close the jaw. The temporalis, masseter 
and medial pterygoid muscles are necessary for jaw closing, and the lateral pterygoid muscles 
for jaw lateralisation (J. A. Cichero & Murdoch, 2006). Mastication is largely a repetitive, 
rhythmic movement produced by a central pattern generator within the brainstem. However, 
the pattern of mastication can be altered, both by conscious control and sensory feedback 
(Lund & Kolta, 2006). Sensory feedback is necessary to ensure that the cheeks and tongue do 
not fall between the teeth, to alter bite force dependent on the hardness of the food and to 
provide information about the position of the bolus and its readiness for safe transfer to the 
pharynx.  
Glossopalatal approximation is maintained throughout the oral preparatory phase to ensure 
the bolus remains in the oral cavity. Once the bolus is adequately prepared for transfer to the 
pharynx, the palatoglossus muscles relax to drop the base of tongue and the genioglossus and 
hyoglossus muscles pull the base of tongue inferiorly. The intrinsic and extrinsic lingual 
muscles then pull the tongue up, to approximate the palate anteriorly to posteriorly. This 
helps to squeeze the bolus out of the oral cavity and into the pharynx to begin the pharyngeal 
phase of swallowing (Daniels & Huckabee, 2014; Kahrilas, Lin, Logemann, Ergun, & 
Facchini, 1993; Matsuo & Palmer, 2015).  
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2.2.2 Pharyngeal phase of swallowing 
The definition of the onset of the pharyngeal response has been debated in the literature. 
Bolus entry to the pharyngeal space is not a reliable indicator of swallowing onset as it is 
highly variable. Bolus position is dependent on factors such as single vs. sequential swallows 
and whether a command of when to swallow is provided (Daniels, Schroeder, DeGeorge, 
Corey, & Rosenbek, 2007; Steele & Miller, 2010; Stephen et al., 2005). Further, the 
occurrence of pharyngeal aggregation of the bolus, in the absence of other indicators of 
pharyngeal swallowing onset, is considered normal. This means that in healthy individuals, 
part of the bolus could be transferred into the pharynx up to 10 seconds prior to initiation of 
the pharyngeal phase of swallowing, without increased risk of airway invasion (Chi-Fishman 
& Sonies, 2000; Daniels & Foundas, 2001; Dua, Ren, Bardan, Xie, & Shaker, 1997; Martin-
Harris, Brodsky, Michel, Lee, & Walters, 2007; Matsuo, Hiiemae, Gonzalez-Fernandez, & 
Palmer, 2008). Therefore, the onset of hyolaryngeal excursion is most commonly used to 
indicate the beginning of the pharyngeal phase of swallowing (Daniels & Huckabee, 2014; 
Nam, Oh, & Han, 2015). 
Once the pharyngeal phase of swallowing is initiated, many overlapping events contribute to 
the safe and efficient passage of the bolus through the pharynx. Velopharyngeal 
approximation creates a barrier, separating the nasopharynx from the oropharynx. This assists 
with pharyngeal pressure generation by preventing loss of pressure through the nose 
(Kahrilas, 1993). Velopharyngeal approximation is achieved through soft-palate elevation 
and approximation of the pharyngeal wall, as well as anterior bulging of the adenoid pad 
(Daniels & Huckabee, 2014; Harrington, 1944). Temporally, velopharyngeal closure occurs 
as the muscles responsible for glossopalatal approximation relax (Kahrilas et al., 1993). 
Separation of the oropharynx and nasopharynx remains throughout the pharyngeal phase of 
swallowing.  
Laryngeal valving is necessary to prevent material from entering the laryngeal vestibule 
during swallowing. There are multiple levels of airway protection that serve as safeguards, 
should there be dysfunction of one level. Airway protection occurs through approximation of 
the true and false vocal folds, and epiglottis to arytenoid contact. Activation of the 
interarytenoid and lateral cricoarytenoid muscles results in adduction of true and false vocal 
folds (Andaloro & La Mantia, 2019). Deflection of the cartilaginous epiglottis is a result of 
external forces. The suprahyoid muscles function to pull the hyoid and larynx superiorly and 
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anteriorly. The submental muscles consist of the bilateral mylohoid, geniohyoid and anterior 
belly of the digastric muscles. The geniohyoid muscles attach to the hyoid from the inferior 
mental spine of the mandible. The mylohyoid muscles insert on the mylohyoid line of the 
mandible; posterior portions of the mylohyoid muscles insert into the body of the hyoid bone 
and the anterior portions insert into the median raphe that connects the left and right 
mylohyoid muscles (Shaw et al., 2017). The anterior belly of the digastric muscles run from 
the intermediate tendon of the digastric muscles to the digastric fossa of the mandible (Shaw 
et al., 2017). Anterior hyoid excursion through contraction of the submental muscles pulls the 
base of the epiglottis anteriorly. The larynx is attached to the hyoid bone by the thyrohyoid 
membrane and thyrohyoid muscles and is pulled up and forwards with the movement of the 
hyoid. Contraction of the thyrohyoid muscles further pull the larynx up. These collective 
movements result in the deflection of the epiglottis for airway protection. There is a large 
amount of variability in the timing of airway closure. If material enters the pharynx prior to 
the onset of pharyngeal swallowing, partial true vocal fold approximation may occur to 
prevent aspiration (Dua et al., 1997). However, complete adduction of the vocal folds often 
does not occur until after hyolaryngeal excursion begins (Inamoto et al., 2011; Ohmae, 
Logemann, Kaiser, Hanson, & Kahrilas, 1995). Temporally, maximal epiglottic deflection 
occurs following onset of hyoid excursion, as hyolaryngeal excursion is a necessary 
facilitator of epiglottic deflection (Inamoto et al., 2011). 
Laryngeal closure results in a period of swallowing apnoea. The pattern of inspiration and 
expiration surrounding swallowing apnoea may impact swallowing safety. In healthy adults, 
swallowing apnoea can occur mid-expiration, mid-inspiration or at the transitions between 
inspiration and expiration or expiration and inspiration (Martin-Harris, Brodsky, et al., 2005). 
However, the most common, and safest, pattern is for swallowing apnoea to occur mid-
expiration (Hiss, Treole, & Stuart, 2001; Martin-Harris, Brodsky, et al., 2005; McFarland & 
Lund, 1995; Paydarfar, Gilbert, Poppel, & Nassab, 1995; J. Smith, Wolkove, Colacone, & 
Kreisman, 1989). Appropriately timed respiratory swallowing coordination is believed to 
contribute to increased subglottic pressure as a result of higher lung volume at the time of 
swallowing (Gross, Atwood Jr, Grayhack, & Shaiman, 2003; Gross, Steinhauer, Zajac, & 
Weissler, 2006). Expiration preceding and following a swallow is likely a protective 
mechanism to help prevent aspiration by increasing subglottic pressure as the airway closes 
and expelling material that remains in the laryngeal vestibule post-swallow (Brodsky et al., 
2010; Martin-Harris, Brodsky, Price, Michel, & Walters, 2003).  
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Bolus movement through the pharynx is a result of driving pressures. As the bolus is 
transferred to the pharynx, the base of the tongue approximates the posterior pharyngeal wall 
and the pharyngeal constrictors contract sequentially (Kahrilas, Logemann, Lin, & Ergun, 
1992) (McConnel, 1988). These movements create driving pressures to push the bolus 
inferiorly. The superior to inferior contraction of the pharyngeal constrictors facilitates 
pharyngeal shortening which decreases the distance that the bolus must travel and reduces 
pharyngeal volume, which helps to increase pressure to drive the bolus through the UES 
(Dejaeger, Pelemans, Ponette, & Joosten, 1997; J. B. Palmer, Tanaka, & Ensrud, 2000).  
In conjunction with airway protection, anterior hyolaryngeal excursion through contraction of 
the submental muscles, facilitates opening of the upper oesophageal sphincter (Matsuo et al., 
2008). The cricopharyngeus is a narrow, semi-sphincteric muscle that connects to the lateral 
borders of the cricoid cartilage. It is tonically contracted at rest to prevent air passing to the 
stomach during passive breathing and to stop reflux from entering the pharynx (Cook, 1993). 
Prior to the arrival of the bolus and hyolaryngeal excursion, the cricopharyngeus muscle 
relaxes. The suprahyoid muscles then contract, allowing hyolaryngeal excursion, which 
assists with opening of the UES. Intrabolus pressure further contributes to UES opening as 
the bolus descends through the pharynx and passes through the UES and into the oesophagus 
(Jacob, Kahrilas, Logemann, Shah, & Ha, 1989; Matsuo & Palmer, 2008). As the UES opens, 
negative pressure in the upper oesophagus aids in pulling the bolus through the UES 
(McConnel, 1988). 
2.2.3 Oesophageal phase 
The cricopharyngeus and lower oesophageal sphincter (LES) are annular muscles that remain 
tonically contracted at rest to prevent the passage of air into the digestive tract and stomach 
contents into the pharynx. These muscles relax during vomiting, burping and swallowing to 
allow material to enter and exit the oesophagus. The oesophageal phase of swallowing 
transports the bolus through the oesophagus, from the UES to the LES. As with other phases 
of swallowing, there is large variability in pressure and temporal characteristics of the 
oesophageal phase, with the oesophageal phase of swallowing lasting between 8 and 20 




Movement of a bolus during the oesophageal phase occurs as a result of a peristaltic wave 
that moves from superior to inferior, creating pressure that pushes the bolus down the 
oesophagus and through the LES (Dornhorst, Harrison, & Pierce, 1954; Matsuo & Palmer, 
2008). When in an upright position, gravity assists with oesophageal peristalsis (Matsuo & 
Palmer, 2008). Conscious changes in pharyngeal swallowing can affect oesophageal 
physiology in healthy individuals (O’Rourke et al., 2014). As an example, when performing 
effortful swallows, the number of non-peristaltic swallows (those in which peristalsis does 
not occur in the distal smooth muscle following proximal oesophageal peristalsis) is reduced 
and the number of peristaltic swallows is increased. Conversely, when volitionally altering 
timing of swallowing during the Mendelsohn manoeuvre, the number of non-peristaltic 
waves is increased (O’Rourke et al., 2014).  
2.3 Neural control of swallowing 
The complex act of swallowing requires input from multiple cortical and subcortical 
structures within the central nervous system (Leopold & Daniels, 2010). Cranial nerves 
connect the central nervous system with peripheral structures of the head and neck 
(Bhatnagar, 2013).  
2.3.1 Motor neurons 
Motor neurons are responsible for carrying motor impulses to the muscles. There are two 
types of motor neurons: upper motor neurons (UMN) and lower motor neurons (LMN). 
UMNs have two tracts that carry impulses from the cortex to the brainstem: the pyramidal 
tract and the extrapyramidal tract (J. A. Cichero & Murdoch, 2006). The classification of 
pyramidal or extrapyramidal is dependent on whether the UMNs send signals directly or 
indirectly to the LMNs (R. M. Miller & Britton, 2011). Neurons in the pyramidal tract travel 
directly from the motor cortex or precentral gyrus to the brainstem. These neurons contribute 
axons to the corticobulbar and corticospinal pathways and are involved in conscious, skilled 
movements (R. M. Miller & Britton, 2011). The extrapyramidal tract contains neurons that 
synapse with other structures during their course from motor cortex to the brainstem. UMNs 
in the extrapyramidal tract influence the LMNs that are responsible for autonomous actions 
(R. M. Miller & Britton, 2011). UMNs can be further subdivided dependent on the path that 
they take. The corticospinal tract originates at the cortex and terminates at the spinal cord. 
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The corticobulbar tract travels between the cortex and the medulla (Fuller, Pimentel, & 
Peregoy, 2012).  
Damage to UMNs may result in muscle spasticity and altered reflexes, thought to be due to 
reduced inhibitory signals (Bhatnagar, 2013; Clark, 2003). Spasticity is characterised by a 
hyperactive stretch reflex. It results in an increase in muscle tone, clonus and spasms, and can 
be painful (Stevenson & Playford, 2016). UMN of the corticobulbar system may synapse to 
either ipsilateral or contralateral nuclei as decussation may occur at the pyramids. Because of 
this pattern of decussation, most muscles of deglutition are bilaterally innervated, providing 
an additional safety mechanism following neural lesion. However, muscles of the lower 2/3 
of the face only receive input from UMNs that arise from the contralateral side of the cortex.  
Bulbar LMNs continue from the motor nuclei of the brainstem to the bulbar muscles (J. A. 
Cichero & Murdoch, 2006). A muscle fibre is innervated by one motor neuron; however, 
each motor neuron may innervate multiple muscle fibres, thus damage to a motor neuron will 
result in a disruption of signal to the muscle fibres innervated by that motor neuron (Clark, 
2003). LMN damage may result in ipsilateral muscle fasciculations, followed by atrophy due 
to disuse and flaccidity due to the lack of efferent motor impulses to the muscle fibres 
(Bhatnagar, 2013; Clark, 2003).  
2.3.2 Cranial nerves 
There are 12 bilaterally represented CNs that relay signals between the brain and various 
regions of the body, seven of which are involved in the process of swallowing. These are the 
olfactory nerves (CN I), optic nerves (CN II), trigeminal nerves (CN V), facial nerves (CN 
VII), glossopharyngeal nerves (CN IX), vagus nerves (CN X) and hypoglossal nerves (CN 
XII).  
CN I and CN II are involved during the pre-oral phase of swallowing. They contain only 
sensory fibres that are stimulated by the smell and sight of food respectively. CN I delivers 
information from the neuroepithelial olfactory cells in the nasal mucosa to the primary 
olfactory area. CN II delivers afferent information from the retina to the primary visual cortex 
in the occipital lobe (Bhatnagar, 2013).  
CN V is divided into three branches: the ophthalmic, maxillary and mandibular nerves. The 
ophthalmic and maxillary nerves carry only afferent information, while the mandibular nerve 
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is made up of both sensory and motor neurons. The principal sensory nucleus of CN V is 
located in the lateral aspect of the pons and the motor nucleus is located medial to the 
primary sensory nucleus. CN V transmits pain, temperature, tactile and proprioceptive 
sensory information from the face, oral cavity, nasal cavity and regions of the scalp 
(Bhatnagar, 2013). Sensory neurons from CN V convey information to the nucleus of the 
trigeminal nerve and subsequently to the nucleus tractus solitarius (NTS) if the information is 
related to swallowing (A. J. Miller, 2008). There are multiple motor branches of CN V. The 
first of these is the masticatory branch, which as the name suggests, innervates the muscles of 
mastication (temporalis, masseters and medial and lateral pterygoid muscles). The mylohyoid 
branch innervates the mylohyoid and the anterior belly of digastric muscles. The final motor 
branch of CN V is the mandibular branch; this innervates the tensor veli palatini muscles, 
which are involved in raising the soft palate to achieve velopharyngeal closure during 
swallowing.  
CN VII provides motor innervation to the posterior belly of digastric and the stylohyoid 
muscles, which are necessary for superior hyolaryngeal excursion. CN VII also innervates 
muscles of the face, including the buccinators and orbicularis oris, which are integral for 
bolus containment and preparation during the oral phase of swallowing. Parasympathetic 
innervation by CN VII to the sublingual and submandibular glands, contributes to saliva 
production during pre-oral and oral phases (Bhatnagar, 2013; Koch, Ferrazzi, Busatto, 
Ventura, & Palmer, 2017). Afferent fibres of CN VII convey sensory information regarding 
the anterior two-thirds of the tongue and the nasopharynx.  
Motor neurons of CN IX innervate the stylopharyngeus muscles, which contribute to 
elevation of the hyoid and larynx during swallowing (Mistry & Hamdy, 2008). The inferior 
salivatory nuclei provide parasympathetic information to the largest salivary gland, the 
parotid gland. Afferent fibres provide taste and general sensory information from the 
posterior one third of the tongue (Vilensky, Robertson, & Suarez-Quian, 2015). CN IX also 
provides the afferent input for the gag reflex, a protective reflex that occurs in response to 
tactile sensory stimulation of the pharyngeal wall, posterior tongue, tonsils or faucial pillars. 
The gag motor response involves contraction and shortening of the oropharynx and is 
innervated by the pharyngeal plexus (PP), discussed below (Campbell & DeJong, 2013; 
Mistry & Hamdy, 2008).  
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CN X is the longest cranial nerve and is made up of both afferent and efferent fibres 
(Campbell & DeJong, 2013). As well as swallowing, CN X also plays a role in speech, 
respiratory, cardiovascular and gastrointestinal function (Vilensky et al., 2015). Three of the 
ten branches of CN X are involved in the pharyngeal phase of swallowing. These are the 
pharyngeal nerve, superior laryngeal nerve (SLN) and recurrent laryngeal nerve (RLN). The 
pharyngeal nerve is the principle motor nerve; it innervates the pharyngeal constrictors and 
muscles of the soft palate, except the tensor veli palatini (innervated by CN V) (Fuller et al., 
2012). There are two branches of the SLN, the internal and external branches. The internal 
branch of the SLN carries sensory information from the tongue, epiglottis and the larynx 
above the vocal folds. The external branch of the SLN provides fibres to the PP and 
innervates the inferior pharyngeal constrictors and the cricothyroid muscles (Kierner, Aigner, 
& Burian, 1998; Sun & Chang, 1991). Stimulation of the SLN results in swallowing, and 
anesthetisation of the SLN increases risk of penetration and aspiration. The RLN is the 
primary efferent nerve for all laryngeal muscles, except the cricothyroid, and is therefore, 
important for airway protection during swallowing (Vilensky et al., 2015). The RLN also 
transmits sensory information from the larynx below the vocal folds and superior oesophagus 
(Fuller et al., 2012).  
The PP is made up of fibres from both CN IX and CN X; however, the contributions of each 
of these nerves are not fully understood (Gutierrez et al., 2020). The PP innervates the levator 
veli palatini muscles, which contribute to elevation the soft palate, to close off the 
nasopharynx during swallowing. The palatoglossus muscles are also innervated by PP; these 
muscles achieve posterior glossopalatal approximation during bolus preparation. The PP is 
integral in base of tongue retraction during swallowing as it innervates the glossopharyngeus 
muscles. The salpingopharyngeus, palatopharyngeus and the pharyngeal constrictor muscles 
are also innervated by PP (Gutierrez et al., 2020). Finally, afferent fibres of the PP convey 
sensory information from the oropharynx and hypopharynx, which is important for detecting 
pharyngeal residue. Innervation of the cricopharyngeus muscle is controversial in the 
literature. It has been proposed that the PP, RLN and the external branch of the SLN 
contribute to innervation of the cricopharyngeus (Gutierrez et al., 2020; Hammond, 
Davenport, Hutchison, & Otto, 1997; Sasaki, Sims, Kim, & Czibulka, 1999; Uludag, Aygun, 
& Isgor, 2017).  
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CN XII innervates all of the intrinsic and extrinsic muscles of the tongue, except the 
glossopharyngeus and palatoglossus muscles (innervated by PP) (Fuller et al., 2012). The 
intrinsic lingual muscles alter the tongue’s shape and the extrinsic lingual muscles change the 
position of the tongue within the oral cavity and allow for lingual protrusion and retraction 
(Daniels & Huckabee, 2014; Koch et al., 2017).  
There are discrepancies in the literature regarding the fibres that make up the ansa cervicalis 
(AC). These discrepancies likely arise due to the variability of the nerve’s course and 
significant differences between individuals in the arrangement of the contributing roots and 
patterns of branches (Chhetri & Berke, 1997). The AC has two roots: the superior root and 
the inferior root. The superior root is made up of fibres from CN XII, and the first and second 
cervical nerves (C1 & C2) (Banneheka, 2008). The inferior root is comprised of branches 
from the first four cervical nerves (C1-C4); however the branches and the course of the 
inferior root were found to be highly variable between individuals (Banneheka, 2008). The 
AC innervates the geniohyoid muscles, which contribute to hyolaryngeal excursion and the 
anterior strap muscles, which elevate the larynx and epiglottis (D. J. Curtis, Braham, Karr, 
Holborow, & Worman, 1988). 
2.3.3 Brainstem control of swallowing 
The motor nuclei of many of the CNs that are essential for swallowing are found within the 
brainstem. The pons houses the sensory nucleus of CN V and the motor nuclei of CN V and 
CN VII. The motor nucleus of CN XII, the nucleus tractus solitarius (NTS) and the nucleus 
ambiguous (NA) are located in the medulla. A central pattern generator (CPG) within the 
brainstem provides the basic motor plan for the sequential, rhythmic patterns of swallowing, 
evidenced by the capacity to induce a replicable swallowing motor pattern with electrical 
current in decerebrate animals (Jean, 2001; Oku, Tanaka, & Ezure, 1994).  
The regions that represent the swallowing CPG are the dorsal swallowing group and the 
ventral swallowing group. The dorsal swallowing group consists of the NTS and surrounding 
regions. The primary sensory nuclei of CN VII, CN IX and CN X are located in the NTS. 
Peripheral nerves associated with these nuclei carry sensory information directly to the NTS 
via afferent pathways. The NTS also receives information that is related to swallowing from 
the cortex and trigeminal sensory nucleus (located in the pons) (Ertekin, 2011). The neurons 
within the dorsal swallowing region are responsible for driving the initiation of pharyngeal 
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swallowing, sequencing of swallowing events and adaptation of swallowing in response to 
bolus characteristics. Once information is received by the dorsal swallowing group, it is 
integrated into a motor plan and sent to the ventral swallowing group via interneurons.  
The ventral region of the swallowing CPG includes the NA and its surrounding area. The 
primary motor nuclei of CN IX and CN X are located in the NA. The NA is organised 
myotopically, corresponding to the rostral-caudal pattern of motor neurons that make up the 
pharynx, larynx and oesophagus. The NA and surrounding reticular formations also have 
strong connections to the trigeminal and hypoglossal motor neurons, aiding timely and 
efficient swallowing (Amri, Car, & Roman, 1990; Holstege, Kuypers, & Dekker, 1977; Jean, 
Amri, & Calas, 1983). Efferent neurons within the motor branches of cranial nerves transmit 
signals from the NA to the peripheral muscles.  
2.3.4 Cortical control of swallowing 
Although swallowing can be initiated via stimulation to the brainstem in decerebrate animals, 
cortical input is necessary for modulation of the basic motor plan in response to sensory 
information and cognitive input. Lesion studies have demonstrated that a unilateral cortical 
lesion can result in dysphagia, highlighting the importance of this region in safe and efficient 
swallowing (Daniels & Foundas, 1999). Historically, the pharyngeal phase of swallowing 
was considered reflexive, as it is not possible to terminate the sequence of events once they 
have begun. However, unlike a true reflex, modification of swallowing can occur in response 
to sensory feedback and/or volitional control. The cortex is essential in the integration of 
sensory information from the bolus and the volitional adaptation of swallowing (Peck et al., 
2010). Volitional manipulation of pharyngeal swallowing can occur through increasing or 
decreasing effort (Doeltgen, Ong, Scholten, Cock, & Omari, 2017; Hind, Nicosia, Roecker, 
Carnes, & Robbins, 2001; Hiss & Huckabee, 2005; Huckabee, Butler, Barclay, & Jit, 2005; 
Molfenter, Hsu, Lu, & Lazarus, 2018) or prolonging aspects of a swallow such as laryngeal 
vestibule closure or UES opening (Azola, Sunday, & Humbert, 2017; Doeltgen et al., 2017; 
Inamoto et al., 2018; Kahrilas, Logemann, Krugler, & Flanagan, 1991; Macrae, Anderson, 
Taylor-Kamara, & Humbert, 2014).  
Onset of cortical activation occurs two seconds prior to swallowing onset and continues up to 
23 seconds after swallowing, indicating that the cortex is involved from the oral to the 
oesophageal phase (Huckabee, Deecke, Cannito, Gould, & Mayr, 2003; Kamarunas, 
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Mulheren, Palmore, & Ludlow, 2017). Cortical activation has been investigated through 
electroencephalography (EEG) (Huckabee et al., 2003), functional magnetic resonance 
imaging (fMRI) (Malandraki, Sutton, Perlman, Karampinos, & Conway, 2009; Martin, 
Goodyear, Gati, & Menon, 2001; Martin et al., 2004) and functional near-infrared 
spectroscopy (fNIRS) (Kamarunas et al., 2017). Cortical areas that are frequently reported to 
be activated during swallowing are the primary sensorimotor cortex, premotor cortex, 
anterior cingulate gyrus, supplementary motor areas, insula and frontal operculum 
(Malandraki et al., 2009; Michou & Hamdy, 2009).  
Sensory information from the bolus is integrated by structures in the cortex to adapt the 
motor response (Miller, 1999). This may include alterations to the strength or duration of the 
swallowing response due to specific bolus characteristics or volitional control. This allows 
safe ingestion of boluses that are different sizes, consistencies, and temperatures (Daniels & 
Huckabee, 2014). Neural control of voluntary swallowing is organised into parallel circuits 
(Mosier & Bereznaya, 2001). These circuits connect the sensorimotor, premotor and parietal 
areas with the cerebellum and insula. It is believed that this organisation facilitates planning 
and implementation of the complex swallowing motor events (Mosier & Bereznaya, 2001). 
During swallowing, neural activation initially occurs in the premotor cortex, supplementary 
motor area and bilateral thalamus, followed by the primary sensorimotor cortex, the posterior 
insula and cerebellum, and finally the pons in the brainstem (Mihai et al., 2014). Additional 
activation in the caudal anterior cingulate cortex has been observed in volitional swallowing 
(Martin et al., 2001).  
Bilateral cortical activation occurs during swallowing; however, the presence of hemispheric 
dominance is debated in the literature, with currently inconclusive results. There is literature 
that argues that the right hemisphere is dominant for the pharyngeal phase of swallowing, 
while the left hemisphere is dominant for the oral phase (Robbins & Levine, 1988; Robbins, 
Levine, Maser, Rosenbek, & Kempster, 1993; Teismann, Dziewas, Steinstraeter, & Pantev, 
2009). Whereas other research argues that although hemispheric dominance may be present 
at the individual level, there is no population wide dominant hemisphere for the pharyngeal 
phase of swallowing (Hamdy et al., 1997; Hamdy et al., 1996; Hamdy et al., 1999; 
Kamarunas et al., 2017; Mosier, Liu, Maldjian, Shah, & Modi, 1999; Vasant et al., 2014).  
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3. Motor Neurone Disease 
Motor neurone diseases are a group of diseases that are predominantly caused by the 
degeneration of motor neurons, resulting in progressive weakness. Amyotrophic Lateral 
Sclerosis (ALS) is the most common form of Motor Neurone Disease (MND), characterised 
by degeneration of both UMN and LMN in the primary motor cortex, brainstem and spinal 
cord (Brown & Al-Chalabi, 2017; Rowland & Shneider, 2001). Primary lateral sclerosis is a 
less common variant of MND, in which degeneration occurs only in the UMN, resulting in 
spasticity, emotional lability, weakness and pathological reflexes (Pringle et al., 1992). There 
are also three LMN variants: progressive bulbar palsy, in which degeneration occurs to only 
the bulbar LMN, progressive muscular atrophy, in which only spinal LMN are affected, and 
spinal bulbar muscular atrophy (Kennedy’s disease), which is a genetic disease that affects 
the bulbar and spinal LMN (Kennedy, Alter, & Sung, 1998). As ALS is the most common 
form of MND, the terms ALS and MND are often used interchangeably. For the purpose of 
this thesis, the term MND will be used to describe all types of motor neurone diseases, 
including ALS. 
The global incidence of MND is reported to be between 1.68 and 2.08 per 100,000 per year 
(A Chio et al., 2013; Marin et al., 2017). MND is most common in men and those aged 
between 60 and 69 (Mehta, 2015; Valadi, 2015). The prevalence of MND is approximately 
5.40 per 100,000 people (A Chio et al., 2013). Murphy, Quinn, Young, Parkin, and Taylor 
(2008) reported that in New Zealand (NZ), the incidence of MND is increasing, changing 
from 1.6 to 3.3 people per 100,000 between 1985 and 2006. However, this study did not 
account for the aging population. When the aging population was considered, mortality rate 
of MND in NZ did not appear to increase over time, instead remaining stable at 
approximately 2.8 per 100,000 (Cao, Chancellor, Charleston, Dragunow, & Scotter, 2018). 
Although the incidence in NZ is greater than the global incidence, the age adjusted incidence 
in the indigenous Māori population in NZ is only 1.21 per 100,000 (Cao et al., 2018). These 
differences could be a result of differences in genetic susceptibility, environmental factors or 
reduced interaction with health care in the Māori population. 
The cause of MND is unknown; however, it is believed to be a result of interplay between 
genetic susceptibility and environmental factors (Oskarsson, Horton, & Mitsumoto, 2015).  
Five to ten percent of cases of MND have been linked to genetics, often dominantly inherited 
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autosomal mutations (Brown & Al-Chalabi, 2017; Saberi, Stauffer, Schulte, & Ravits, 2015; 
Scotter, 2015). The number of known genetic mutations leading to MND has been increasing 
since the 1993 discovery of the SOD1 gene, which accounts for 20% of familial MND cases 
(Rosen et al., 1993; Saberi et al., 2015). There are now more than 25 identified genes that are 
associated with familial and/or sporadic MND (Brown & Al-Chalabi, 2017). Other common 
genetic mutations that lead to susceptibility for MND include mutations to the TDP-43 gene, 
responsible for the TAR-DNA binding protein, and the FUS gene, responsible for the FUS-
RNA binding protein (Kiernan et al., 2011). Although largely speculative, it is believed that 
MND develops when an individual who is genetically predisposed to the condition is exposed 
to certain environmental factors (Al-Chalabi & Hardiman, 2013). Possible contributing 
environmental factors include head trauma (Armon & Nelson, 2012), heavy metal exposure 
(Portaro, Naro, Giorgianni, Mazzon, & Calabrò, 2019), and tobacco smoking (De Jong et al., 
2012). Military service has also been observed to be correlated with high rates of MND; 
however, causal factors associated with service have not been identified (Beard & Kamel, 
2015; Tai et al., 2017; Weisskopf et al., 2005).  
The defining neuropathology of MND is the degeneration of motor neurons. Motor neuron 
degeneration often occurs in the motor cortex, nuclei in the lower brainstem and the anterior 
horns of the spinal cord (Hohenfeld, Werner, & Reetz, 2018; J. P. Taylor, Brown, & 
Cleveland, 2016; Williams & Windebank, 1991). The neurons that innervate the extraocular 
muscles and the bladder are usually spared until late in disease progression (Brown & Al-
Chalabi, 2017). The exact pathogenesis of MND is unknown, but there are several cellular 
mechanisms and processes that are believed to be involved. These include protein 
aggregation and mis-folding, inflammation, glutamate excitotoxicity, generation of free 
radicals, oxidative stress and mitochondrial dysfunction (J. P. Taylor et al., 2016). 
There is a large amount of variation in symptom presentation and progression between 
individuals with MND (Renton, Chiò, & Traynor, 2014; Swinnen & Robberecht, 2014). In 
75% of patients, the initial symptoms involve the upper or lower limbs. Approximately 25% 
of patients present with bulbar symptoms and only a small number present with respiratory 
symptoms as the initial symptom (Wijesekera & Leigh, 2009; Zoccolella et al., 2006). 
However, in most cases, symptoms spread to include spinal, bulbar and respiratory muscles 
by the end stages of the disease. Demographic factors can help to predict disease onset type. 
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For example, females and older patients (diagnosed after 75) are more likely to present with 
bulbar onset MND than males and younger patients (Zoccolella et al., 2006).  
Due to the large amount of symptom variation between patients, and the lack of a biological 
diagnostic marker for MND, providing a definitive diagnosis is challenging, and rates of 
misdiagnosis are high (Brooks, Miller, Swash, & Munsat, 2000; Househam & Swash, 2000). 
Time from symptom onset to diagnosis of MND is, on average, 11 months, with an increase 
in delay for those who are initially misdiagnosed (Cellura, Spataro, Taiello, & La Bella, 
2012). Research investigating possible biomarkers for MND is ongoing. Possible methods of 
facilitating earlier diagnosis include the use of ultrasound to detect fasciculations (Misawa et 
al., 2011) or electrical impedance myography to detect changes in muscle composition (Alix 
et al., 2020). Increasing the speed of diagnosis and diagnostic accuracy is crucial for patients 
with MND, as earlier intervention may increase life expectancy through earlier 
implementation of treatments.  
As a result of rapid motor decline following initial symptoms, half of the patients diagnosed 
with MND do not survive the first 30 months from the time of symptom onset (Kiernan et al., 
2011). However, there is a large amount of between patient variability in disease progression, 
and approximately 12% of patients survive longer than 10 years from the time of diagnosis 
(Pupillo, Messina, Logroscino, Beghi, & Group, 2014). Older age at symptom onset and 
bulbar onset of symptoms have been demonstrated to be independent factors that result in a 
poorer prognosis (A. Chio et al., 2009; A. Chiò et al., 2002; Millul et al., 2005).  
3.1 Cognition in MND 
Traditionally, there was the belief that, for patients with MND, neural degeneration was 
restricted to the motor neurons, and therefore, cognition was spared. However, approximately 
40 - 51% of patients with MND have some degree of cognitive impairment, and 10 – 15% 
meet the criteria for frontotemporal dementia (Gordon et al., 2011; Ringholz et al., 2005). In 
patients with MND, cognitive impairment is associated with changes to the temporal and 
frontal lobes (Abrahams et al., 2004). Therefore, impairments include deficits in executive 
function and working memory, which extend to altered language and social cognition 
(Goldstein & Abrahams, 2013). Interestingly, of those with frontotemporal dementia and 
MND, there is an overrepresentation of patients with corticobulbar onset MND compared to 
the corticospinal type (Lomen-Hoerth et al., 2003).  
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Survival time in patients with MND who have associated frontal impairment has been shown 
to be shorter than for patients with normal cognitive functioning (R. G. Miller et al., 2009; 
Olney et al., 2005). Reduced acceptance of medical interventions such as percutaneous 
endoscopic gastroscopy (PEG) feeding and non-invasive ventilation (NIV) has been 
demonstrated in this population this subgroup of patients (Achi & Rudnicki, 2012), which 
may contribute to length of survival. 
3.2 Dysphagia in MND  
Over the course of MND, dysphagia presents in 86% to 98% of patients with the 
corticobulbar subtype, and in approximately 73% of patients with the corticospinal subtype 
(A. Chen & Garrett, 2005; Kühnlein et al., 2008; Onesti et al., 2017). Dysphagia in MND is 
progressive, and, as with the disease itself, the rate of progression is highly variable between 
patients (Higo, Tayama, & Nito, 2004). Dysphagia is often underreported by patients with 
MND, likely due to gradual adaptation to progressive decline (Onesti et al., 2017). With high 
levels of individual variability, risk of underreporting and the progressive nature of 
dysphagia, frequent assessment is necessary (Garand, Schwertner, Chen, & Pearson, 2018).  
Any and all phases of swallowing can be affected by MND (Kühnlein et al., 2008), resulting 
in negative impacts on both quality and duration of life (Paris et al., 2013).  Spastic and 
flaccid characteristics can be present in bulbar muscles, as demonstrated by the common 
presentation of mixed spastic-flaccid dysarthria (Darley, Aronson, & Brown, 1969). 
Therefore, although it has not been directly investigated, it is feasible to speculate that 
characteristics of both flaccidity and spasticity may contribute to aspects of dysphagia.  
3.2.1 Oral phase dysphagia  
The oral phase is often the first phase of swallowing to be affected by MND (Briani et al., 
1998; Higo, Tayama, Watanabe, & Nitou, 2002; Hillel & Miller, 1989; Kawai et al., 2003; 
Ruoppolo et al., 2013). Oral phase dysphagia is predominantly due to degeneration of motor 
neurons associated with CN XII. This can result in atrophy, weakness and fasciculation of the 
tongue (Britton, Cleary, & Miller, 2013; Kawai et al., 2003). Changes in the strength and 
range of motion of lingual muscles often lead to oral residue and decreased masticatory 
efficiency, increasing the time and effort necessary to consume a meal (D’Ottaviano, 
Linhares Filho, de Andrade, Alves, & Rocha, 2013; Fattori et al., 2006; Jani & Gore, 2016; 
Ruoppolo et al., 2013). Tongue speed and range of motion have also been correlated with 
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swallowing safety when drinking thin liquids and tongue strength associated with swallowing 
safety when consuming puree (B. J. Perry, Stipancic, Martino, Plowman, & Green, 2020). 
Tongue thickness measured by ultrasound is correlated with oral transit time and body mass 
index (BMI) in patients with MND, but not in healthy controls, demonstrating that oral phase 
dysphagia is associated with poor nutritional outcomes (Nakamori et al., 2015). However, it 
is important to consider that atrophy of muscles over disease progression will contribute to a 
decrease in BMI so it cannot be assumed that the correlation between tongue thickness and 
BMI is causative.  
Muscles of mastication are also impacted by MND, resulting in reduced bite strength. 
Interestingly, despite the reduction in bite strength, self-injury due to biting oneself during 
mastication is increased in patients with bulbar onset MND compared to controls. This may 
indicate disruption to the sensory feedback loop having a greater impact than reduced 
strength (Riera-Punet, Martinez-Gomis, Paipa, Povedano, & Peraire, 2018; Riera‐Punet, 
Martinez‐Gomis, Willaert, Povedano, & Peraire, 2018). Anterior loss of a bolus or saliva is 
common due to poor labial seal and decreased frequency and efficiency swallowing saliva at 
rest (Dand & Sakel, 2010). In addition to drooling, patients with MND report that the excess 
saliva can hinder speech, that it has negative social implications and that it can cause 
coughing, likely due to aspiration (McGeachan, Hobson, Shaw, & McDermott, 2015).  
An additional aspect of oral phase dysphagia is reduced glossopalatal approximation (Higo et 
al., 2004; Higo et al., 2002; Leder, Novella, & Patwa, 2004; Walshe, 2014). This 
biomechanical impairment has been demonstrated to result in premature spillage of a bolus 
into the pharynx, which can contribute to airway invasion. The depth of pre-swallow 
pharyngeal pooling has been demonstrated to increase with disease progression (Leder et al., 
2004). 
3.2.2 Pharyngeal phase dysphagia 
Due to the complexity of pharyngeal swallowing, there are many aspects that may be affected 
by MND. Inefficient swallowing, demonstrated by post-swallow residue, is often one of the 
earliest changes to pharyngeal stage (D’Ottaviano et al., 2013; Fattori et al., 2006; Higo et al., 
2004; Teismann et al., 2011; Waito et al., 2020; Waito, Tabor‐Gray, Steele, & Plowman, 
2018; Walshe, 2014; Wright & Jordan, 1997). Swallowing inefficiency can contribute to 
fatigue, prolonged meals and reduced quality of life (Paris et al., 2013; Tabor, Gaziano, 
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Watts, Robison, & Plowman, 2016). The presence of pharyngeal residue is likely a result of 
reduction in pharyngeal pressure generation due to reduced base of tongue to posterior 
pharyngeal wall contact and reduced pharyngeal constriction (Goeleven, Robberecht, Sonies, 
Carbonez, & Dejaeger, 2006; Waito et al., 2018). The levator veli palatini muscles that 
elevate the soft palate and separate the oropharynx from the nasopharynx during swallowing 
may become weak as a result of the disease (J. Tomik et al., 2017). This is demonstrated by 
hypernasal speech, a common presentation in individuals with MND (B. Tomik & Guiloff, 
2010). Decreased palatal elevation may be a contributing factor to reductions in pharyngeal 
pressure. The decline in pharyngeal pressure generation during swallowing is progressive 
over time, often beginning in the oropharynx and expanding to include hypo-pharyngeal 
weakness approximately one year post-onset of bulbar symptoms (Higo et al., 2004; J. Tomik 
et al., 2017). Post-swallow residue increases the risk for post-swallow airway invasion 
(Goeleven et al., 2006). To compensate for inefficiency and reduce the amount of residue, 
patients often spontaneously reduce the size of the bolus that they ingest, taking multiple 
swallows to complete one mouthful (Tamburrini et al., 2010; Waito et al., 2018).  
MND can result in reduced speed and distance of anterior hyolaryngeal excursion, likely 
indicating dysfunction of the submental muscles (Waito, 2019). Further, during swallowing, 
duration of submental muscle activity is increased compared to healthy controls; however, 
this does not result in prolonged hyolaryngeal excursion (Ertekin et al., 2000). Impaired 
submental muscle activity can lead to inadequate and delayed epiglottic deflection, which can 
contribute to airway invasion (Waito, 2019; Waito et al., 2020). Patients with MND do not 
demonstrate differences in hyoid excursion between different liquid consistencies, indicating 
reduced ability to spontaneously adapt swallowing in response to bolus properties (Waito, 
2019). This may indicate that patients are compensating for dysfunction by constantly 
swallowing with their maximal power output, resulting in an inability for greater muscle 
recruitment and structural displacement in response to thicker boluses.  
UES opening is preserved in approximately two thirds of patients and has been shown to be 
well maintained until the late stages of the disease (Higo et al., 2004). However, in one third 
of patients, opening of the UES is delayed in relation to onset of submental muscle activity, 
the duration of opening is reduced and cricopharyngeal motor bursts occur within the period 
of UES opening (Ertekin et al., 2000). Reduced opening of the UES suggests hypertonicity of 
the cricopharyngeus muscle due to UMN damage or weakness of the submental muscles 
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resulting in inadequate laryngeal excursion (Fattori et al., 2006; J. Tomik et al., 2017). A 
reduction in the time and extent of UES opening can lead to pyriform sinus residue and 
airway invasion during or after swallowing. 
3.2.3 Oesophageal phase dysphagia 
Oesophageal phase dysphagia has not been as thoroughly investigated as oropharyngeal 
dysphagia, likely because the level of impairment is not as significant (Briani et al., 1998). 
However, it has been reported that patients with MND experience changes to oesophageal 
peristalsis (Briani et al., 1998; J. Tomik, Sowula, Ceranowicz, Dworak, & Stolcman, 2020) 
and impaired function of the lower oesophageal sphincter in a small percentage of patients 
(Briani et al., 1998).  
3.2.4 Respiratory contribution to dysphagia 
In a small group of patients, respiratory weakness is the initial symptom of MND, and by the 
late stages of the disease, almost all patients will suffer from respiratory insufficiency 
(Heffernan et al., 2009). All muscles of respiration can be impacted, including the intercostal 
muscles, the diaphragm and the accessory muscles. Symptoms of respiratory weakness may 
include fatigue secondary to awakening during the night, hypercapnia, weak voice, weak 
cough and dysphagia (Hardiman, 2011; Morelot‐Panzini, Bruneteau, & Gonzalez‐Bermejo, 
2019). Percentage of baseline forced vital capacity (FVC) is the most common method of 
monitoring decline in pulmonary function (Melo et al., 1999). It has been shown to be a 
significant predictor of disease progression and survival time (Czaplinski, Yen, & Appel, 
2006).  
Respiratory weakness can contribute to dysphagia as it affects respiratory swallow 
coordination and supraglottic pressure during swallowing (Gross et al., 2003; Gross, Atwood 
Jr, Ross, Olszewski, & Eichhorn, 2009; Gross et al., 2006). Individuals with MND have an 
increased duration of swallowing apnoea when compared to healthy controls  (Nozaki et al., 
2008). This means that patients are more likely to inspire after swallowing, which could lead 
to aspiration (Hadjikoutis & Wiles, 2001; Nozaki et al., 2008). Weak respiratory muscles 
may also decrease an individual’s ability to produce an effective cough response, resulting in 
an inability to clear aspirated material. Plowman, Watts, Robison, et al. (2016) demonstrated 
that patients whose swallowing was unsafe (PAS ≥ 3), had a lower cough volume 
acceleration, lower peak expiratory flow rate and greater time to reach peak flow during 
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voluntary cough than patients in the safe swallowing group. This relationship may be due to a 
concomitant reduction in strength of both of these subsystems or could be more directly 
related, with a reduction in respiratory muscle strength leading to poor respiratory swallow 
coordination and reduced ability to clear aspirate through coughing.  
The motor pattern associated with coughing is altered in patients with MND compared to 
healthy individuals (Tabor‐Gray, Gallestagui, Vasilopoulos, & Plowman, 2019). Velocity of 
vocal fold adduction during the expulsive phase of coughing is reduced, which may 
contribute to reduced cough effectiveness (Britton et al., 2014). During voluntary and 
reflexive coughing, patients demonstrate a longer inspiratory phase duration and a longer 
time to produce peak expiratory velocity, which results in reduced peak cough flow, 
indicating impairment in muscles of inspiration and expiration (Tabor‐Gray et al., 2019; 
Tabor‐Gray, Vasilopoulos, Wheeler-Hegland, Wymer, & Plowman, 2020). This slower and 
weaker cough response is likely to be less effective at clearing aspirated material and 
pulmonary secretions, and a reduced spike in peak flow during cough has been demonstrated 
to be associated with increased mortality (Chaudri, Liu, Hubbard, Jefferson, & Kinnear, 
2002). Importantly, when assessing cough strength in patients with MND, cough volume 
acceleration and peak expiratory flow rate have been shown to be greater during voluntary 
coughing than reflexive coughing. (Tabor‐Gray, Vasilopoulos, & Plowman, 2020). If used as 
a clinical assessment voluntary coughing may overestimate a patient’s true reflexive function. 
This is likely due to the fact that a greater lung volume results in a greater peak cough flow. 
Voluntary coughs are able to be produced at a full lung volume, however an individual has 
less control over this during reflexive coughing as it occurs at the point of sensory input (J. A. 
Smith et al., 2012). Sensory changes associated with reflexive coughing are discussed below.  
3.2.5 Sensory changes to swallowing in MND 
Historically, it was believed that MND solely affected motor neurons; however, there is 
emerging evidence that sensation can also be impacted over the course of the disease. Up to 
20% of patients report sensory symptoms, including numbness, decreased sensation to 
temperature, tingling and neuropathic pain (Tao, Wei, & Wu, 2018). Nerve conduction 
studies and biopsies have demonstrated that disruption to the sensory mechanism in spinal 
nerves is common in patients with MND (Hammad, Silva, Glass, Sladky, & Benatar, 2007; 
Isak et al., 2016; Nolano et al., 2017; Pugdahl et al., 2007; Weis et al., 2011). Evidence of 
sensory impairment to bulbar regions includes altered reflexes, reduced taste, reduced smell 
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and the presence of odynophagia (Hawkes, Shephard, Geddes, Body, & Martin, 1998; Jesus 
et al., 2012; Karen Fontes Luchesi, Kitamura, & Mourão, 2014; Pelletier, Abou-Zeid, 
Bartoshuk, & Rudnicki, 2013).  
The laryngeal adduction reflex (LAR) is a rapid closure of the vocal folds in response to 
sensory stimulation of the larynx. The absence of a reflexive response is a predictor of 
penetration and aspiration during swallowing (Aviv et al., 2002; Domer, Kuhn, & Belafsky, 
2013). To investigate changes in pharyngeal sensitivity, Amin, Harris, Cassel, Grimes, and 
Heiman-Patterson (2006) recruited 27 patients, 22 of which tolerated the assessment. Patients 
underwent flexible endoscopic evaluation of swallowing with sensory testing (FEESST). 
Sensory threshold was tested by applying varying intensities of air pulses to the arytenoids 
and assessing a patient’s response. Approximately half of the patients with MND who 
tolerated the assessment demonstrated a sensory threshold below what is considered normal. 
This was the first study to identify laryngeal sensory changes in patients with MND.  
Another swallowing related reflex that can be impaired due to changes in sensation is the 
cough response to aspiration. A high incidence of silent aspiration on VFSS has been 
reported (Goeleven et al., 2006; Lo Re et al., 2007), indicating that a reduction in laryngeal 
sensation is common in individuals with this disease. Cough response was reported to be 
impaired in 10 of 49 patients, as measured by FEES; however, the precise method for 
detecting impairment was not specified (Ruoppolo et al., 2013). Further research 
investigating reflexive cough in response to nebulised capsaicin has demonstrated an increase 
in cough sensitivity in patients with no evidence of aspiration when compared to healthy 
controls and a decrease in sensitivity in those who demonstrated silent aspiration on VFSS 
(Tabor‐Gray, Vasilopoulos, Wheeler-Hegland, et al., 2020). The observed increase in cough 
sensitivity may be due to UMN degeneration resulting in hyperreflexia. Alternatively, as the 
scale used was a perceptive scale of a participants urge to cough, those in the patient group 
may have rated higher due to heightened awareness and fear associated with the need to 
cough. Conversely, those with silent aspiration demonstrated a blunted sensorimotor 
response. This indicates a progressive change in upper airway sensitivity, potentially due to 
degradation of afferent cough receptors or desensitisation as a result of chronic aspiration.  
25 
 
3.2.6 Effects of dysphagia in MND 
Dysphagia can lead to negative health outcomes such as malnutrition and aspiration 
pneumonia, which can result in death. Aspiration pneumonia can contribute to respiratory 
failure, which has been reported as the cause of death in between 65.5% (Yang et al., 2011) 
and 97% (Burkhardt, Neuwirth, Sommacal, Andersen, & Weber, 2017) of patients with 
MND. The large variation in cause of death between these studies may be due to the date of 
publication and differences in health care between the locations. In the Chinese cohort, only 
1.4% of patients received nutrition through a PEG tube found that 26% of patients died from 
nutritional causes (Yang et al., 2011). In the Swiss population evaluated by Burkhardt et al. 
(2017), 65% of patients received nutrition through a PEG tube and no patients were reported 
to die due to nutritional causes. Post-mortem evaluations identified that aspiration pneumonia 
was the direct cause of death in 11% to 31% of patients (Burkhardt et al., 2017; Corcia et al., 
2008; Kurian, Forbes, Colville, & Swingler, 2009). One possible explanation for the large 
variation in mortality as a result of aspiration pneumonia may be the authors’ definition of 
aspiration pneumonia as a cause of death. Burkhardt et al. (2017), who reported the greatest 
incidence of aspiration pneumonia as cause of death, defined aspiration pneumonia as “…the 
presence of putrid pneumonia intermixed with aspiration material, squamous epithelium 
(from the oesophagus and oropharynx) and bacteria, as well as characteristic brownish 
coagulation necrosis and haemorrhages of lung tissue as a reaction of gastric acid.” (p. 3). 
The higher rate of aspiration pneumonia identified by this study may be due to more 
extensive testing for the presence of aspiration compared to other research, which did not 
define aspiration pneumonia and may, therefore, have attributed death to the more general 
bronchopneumonia.  
Patients with MND are highly susceptible to malnutrition as they may have an increased 
resting metabolic rate, dysphagia, difficulty self-feeding, food avoidance behaviours and 
reduced appetite (Bouteloup et al., 2009; Dupuis, Pradat, Ludolph, & Loeffler, 2011; 
Kühnlein et al., 2008; Limousin et al., 2010; Muscaritoli et al., 2012; Ngo, Steyn, & 
McCombe, 2014). Approximately 60% of patients demonstrate a 10% increase in resting 
energy expenditure. The reason for this is unknown but it is theorised that hypermetabolism 
may be either a consequence of increased energy demand of the atrophying muscles or 
increased energy expended when fighting infection (Claude Desport, 2000). Malnutrition is a 
significant risk factor that has been reported to result in up to 26% of deaths (A Chio et al., 
26 
 
2013; Yang et al., 2011), and increases the risk of mortality by 7.7 times when compared to 
an individual who is not malnourished (Desport et al., 1999). 
Not only does dysphagia increase the risk of pneumonia and malnutrition, it also has a 
negative effect on the quality of life of patients with both spinal and bulbar onset MND (da 
Costa Franceschini & Mourao, 2015; Korner et al., 2013; Paris et al., 2013; Tabor et al., 
2016). Swallowing and respiratory symptoms were the only symptoms measured by the 
Amyotrophic Lateral Sclerosis Functional Rating Scale Revised (ALSFRS-R) that 
significantly correlated with self-rated depression (Hillemacher et al., 2004). Further research  
also documents correlations between the presence of dysphagia and reduced quality of life as 
measured by the Swal-QOL (Paris et al., 2013; Tabor et al., 2016). When compared to 
patients who did not have dysphagia, dysphagic patients had significantly higher impairment 
scores on the subscales of burden, food selection, eating duration, eating desire, fear, 
communication, mental health and social aspects of eating (Paris et al., 2013). This 
demonstrates the wide-reaching effects that dysphagia has on quality of life. Patients with 
spinal onset MND demonstrate the most impairment in the domains of eating duration and 
social function of the Swal-QOL, with 70% of patients in this group avoiding eating socially 
(da Costa Franceschini & Mourao, 2015). This likely reflects the difficulty using the upper 
limbs to move food to the mouth in patients with spinal symptoms.  
4. Routine management 
There is no cure for MND; therefore, symptom management is the focus of medical 
professionals. The symptoms associated with MND are heterogeneous and management 
requires a variety of behavioural, surgical and medicinal approaches.  
4.1 Medicinal management of MND 
Medical intervention may slow the progression of MND or reduce symptoms for a period of 
time. Riluzole is the only publicly funded drug available in NZ. It is used to slow the 
progression of symptoms and prolong life, albeit by only approximately two to four months 
(R. G. Miller, Mitchell, & Moore, 2012; Traynor, Alexander, Corr, Frost, & Hardiman, 
2003). A Cochrane review of the literature identified three studies that investigated the effect 
of Riluzole on bulbar function (R. G. Miller et al., 2012). None of these studies demonstrated 
significant improvement in bulbar function; however, pooled data from the three studies 
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showed a decreased rate of decline in bulbar symptoms for patients who took the active drug 
compared to the placebo. All of these studies used the Norris scale as the primary outcome 
measure of bulbar symptoms. The Norris scale is a subjective scale that assesses a patient’s 
ability to perform 13 tasks associated with bulbar muscles, and grades each on a three-point 
scale. There is no evidence of correlation of this scale to swallowing safety or efficiency. To 
date there has been no instrumental assessment investigating swallowing outcomes in 
response to Riluzole and the evidence for improvement in swallowing as a result of Riluzole 
is, therefore, limited.   
Edaravone is an intravenous drug that has been approved in the United States of America 
(USA). The exact mechanism for success of Edaravone is unknown, but it is believed that the 
effects are due to the drug’s ability to clear free radicals from the system. This may alter the 
course of MND by preventing oxidative stress (Abe et al., 2017; Cruz, 2018). The efficacy of 
Edaravone is inconclusive in the literature. In a study of 206 patients with MND, Abe et al. 
(2014) found no significant differences in outcomes for patients taking Edaravone compared 
to a placebo over a 24-week treatment period. A subsequent phase III trial indicated a 
significantly reduced rate of decline in patients who received Edaravone compared to controls 
(Takei et al., 2017). Participant recruitment in this study was more specific to avoid the 
previously observed flooring effects. However, the primary outcome measure used in these 
studies was the ALSFRS-R, which is often patient reported, and therefore allows for placebo 
influence. More research, with appropriate outcome functional and physiological measures, is 
necessary to determine the effectiveness of this drug and appropriate patient selection. 
Neudexta, another prescribed drug, reduced the rate of deterioration compared to a placebo 
control group, as measured by the ALSFRS-R (R. Smith et al., 2017). Additionally, 30 days 
of Neudexta significantly decreased pause frequency and duration during speech, a measure 
that differentiates individuals with MND from healthy controls (J. R. Green et al., 2018; J. R. 
Green, Beukelman, & Ball, 2004). The impacts of Neudexta on other functional measures of 
speech and swallowing have been assessed but changes were not significant (J. R. Green et 
al., 2018; R. Smith et al., 2017). Neudexta is an antitussive agent (C. P. Taylor, Traynelis, 
Siffert, Pope, & Matsumoto, 2016); it is therefore possible that the patient reported 
improvements in the ALSFRS-R were a result of reduced sensitivity to airway invasion. 
Further research, including instrumental assessment of swallowing, is necessary to investigate 
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the effects of Neudexta on swallowing symptoms, particularly in terms to sensitivity to 
airway invasion. 
Drug treatments are also used for symptom management. An example of this is the use of 
hyoscine patches and botulinum toxin to the salivary glands for management of sialorrhoea. 
Although these treatments may be effective for a period of time, as the disease progresses, 
they are often no longer adequate to facilitate elimination of the increasing symptom demand 
(Jenkins, Hollinger, & McDermott, 2014).  
Because of the lack of effective prescribed medications, patients commonly explore 
alternative medications. These can be both unsafe and expensive but entice patients with the 
hopes of finding a cure, improving their condition or slowing the rate of symptom 
progression (Wasner, Klier, & Borasio, 2001). The ALSUntangled group is working towards 
providing clarity regarding the effects of alternative medication. This group summarises the 
risk and level of evidence for taking a given alternative treatment and publishes this in an 
open access journal and on their website (ALSUntangled, 2018). The website currently does 
not recommend any alternative medications for the treatment of MND.  
4.2  Non-Invasive Ventilation 
Non-invasive ventilation (NIV) is used to improve survival and quality of life in patients with 
respiratory insufficiency. NIV has been shown to improve symptoms associated with 
hypercapnia, including improved oxygen saturation and better sleep (Bourke et al., 2006; 
Vrijsen et al., 2015). Importantly, this has been demonstrated to improve quality of life as 
NIV results in a reduction of daytime fatigue and depression (Bourke et al., 2006). There is 
only one randomised controlled trial investigating the effects of NIV (Bourke et al., 2006). In 
this study, the use of NIV increased survival by seven months in patients without severe 
bulbar dysfunction; however, no significant improvements were found for patients with 
severe bulbar symptoms (Bourke et al., 2006). Following this trial, it was deemed to be 
unethical to withhold NIV to conduct further randomised control trials. More recent 
retrospective studies have demonstrated that the use of NIV increases survival by 11 to 15.5 
months (Berlowitz et al., 2016; Hirose et al., 2018; Sancho et al., 2018). However, as these 
studies were not randomised controlled trials, these patients may have been more willing to 
undergo additional life sustaining procedures (e.g. PEG, drug treatments) than those who 
were in the no NIV cohort.  
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The literature regarding the use of NIV in patients with bulbar symptoms due to MND is less 
definitive. For patients with bulbar symptoms, labial weakness reduces the effectiveness of a 
nasal mask as air can escape through the mouth. Bourke et al. (2006) did not demonstrate a 
difference in survival in patients with severe bulbar dysfunction with and without NIV. 
However, the primary aim of this study was not to investigate patients with bulbar 
impairment and the sample size of patients with severe bulbar impairment was limited to 21 
patients. Additionally, this research was performed in 2006, and technology and assessment 
procedures have since progressed. More recent research has demonstrated increased survival 
time as a result of NIV in patients with bulbar symptoms to be between 10 and 19 months. 
(Berlowitz et al., 2016; Dorst & Ludolph, 2019; Sancho et al., 2018). These studies were 
retrospective, not randomised controlled trials and as discussed previously, this may have led 
to bias. However, the significant effect of NIV on survival remained following adjustment for 
age, gender, Riluzole and PEG use (Berlowitz et al., 2016). This indicates that NIV likely 
increases survival in patients with bulbar symptoms and the potential increase in quality of 
life and life expectancy outweigh those of any drug assessed to date. 
4.3 Palliative care 
Due to the poor prognosis associated with MND, it is suggested that palliative care teams are 
involved from the time of diagnosis (Bede et al., 2011). The World Health Organisation 
defines palliative care as “…an approach that improves the quality of life of patients and their 
families facing the problem associated with life-threatening illness, through the prevention 
and relief of suffering by means of early identification and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial and spiritual” (World Health 
Organization, 2018, para. 1). Palliative care does not aim to increase length of life but can 
help to manage symptoms such as pain, increase quality of life and reduce caregiver burden 
(Blackhall, 2012; Hogden, Aoun, & Silbert, 2018; Oliver et al., 2016).  
5. Dysphagia assessment 
Due to the range of symptoms experienced by patients with MND, multidisciplinary 
management is crucial (R. G. Miller et al., 2009). Attendance at a specialist clinic with 
multidisciplinary input results in fewer hospital admissions and an increased length of 
survival for these patients, due to more frequent monitoring of symptom progression and a 
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higher rate of intervention implementation (A Chio, Bottacchi, Buffa, Mutani, & Mora, 
2006).  
5.1 Screening for cognitive impairment in MND 
It is important to understand a patient’s cognitive function, as it may influence their ability to 
follow instructions and participate in treatment. There are many screening tools for cognitive 
impairment available; however, there is no consensus regarding which is the most appropriate 
for individuals with MND (R. G. Miller et al., 2009). The Mini-Mental State Examination 
(MMSE) is a commonly utilised screening tool for cognitive changes. However, the 
sensitivity of the MMSE is not sufficient to detect mild cognitive impairment (MCI) in MND 
as it does not assess executive dysfunction (R. G. Miller et al., 2009; Strong et al., 2009). The 
Montreal Cognitive Assessment (MoCA) is a screening tool that is more sensitive to 
detecting MCI (Folstein, Folstein, & McHugh, 1975; Nasreddine et al., 2005; Trzepacz et al., 
2015). The MoCA screens for short-term memory recall, delayed recall, working memory, 
attention, concentration, visuospatial abilities, executive function, language and orientation to 
time and place, many of which can be affected by MND. The MoCA is a valid test with high 
test-retest reliability and internal consistency (Nasreddine et al., 2005). Assessment of 
cognition can be difficult in patients with MND due to concomitant motor speech and limb 
dysfunction. This means that timed assessments and tasks involving speech or writing may 
need to be avoided or altered to accommodate the needs of an individual. 
5.2 Clinical assessment of swallowing 
Although limited in its scope, a clinical swallowing assessment (CSA) can provide important 
information about functional swallowing. CSAs often include gathering information about a 
patient’s history with or without the use of validated survey tools, assessment of cranial 
nerves and observation of oral intake. Some aspects of a CSA are outlined below. Advantages 
of the CSA are that it can be performed anywhere, it is inexpensive and it is easily repeatable. 
CSAs are often used to determine if further instrumental evaluations are necessary (Garand, 
McCullough, Crary, Arvedson, & Dodrill, 2020). In a survey of MND clinics in the USA, 
55% reported completing a CSA as part of the routine assessment of patients with MND 
(Plowman, Tabor, Wymer, & Pattee, 2017).  
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5.2.1 Swallowing history 
A thorough history of the presence and presentation of dysphagia is an integral part of the 
CSA. History of dysphagia is often gathered through a verbal interview. Targeted questions 
such as asking what a patient eats and drinks most days and if there are any foods that they 
avoid may give more insight into the presence of dysphagia than general questions, such as if 
a patient has difficulty swallowing (Garand et al., 2020). Validated questionnaires are a 
beneficial addition to a verbal interview to gather more information about the presence and 
effects of dysphagia.  
The ALSFRS-R is a scale that is commonly used in the literature to determine a patient’s 
level of function during various activities of daily living. It is a valid and reliable assessment 
consisting of 12 sets of statements, for which patients rate their ability to perform activities of 
daily living on a five-point scale (Cedarbaum et al., 1999). Bulbar symptoms are addressed in 
terms of speech, salivation and swallowing with the score of zero for “loss of useful speech”, 
“marked drooling; requires tissue of handkerchief” and “NPO (exclusively parenteral or 
enteral feedings)” respectively, and a score of four for “normal” (Cedarbaum et al., 1999). 
Overall change in ALSFRS-R score over time is a sensitive predictor of survival, and it is 
therefore, widely used both clinically and in research trials (Kollewe et al., 2008). There is an 
inverse relationship between ALSFRS-R scores and dysphagia severity, indicating that gross 
changes in function are represented by changes on the scale (Ruoppolo et al., 2013). 
However, the bulbar subscale on the ALSFRS-R does not have sensitivity or diagnostic 
accuracy to detect changes in bulbar function, including the presence of dysphagia that is 
evident on instrumental assessment (Allison et al., 2017; Chapin et al., 2020; J. R. Green et 
al., 2013). 
The Eating Assessment Tool (EAT-10) was created as a short screening tool for dysphagia 
that incorporates both physiological and psychosocial domains of swallowing (Belafsky et 
al., 2008). It is a ten item self-report questionnaire, in which patients rate their symptoms on a 
four-point scale, providing a total score out of 40. The EAT-10 was reported to have 
excellent internal consistency, test-retest reproducibility and criterion based validity 
(Belafsky et al., 2008). It is quick and easy to administer, and as such, has been translated 
into several languages including Spanish, Arabic and Swedish (Burgos et al., 2012; Farahat & 
Mesallam, 2015; Möller, Safa, & Östberg, 2016). A positive linear correlation between 
aspiration events and the EAT-10 has been demonstrated (Cheney, Siddiqui, Litts, Kuhn, & 
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Belafsky, 2015), and a score of three or higher has been found to be representative of the 
presence of dysphagia (Belafsky et al., 2008). In patients with MND, a score of three or 
higher has a sensitivity of 88% and specificity of 57% for predicting airway invasion with 
higher scores recorded for patients who aspirate (Plowman, Tabor, et al., 2016). Scores from 
the EAT-10 have also been shown to correlate with lingual speed in patients with MND (B. J. 
Perry et al., 2020). Recently, the construct validity of the EAT-10 was investigated by two 
similar studies using Rasch models (Cordier et al., 2017; Wilmskoetter et al., 2019). Both 
studies highlighted similar limitations of the survey in clinical and research practice. Two 
items of the EAT-10 (“I cough when I eat” and “My swallowing problem has caused me to 
lose weight”) have been shown to misfit the model (Cordier et al., 2017; Wilmskoetter et al., 
2019). Further, differential item functioning analyses highlighted four items with differential 
item functioning between patients who aspirate and those who do not. If there are inherent 
differences between groups on a scale, it indicates that the scale cannot be used to directly 
compare between patients in these groups, or within a patient if that patient moves between 
groups due to improvement or decline in swallowing. Further, the EAT-10 performs poorly at 
separating individuals into groups based on severity of dysphagia (Cordier et al., 2017; 
Wilmskoetter et al., 2019). It was found to be able to separate patients into 3 strata (e.g. no 
dysphagia, moderate and severe) in one study (Wilmskoetter et al., 2019) and less than two in 
the other study (Cordier et al., 2017). It is therefore unlikely to detect small changes over 
time or as a result of treatment. These limitations suggest that the EAT-10 is not an 
appropriate outcome measure and that care should be taken when using it to compare 
between patients e.g. as a screening tool. However, clinical benefit of the EAT-10 may 
remain as the questions asked can provide beneficial information regarding a patient’s 
perspective of their swallowing difficulties.  
Oropharyngeal dysphagia has a negative impact on the quality of life of patients with MND 
(Paris et al., 2013). For a therapist to provide appropriate care, and to measure meaningful 
outcomes of an intervention, it is necessary to have a means of gauging the extent of this 
impact on patients. The Swal-QOL obtains information pertaining to a patient’s perception of 
their swallowing, and related quality of life factors. The Swal-QOL consists of 44 questions 
with subsections including eating desire and food selection (McHorney et al., 2002). Patients 
respond to each statement on the Swal-QOL using a five-point scale relating to the frequency 
of a symptom, or the level to which they agree with a statement. The Swal-QOL can be 
scored out of 100 in various categories, with higher scores indicating a better quality of life. 
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In a systematic review of literature investigating the use of self-reported assessments of 
swallowing for patients with progressive neurological disorders, the Swal-QOL was judged to 
be the questionnaire with the best combination of reliability, convergent validity and clinical 
application (Keage, Delatycki, Corben, & Vogel, 2015). Importantly, scores from the Swal-
QOL can discriminate between MND patients with and without dysphagia under 
videofluoroscopy (Paris et al., 2013; Tabor et al., 2016). Paris et al. (2013) investigated this 
by comparing Swal-QOL outcome for patients with as without dysphagia determined by the 
dysphagia outcome severity scale on VFSS. Thirty patients were recruited, 14 with normal 
swallowing and 14 with oropharyngeal dysphagia. Interestingly, there was no difference in 
BMI between the groups. Patients with dysphagia scored significantly worse in the symptom 
frequency categories of pharyngeal, oral and salivary symptoms. Additionally, patients with 
dysphagia reported increased burden, eating duration, food selection, eating desire, fear, oral 
communication, mental heals and social factors. Patients in this study were only split into two 
groups based on presence or absence of dysphagia, so this study does not provide information 
regarding whether the Swal-QOL is sensitive to changes over time. Tabor et al. (2016) further 
investigated this relationship by comparing Swal-QOL outcomes to the penetration aspiration 
scale and the ALSFRS-R. In a group of 81 patients, a significant difference was found in 
Swal-QOL scores between patients who were identified as safe swallowers (n = 45), 
penetrators (n = 21) and aspirators (n = 15). Scores in the Swal-QOL were negatively 
correlated with PAS scores, indicating that patients with unsafe swallowing scored worse on 
the Swal-QOL. There was also a significant correlation between Swal-QOL and ALSFRS-R 
scores, demonstrating that changes in swallowing quality of life are associated with global 
progression of the disease. However, these are both self-reported questionnaires and further 
research documenting disease progression with alternative measures of patient functioning 
may help to confirm the results.  
Romero-Gangonells et al. (2020) used VFSS to compare the sensitivity and specificity of 
commonly utilised scales: the Functional Oral Intake Scale, EAT-10, swallowing category 
from the ALS Severity Scale and the symptom frequency section of the Swal-QOL 
questionnaire. All scales demonstrated a low sensitivity and fair specificity at detecting 
dysphagia. The authors were able to increase sensitivity and specificity with a modified 
version of the Swal-QOL, indicating the need for development of a questionnaire that is 
specific to symptoms associated with MND (Romero-Gangonells et al., 2020). 
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5.2.2 Cranial nerve evaluation 
Evaluation of the five cranial nerves associated with oral and pharyngeal phases of 
swallowing (CN V, CN VII, CN IX, CN X and CN XII) provides information regarding 
potential symptoms and causes of dysphagia. In MND, reduced strength and range of motion 
may occur for muscles associated with each of these cranial nerves (Hillel & Miller, 1989). 
During a cranial nerve evaluation, changes to strength and range of motion are often detected 
through observation or palpation of various motor movements (Hillel & Miller, 1989). 
However, there is no standard regarding what is considered adequate strength or range of 
motion, making the assessment highly subjective (Clark, 2005).  
Cough reflex testing (CRT) is an adjunct to the traditional cranial nerve exam, which 
provides information about laryngeal sensitivity. CRT assists with clinical decision making 
by identifying patients with impaired laryngeal sensation, and therefore, the potential to 
silently aspirate. Use of the cough reflex test allows more efficient referral for instrumental 
examination (Miles et al., 2013; S. E. Perry, Miles, Fink, & Huckabee, 2019). CRT has been 
investigated in 32 patients with MND who were compared to 34 healthy controls. Individuals 
in this study inhaled nebulised capsaicin of varying concentrations following an instruction to 
“cough if you need to” (Tabor‐Gray, Vasilopoulos, Wheeler-Hegland, et al., 2020, p. 3). 
Participants then rated their urge to cough using a Modified Borg scale and those with MND 
underwent VFSS. Increased urge to cough ratings were found for increased concentrations of 
capsaicin in both patients and healthy controls. During VFSS, one patient reflexively coughed 
to aspiration and five patients demonstrated silent aspiration (PAS = 8). During capsaicin 
trials, the patients who silently aspirated had blunted urge to cough sensitivity slopes and 
evoked cough response slopes. Two of the patients who silently aspirated reported zero urge 
to cough and no motor response to any concentration of capsaicin. However, there was a lot 
of variability between the other patients who demonstrated silent aspiration on VFSS. In the 
patients with who did not silently aspirate (n = 21), urge to cough of at least one was reported 
for all capsaicin trials. Cough motor response to capsaicin was absent in two patients who did 
not demonstrate silent aspiration. However, it is important to consider that there may be 
patients who did not aspirate during the VFSS but have impaired laryngeal sensation. 
Interestingly, patients with MND who did not aspirate demonstrated greater sensitivity to 
higher concentrations of capsaicin than healthy controls. Despite higher urge to cough 
ratings, patients showed reduced motor responses, suggesting reduced physiologic reserve. 
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This study did not provide information about the sensitivity and specificity of using cough 
reflex testing as a screening tool in patients with MND but highlighted physiological 
differences between patients and healthy controls. More information about cough reflex 
testing in this population is required before including it as a routine screening tool. 
5.2.3 Swallowing trials 
If deemed appropriate following a detailed case history and cranial nerve evaluation, a patient 
will perform trials of various foods and drinks. During oral trials, the clinician observes a 
patient for signs of dysphagia, including cough and changes in vocal quality (Garand et al., 
2020). The observation of swallowing at bedside generally has low inter- and intra-rater 
reliability (McCullough et al., 2000). The validity and reliability of oral trials in patients with 
MND have not been investigated. However, oral trials are unlikely to identify all patients 
with dysphagia as silent aspiration is common (Goeleven et al., 2006; Lo Re et al., 2007).  
The Timed Water Swallow Test (TWST) was developed as a simple, functional test to 
improve the predictive value of a bedside assessment and allow monitoring of change in 
swallowing capability. To complete the TWST, patients are presented with 150 mL of water 
if they are under 75 years of age or 100 mL if they over 75. They are asked to drink the water 
“as quickly as is comfortably possible” (Hughes & Wiles, 1996, p. 111) while the therapist 
records the number of swallows and the time taken for the patient to consume the water. 
From these measures, the average volume per swallow (mL), time per swallow (s) and the 
volume swallowed per sec (ml/s) can be calculated and compared to normative data. 
Normative data are stratified by sex and age group. Importantly, the TWST is effective in 
identifying swallowing changes secondary to MND, as scores for this population are 
significantly different from healthy controls (Hughes & Wiles, 1996). The TWST has 
highlighted a reduction in bolus size for patients with MND compared to healthy controls. 
For patients with MND, bolus size was 4 mL for females and 7 mL for males compared to 
over 10.5 mL for all healthy females and over 20 mL for healthy males (Hughes & Wiles, 
1996). 
The Test of Masticating and Swallowing Solids (TOMASS) is an adjunct to the TWST, 
which provides additional information about pharyngeal and oral phases of swallowing solids 
(Huckabee et al., 2017). It has been shown to be a valid measure of masticatory and 
swallowing efficiency, with high inter-rater and test-retest reliability (Huckabee et al., 2017). 
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The assessment protocol for the TOMASS is similar to that of the TWST. To complete the 
TOMASS, patients are presented with a cracker and given the instruction to eat it “as quickly 
as is comfortably possible and when you have finished, say your name out loud” (Huckabee 
et al., 2017, p. 147). As the patient eats a cracker the number of bites, masticatory cycles, 
swallows and the time taken to consume the cracker are recorded (Huckabee et al., 2017). 
When under the influence of topical oral anaesthesia, the number of chews and amount of 
time taken to complete the TOMASS is increased compared to baseline (Lamvik‐
Gozdzikowska, Guiu Hernandez, Apperley, McIntosh, & Huckabee, 2019). These results 
demonstrate that the oral phase contributes significantly to TOMASS outcomes and that the 
TOMASS is sensitive to detecting changes in oral sensation.  
An important consideration when performing this assessment between locations is that there 
are implicit differences between crackers that are readily available around the world, and 
these differences have an effect on scores of the TOMASS (Huckabee et al., 2017). 
Normative data have been collected for the TOMASS using different types of crackers, which 
are available in various centres around the world including, but not limited to NZ/ Australia, 
the USA and the United Kingdom/ Ireland (Huckabee et al., 2017). Normative data for the 
TOMASS have been calculated for raw outcome measures and derived measures of 
masticatory cycles per bite, swallows per bite, time per bite, time per masticatory cycle and 
time per swallow. Due to the observed differences between cracker type and significant 
differences in performance as a result of age and sex, normative data are stratified by cracker 
type, age and sex (Huckabee et al., 2017).  
5.3 Instrumental assessment of swallowing 
CSAs provide limited information about safety and efficiency of swallowing or 
pathophysiology associated with dysphagia. Information attained through instrumental 
assessment is often more objective than clinical swallowing exams. Videofluoroscopic 
swallowing studies (VFSS) and flexible endoscopic evaluation of swallowing (FEES) are the 
most widely utilised instrumental swallowing assessments (Langmore, 2003). Pharyngeal 
manometry, ultrasound and surface electromyography are adjunct swallowing assessments 
that are emerging within the swallowing literature.   
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5.3.1 Flexible Endoscopic Evaluation of Swallowing  
Flexible endoscopic evaluation of swallowing (FEES) allows visualisation of the 
hypopharynx, larynx and proximal trachea by passing a flexible endoscope trans-nasally 
(Hiss & Postma, 2003). Benefits of FEES are that it is portable, it does not involve harmful 
radiation and it allows direct visualisation and evaluation of extent of pharyngeal and 
laryngeal movements when performing non-swallowing tasks. FEES may be completed at a 
patient’s bedside and can be repeated without additional risk. However, due to light reflection 
during epiglottic deflection there is a period of whiteout during the pharyngeal stage of 
swallowing. FEES, therefore, provides less information than VFSS regarding the extent of 
structural movement during swallowing and the pathophysiology of dysphagia. 
There is discrepancy in the literature regarding the efficacy of FEES in patients with MND. 
Leder et al. (2004) reported that FEES was highly beneficial for patients with MND as it 
provided sufficient information to diagnose pharyngeal dysphagia and provide swallowing 
biofeedback, whilst being portable and safe enough to repeat over the course of disease 
progression. However, when compared to patient report and VFSS findings, FEES was not 
found to be sensitive in detecting dysphagia in patients with MND (Briani et al., 1998). 
Further, FEES is not always well tolerated in patients with MND, likely due to an increased 
gag reflex as a result of hyperreflexia associated with UMN dysfunction (Aviv et al., 2002; 
Cohen et al., 2003; Domer et al., 2013; Leder et al., 2004).  
5.3.2 Videofluoroscopic swallowing studies 
Videofluoroscopic swallowing studies (VFSSs) use x-ray imaging to allow visualisation of 
bolus flow, airway invasion and the extent and efficiency of structural displacement during 
the oral, pharyngeal and oesophageal phases of swallowing (Daniels & Huckabee, 2014). 
Both qualitative and norm referenced quantitative information can be acquired through 
VFSS, making it beneficial in the clinical and research settings. Despite the many benefits of 
VFSSs, Plowman et al. (2017) found that only 27% of sites, which participated in a survey of 
current clinical practice, routinely referred patients with MND for a VFSS. Clinicians 
reported various reasons for this, including that dysphagia is expected in this population and 
that the reaction to the presence of dysphagia would instigate referral for PEG, so knowledge 
of the specific pathology is not necessary (Plowman et al., 2017).  
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One disadvantage of VFSS is that radiation is necessary to produce videofluoroscopic 
images. Excessive doses of radiation can have an ionising effect on cells, which can result in 
skin burns and radiation sickness when exposed to large amounts over a short period of time 
and cancer if exposed to small amounts for an extended period. However, during a usual 4.82 
minute clinical VFSS, a patient is only exposed to 1.23mSv of radiation (Kin, Choi & Kim, 
2013), this is less than half of the radiation exposure (2.94mSv) that would be expected on a 
long haul flight (Enyinna et al., 2016) and approximately equal to the amount of natural 
background radiation a person would encounter in six months (Hendry et al., 2009). In a 
well-structured VFSS, the radiation exposure is low but assessments are time constrained and 
cannot be repeated on a regular basis. Although assessments should be time constrained, it is 
important to note that dose area product (DAP), the amount of radiation that is delivered to a 
patient, is not correlated with radiation exposure time (Bonilha et al., 2019). Therefore, 
timing of a study should not be the threshold for limiting radiation exposure during an exam. 
One major contributing factor to DAP was whether images were obtained in the anterior 
posterior (AP) or lateral projection due to the need for more radiation to penetrate the body in 
an AP view (Bonilha et al., 2019).  
Radiation may be presented in either a continuous or a pulsed manner. In the continuous 
setting, the radiation is produced continuously over the period of time. The pulsed setting 
produces multiple short bursts of radiation, from which images are acquired. Pulsed radiation 
has multiple benefits; it reduces radiation exposure as there are greater periods in which the 
radiation is not on and it allows for less blurring of images as a result of motion artefact 
(Schueler, 2000). The frame rate is the number of individual images that are saved per second 
of fluoroscopy time. A higher frame rate results in more accurate interpretation of the study 
and a significant difference in recommendations has been observed for clinicians who 
reviewed a study at 15 and 30 frames per second (Bonilha et al., 2013). Bonilha et al. (2013) 
suggest 30 frames per second and 30 pulses per second when performing a VFSS, as this 
allows the examiner to visualise important transient effects of disordered swallowing.  
VFSS typically has high intra-rater and low inter-rater reliability and various methods of 
analysis have been developed to increase consistency between raters (McCullough et al., 
2001). Methods of analysis of VFSS include the Penetration Aspiration Scale (PAS) 
(Rosenbek, Robbins, Roecker, Coyle, & Wood, 1996), Dynamic Imaging Grade of 
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Swallowing Toxicity (DIGEST) (Hutcheson, Barrow, et al., 2017) and Dynamic Swallow 
Study (DSS) objective measurements (Leonard & Kendall, 2018).  
The PAS is an eight point scale that quantifies the depth of airway invasion and an 
individual’s response (Rosenbek et al., 1996). It was developed as a means of quantifying 
airway invasion to demonstrate changes in single patient. The PAS is commonly used in the 
dysphagia literature to detect change over time or in response to treatment. However, there 
are limitations to the use of this scale. Swallowing is often variable from one swallow to 
another and between boluses. It is therefore necessary to complete multiple swallows to 
determine a pattern. This creates difficulty in reporting PAS scores, as averaging over trials 
may result in decimal points, which are not included in the scale. As this is a descriptive 
scale, reporting a decimal point would not provide a useful description of a patient’s 
swallowing safety. It is common for the worst score to be considered; however, this can skew 
the data to make the population appear worse than they are. A common mistake made by 
researchers is to treat the PAS as an ordinal or interval scale (Steele & Grace-Martin, 2017). 
However, for statistical purposes, data from the PAS should be considered categorical as it 
cannot be assumed that a higher score is a worse outcome than a lower score. For example, a 
score of three (material enters the airway, remains above the level of the true vocal folds and 
is not ejected from the airway) is often considered more severe than a score of four (material 
enters the airway contacts the true vocal folds and is ejected from the airway) (McCullough, 
Rosenbek, Robbins, Coyle, & Wood, 1998). The options for statistical analysis of a 
categorical scale are limited compared to that of ordinal or interval scales. Additionally, 
scores of 4 and 6 are very uncommon, which may indicate that these scores are not clinically 
relevant scores as they do not often or that they are events that are more often misreported 
(Rosenbek et al., 1996; Steele & Grace-Martin, 2017).  
The DIGEST consists of subscales for efficiency and safety of swallowing. These subscales 
are then combined to produce an overall swallowing score. Safety is determined by airway 
invasion, using the criteria from the PAS, which are further modified by the number of events 
and degree of airway invasion. It is therefore subject to many of the limitations discussed 
above. Efficiency is determined by the amount of residue and modified by the type of bolus 
that resulted in residue. The DIGEST must be considered ordinal or categorical data and 
should be analysed as such, limiting its use in research studies. DIGEST was designed to be 
used with patients with dysphagia as a result of head and neck cancer (Hutcheson, Barrow, et 
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al., 2017), and transference of the scale to other populations such as MND has not been 
assessed. One potential limitation of using the DIGEST in patients with MND that has not 
been investigated is that it a categorical scale and may not account for small changes that 
occur in response to functional decline or treatment. The DIGEST has been used to 
investigate treatment effects in patients with MND (Plowman et al., 2019). Due to the ordinal 
nature of the scale, for statistical analysis Plowman et al. (2019) dichotomised DIGEST 
efficiency, safety and total scores. Dichotomising a variable reduces the variability in the 
data, which may lead to bias (Altman & Royston, 2006).  
Objective measurements of DSS include quantitative analysis of timing (Kendall, McKenzie, 
Leonard, Gonçalves, & Walker, 2000) and structural displacement (Leonard, Kendall, & 
McKenzie, 2004) during pharyngeal swallowing. Normative values have been obtained for 1 
mL, 3 mL and 20 mL thin liquid boluses. These measures are continuous, allowing for 
observation of a smaller degree of change than in DIGEST score. Further, specific instruction 
on how to perform measurements is provided to help to reduce the subjectivity involved in 
analysis. Structural displacement measures compare peak excursion to a pseudo-rest position 
obtained through a 1 mL bolus hold. These measures include pharyngeal constriction ratio 
(PCR), hyoid excursion and extent of UES opening. Each of these measures had an inter-rater 
reliability of greater than 90% when analysing VFSS’s of healthy participants (Leonard et al., 
2004). Timing measures include bolus transit time, timing of supraglottic closure and 
duration of UES opening and airway closure. All reported timing measures were found to 
have an inter-rater reliability of greater than 90% when assessing healthy individuals 
(Kendall et al., 2000). Temporal and kinematic measures from DSS have been used to 
measure change following swallowing treatment in patients with MND (Plowman, Watts, 
Tabor, et al., 2016); however, measurement reliability was not reported for this study. 
Significant improvements were reported for hyoid kinematics following treatment but no 
other significant differences were observed. Standard error for hyoid excursion was large 
indicating a high rate of variation between participants. Standard errors of the other measures 
were not reported. This large degree of variation on these measures for patients with MND 
may limit the ability to detect change in this heterogeneous population using the DSS. 
5.3.3 Ultrasound 
Ultrasound (US) is a non-invasive, safe, low-cost method of obtaining both quantitative and 
qualitative information about swallowing (Chi‐Fishman, 2005). US converts electrical energy 
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into high frequency sound waves that pass through tissues of the body. Sound waves travel at 
a speed that is determined by the density and stiffness of the structure, known as the 
propagation speed (Aldrich, 2007). They are then reflected back to the transducer which 
allows visualisation of the boundaries between structures. Attenuation and/or alteration of a 
sound wave occurs as the wave passes through tissue. The predominant form of attenuation is 
absorption. This occurs as the US waves travel through soft tissue due to the friction of 
vibrating particles causing energy to be lost as heat. Rate of attenuation due to absorption is 
based on the frequency of the US wave. Higher frequency waves have a higher rate of 
attenuation and are less able to penetrate to deeper structures. However, higher frequencies 
have the benefit of increased spatial resolution. Clinical US is usually in the range of 2 MHz 
to 10 MHz (Aldrich, 2007).  
An echo is the reflection of the sound waves, this is produced when there is a difference in 
the acoustic impedance of the tissues or structures and can be seen as a band. The larger the 
contrast in the density of the mediums, the darker the echo, as more of the sound wave is 
reflected back. At an intersection such as that between soft tissue and bone, a shadow is cast 
as none of the sound wave is able to travel through, so it is reflected (Aldrich, 2007). The 
method of image acquisition with US can affect the quality and reliability of images. 
Methodological considerations include the use of ample ultrasonic gel to create a barrier with 
no air gaps between the transducer and the patient’s skin surface. This will reduce the 
reflection between air and soft tissue and substantially improve image quality (Aldrich, 
2007).  
US may be a beneficial tool for monitoring patients with MND as it is a non-invasive 
procedure that provides information regarding muscle mass and structural displacement, 
without the use of radiation. As US is low risk, it can be repeated to provide a quantitative 
measure of change in muscle cross sectional area over time. This may be beneficial in 
monitoring the atrophy of muscles and changes to structural displacement in patients with 
MND over time (Nakamori et al., 2015). For patients with potential MND, US has also been 
proposed as an adjunct to the diagnostic process as it can be used to visualise muscle 
fasciculations. When used in conjunction with needle EMG, US increases diagnostic 
accuracy when compared to needle EMG alone (Misawa et al., 2011; Nakamori et al., 2015; 
Tsuji et al., 2017). Denervation of a muscle can also be visualised via US, indicating LMN 
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dysfunction. This can be seen as an increase in echogenicity of the muscle (Simon, Noto, & 
Zaidman, 2016; Simon, Ralph, et al., 2015).  
5.3.3.1 US of cross-sectional area of submental muscles 
As previously discussed, the submental muscles are a vital muscle group for the opening of 
the UES and airway protection (Matsuo & Palmer, 2008). As they are close to the surface, the 
anterior belly of digastric muscles and the geniohyoid muscles can be safely viewed and 
measured with US (fig. 5.1). Ultrasound images of the cross-sectional area (CSA) of the 
anterior belly of the digastric muscles provide measurements that are highly correlated with 
those obtained by Magnetic Resonance Imaging (MRI) (Macrae, Jones, Myall, Melzer, & 
Huckabee, 2013). US imaging also provides additional information to MRI, as the technique 
allows for visualisation of the deeper geniohyoid muscles (Macrae et al., 2013). 
 
Figure 5.1: US of the submental muscles visualising: a) surface of the skin, b) geniohyoid 
muscles, c) anterior belly of digastric muscles, d) mylohyoid muscles. 
5.3.3.2 US of dynamic swallowing 
In addition to muscle CSA, US can provide quantitative information about dynamic features 
of swallowing such as hyoid excursion (figs. 5.2 and 5.3). As previously mentioned, due to 
the high difference in acoustic impedance, the boundary between soft tissue and bone results 
in an acoustic shadow, which allows both the hyoid bone and mandible to be easily visualised 
(Chi‐Fishman, 2005). The acoustic shadow cast by the mandible is a good reference point for 
measuring displacement of the hyoid bone as alterations in patient or transducer position 
during swallowing will not influence the measurements (Macrae, Doeltgen, Jones, & 
Huckabee, 2012). With the use of US, significant differences can be seen in extent of hyoid 







There is good inter-rater and intra-rater reliability when analysing US videos of hyolaryngeal 
excursion in both healthy participants and patients with dysphagia (Hsiao et al., 2012; Macrae 
et al., 2012). Test re-test reliability is also high when images are collected by one individual 
(Shimizu et al., 2016). However, this high level of test-retest reliability could not be 








Figure 5.2. Measure of distance between the hyoid and mandible at rest: a) shadow of the 
hyoid b) shadow of the mandible c) geniohyoid muscle d) hyoid to mandible distance at rest 
 
 
Figure 5.3. Measure of distance between the hyoid and mandible at rest: a) shadow of the 











Dynamic US has been investigated in patients with MND, using the thickness of the 
mylohyoid-geniohyoid muscle complex. The change in the thickness of the mylohyoid-
geniohyoid muscle complex during swallowing, compared to the muscle at rest, was 
significantly lower in patients with bulbar onset MND compared to those with limb onset 
MND or healthy controls (Noto et al., 2017). This study did not compare dysphagic patients 
to non-dysphagic patients; this information would be beneficial in determining if this measure 
could indicate patients who would need to be followed up with further swallowing 
assessment. Interestingly, thickness ratio negatively correlated with measures of UMN but 
not LMN involvement, indicating that the reduction in muscle movement may be due to 
spasticity. However, it is important to note that although significant, the correlation between 
UMN involvement and mylohyoid-geniohyoid muscle complex thickness ratio was not strong 
(r = -.53; p < 0.05) (Noto et al., 2017). 
5.3.4 Pharyngeal manometry 
High resolution manometry (HRM) is frequently used for assessment of oesophageal motility 
and bolus transfer. More recently, this technique has been adapted to assess pressures in the 
pharynx during swallowing. HRM provides quantitative information about pharyngeal 
pressure generation, that can be extracted by an algorithm, removing any subjective bias 
(Mielens, Hoffman, Ciucci, Jiang, & McCulloch, 2011). However, highly variable pressure 
drifts have been reported that could not be corrected by standard correction strategies. These 
drifts in pressure can negatively impact both clinical and research use of HRM as pressure 
drifts can be close to one standard deviation of normal pressures (Lamvik, Guiu Hernandez, 
Jones, & Huckabee, 2016). Variability in methodology exists regarding both acquisition and 
analysis of HRM data. Significant variation exists in the literature between catheter size, 
HRM system used, use of anaesthesia and positioning of the patient. These methodological 
variations make comparisons between studies and the use of normative data difficult 
(Winiker, 2019).  
HRM has documented reductions in pharyngeal pressure in patients with MND compared to 
healthy controls (Suh et al., 2019). Over the course of the disease, pharyngeal pressure 
continues to decrease and this can be monitored with manometry (Higo et al., 2004). To date, 
HRM has not been used as an outcome measure to investigate the effects of treatment in 
patients with MND. As HRM catheters are inserted transnasally, discomfort is common, and 
as with FEES, it may be difficult for patients with MND to tolerate due to a hyperreflexia. 
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The use of a topical nasal anaesthetic has been suggested to help reduce discomfort during 
catheter insertion. However, in healthy participants topical nasal anaesthetic has been found 
to have no benefits for comfort, and to result in reduced pharyngeal pressures when compared 
to a placebo (Guiu Hernandez, Gozdzikowska, Apperley, & Huckabee, 2018). The effects of 
topical nasal anaesthetic has not been investigated in patients with MND.    
High resolution impedance manometry (HRIM) adds additional information about bolus flow 
to HRM (Daniels & Huckabee, 2014). A highly conductive, ionic compound such as saline 
(NaCl) is ingested during HRIM as it creates a closed circuit when it is positioned over 
proximal electrodes (Pandolfino & Kahrilas, 2009). The bolus position during swallowing 
can therefore be mapped, and residue is apparent with a sensitivity of 75% and specificity of 
80% (Omari et al., 2011).   
5.3.5 Surface electromyography  
Electromyography (EMG) measures electrical signals produced by muscle contraction. The 
impulse from the motor neuron results in depolarisation and repolarisation of the muscle 
fibre, known as an action potential. Depolarisation of one neuron causes depolarization of 
adjacent neurons, which occurs in both directions towards the ends of the muscle fibre 
(Stepp, 2012). Depolarisation is associated with the transfer of Cl-, Na+ and K+ ions across 
the cell membrane and results in the creation of an electric field. The number of motor units 
recruited and their frequency of firing determines both the force that a muscle produces and 
the electrical signal created by the muscle contraction (Moritani, Stegeman, & Merletti, 
2004). There is, therefore, a relationship between the surface EMG (sEMG) output and force 
produced by a muscle. However, sEMG is also influenced by a number of other factors 
including muscle fatigue, muscle temperature, skin-fold thickness, degree of synchronization 
of motor unit discharge, the muscle fibre potential, distance between electrodes and the 
position of the electrode on the muscle (Moritani et al., 2004; Vigreux, Cnockaert, & 
Pertuzon, 1980). The addition of these factors means that the relationship between the force 
produced and sEMG amplitude is not linear (Bilodeau, Schindler-Ivens, Williams, Chandran, 
& Sharma, 2003; Disselhorst-Klug, Schmitz-Rode, & Rau, 2008).  
There are two methods of measuring EMG signals, intramuscular EMG and sEMG. 
Intramuscular EMG is invasive as it requires the insertion of a needle into the muscle. The 
use of intramuscular EMG increases the specificity of the signal, as readings can be taken 
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from specific motor units. Unlike intramuscular EMG, sEMG is a polyphasic signal, as it 
detects the action potentials generated from multiple motor units. The contribution of each 
motor unit to the signal is dependent on the distance between the motor unit and the electrode 
(Stepp, 2012). Layers of tissue between the electrodes and the muscles, including skin and 
subdermal fat, smooth and decrease the amplitude of the sEMG signal. Therefore, sEMG is 
most effective at measuring the activity of superficial muscles, such as submental muscles, as 
there is less signal dampening than for deeper muscles (Merletti, Botter, Troiano, Merlo, & 
Minetto, 2009; Stepp, 2012). During swallowing, sEMG allows for measurement of the 
activation of the entire submental muscle group, rather than a select number of motor units 
(Stepp, 2012). A significant benefit of sEMG is that it is non-invasive, and therefore, will not 
result in changes to behaviour as a result of discomfort as can occur with intramuscular EMG 
(Stepp, 2012).  
During swallowing, the primary muscles that contribute to a reading of an sEMG electrode 
placed on the surface of the skin under the chin are the mylohyoid, geniohyoid and anterior 
belly of the digastric muscles (P. M. Palmer, Luschei, Jaffe, & McCulloch, 1999). However, 
more recent research has demonstrated that output from submental sEMG recordings can also 
be influenced by lingual activity during tasks such as effortful swallowing (Huckabee & 
Steele, 2006). As the submental muscles contribute to hyoid displacement during swallowing, 
there is a strong correlation between timing and extent of hyoid excursion and sEMG output 
(Crary, Carnaby, & Groher, 2006; Wheeler-Hegland, Rosenbek, & Sapienza, 2008).  
In the dysphagia literature, sEMG has been used to provide quantitative information about the 
timing and extent of muscle activation during swallowing manoeuvres and functional 
swallowing tasks (Huckabee et al., 2005; Staudenmann, Roeleveld, Stegeman, & Van Dieën, 
2010; Wheeler-Hegland et al., 2008). SEMG is sensitive enough to detect differences in bolus 
type and taste (Ding, Logemann, Larson, & Rademaker, 2003; Leow, Huckabee, Sharma, & 
Tooley, 2007). Increased amplitude of muscle activation has been recorded when swallowing 
thick consistencies and sour boluses, and longer duration of sEMG signal has been 
demonstrated with bitter boluses (Ding et al., 2003; Leow et al., 2007). One limitation of the 
current research investigating the use of sEMG for assessment of swallowing is that the 
majority of research has been performed with young healthy participants. Because of this, 




6. Dysphagia management 
The primary goals of dysphagia management are to maintain or improve safety and efficiency 
of oral intake. The outcomes from achieving these goals would be increased pulmonary 
safety, improved hydration and nutritional status and improved quality of life. Approaches to 
manage dysphagia can be subdivided into the categories of compensatory and treatment 
strategies.  
Treatment for speech and swallowing disorders is not routinely provided to patients with 
MND (Beukelman, Fager, & Nordness, 2011). Management of worsening dysphagia in 
patients with MND has historically been restricted to the implementation of compensatory 
strategies and the use of PEG tubes for non-oral feeding (Kühnlein et al., 2008; Rosenbek & 
Troche, 2013). As previously discussed, patients with MND are seldom sent for instrumental 
swallowing assessments (Plowman et al., 2017). Without the use of instrumental assessment, 
there is the risk that recommended treatment or compensatory strategies will not be 
appropriate. 
6.1 Compensatory strategies 
Compensatory strategies aim to promote immediate change in bolus flow to increase safety or 
efficiency of swallowing. Two common approaches to compensation include diet 
modification (e.g. increasing thickness of fluids or pureeing solids) and postural changes (e.g. 
chin tuck or head turn). Compensatory strategies may increase the amount of time patients 
are able to eat orally. However, an important consideration with all compensatory strategies 
is that they do not alter the course of dysphagia progression and may in fact result in a 
reduction in range of motion, limiting true recovery of function, as has been observed in the 
limb literature (Takeuchi & Izumi, 2012). Therefore, in patients with a rapidly progressive 
disease, it is likely that a given compensatory strategy will be effective for only a short 
amount of time. 
Diet modification is often recommended to patients with MND by speech-language therapists 
(SLTs) (Kühnlein et al., 2008; K. F. Luchesi, Kitamura, & Mourao, 2013). Pureed food can 
assist patients who have difficulty with mastication as the amount of oral preparation required 
for safe swallowing is reduced, thereby reducing fatigue across the meal. In this population, 
penetration and aspiration are more common with thin liquids than thicker liquids or solid 
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textures. Thickening liquids reduces the speed at which the liquids travel into and through the 
pharynx, which can lead to reduced depth of pre-swallow pooling and reduced aspiration. 
However, the amount of pharyngeal residue is often greater for thicker liquids (Dantas et al., 
1990; Kuhlemeier, Palmer, & Rosenberg, 2001). When considering rates of aspiration, many 
studies consider only the first swallow and do not address the potential for airway invasion 
associated with pharyngeal residue (D’Ottaviano et al., 2013; Kuhlemeier et al., 2001; J. B. 
Palmer, Kuhlemeier, Tippett, & Lynch, 1993; Pizzorni et al., 2020). It is therefore likely that 
rates of airway invasion are under-reported for patients with significant post-swallow residue. 
Another consideration is that increased bolus viscosity leads to an increase in intrabolus 
pressure and requires greater lingual and pharyngeal muscle recruitment for bolus transfer 
(Dantas et al., 1990; J. L. Miller & Watkin, 1996). This increased effort could lead to greater 
fatigue over a meal and therefore put the patient at increased risk of aspiration, something 
that is not likely observed during short instrumental assessments.  
Many patients with MND refuse thickened liquids (Onesti et al., 2017), perhaps due to the 
unpleasant taste, difficulty in social situations and discomfort associated with increased 
pharyngeal residue. In addition, serious adverse health outcomes may be linked to thickening 
liquids. In a study on rabbits, aspiration of thickened fluids was shown to be more harmful to 
the lungs than thin fluids, resulting in increased risk of pulmonary injury and death (Nativ‐
Zeltzer et al., 2017). Although information from animal studies cannot be directly compared 
to patients with dysphagia, this indicates the negative effects that thickener can have on body 
tissues. Thickened liquids have also been shown to lead to an increased incidence of 
dehydration, urinary tract infections and fever, and a reduction in patient satisfaction and 
quality of life (Davis, 2007; Robbins, Gensler, et al., 2008). There is not strong evidence in 
the literature that modifying food and liquid consistency is beneficial for patients with MND. 
Further, modification of diet should only be recommended following instrumental assessment 
because of the possible adverse effects and individual differences in response to various 
consistencies (Davis, 2007; Logemann et al., 2008). 
Postural changes are often preferred by patients over diet modification (Logemann et al., 
2008). Postural strategies change pharyngeal dimensions with the aim to redirect bolus flow. 
For example, the chin tuck narrows the laryngeal entrance, increases the duration of laryngeal 
vestibule closure and reduces the distance between the thyroid cartilage and the hyoid bone, 
resulting in decreased depth of airway invasion (Bülow et al., 1999; Macrae, Anderson, & 
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Humbert, 2014). For effective use of postural strategies, it is required that the patient has 
adequate cognition, attention and consistently adheres to the recommendations, as there is no 
effect once the posture is removed (Rasley et al., 1993). Postural modifications are often 
recommended to improve swallowing safety for patients with MND. The chin tuck, head turn 
and hyperextension of the neck have each been found to be effective at reducing airway 
invasion in specific patients (Solazzo et al., 2011). However, no strategy was effective for all 
patients, again highlighting again the need for instrumental assessment to determine 
appropriate management (Solazzo et al., 2011).  
6.1.1 Non-oral feeding 
Arguably, the most extreme compensatory approach to dysphagia is restriction of oral intake 
altogether. Non-oral feeding options such as nasogastric (NG) or percutaneous endoscopic 
gastrostomy (PEG) tubes allow nutrition and hydration to be delivered by bypassing the 
disordered swallowing system. There are risks associated with non-oral feeding options such 
as infection of the tube site, mechanical complications (e.g. blockage of the tube) and 
metabolic complications (e.g. refeeding syndrome) (Blumenstein, Shastri, & Stein, 2014). 
Importantly, although they may provide short term benefit for nutrition and hydration, as with 
other compensatory strategies, non-oral feeding options do not alter the pathophysiology of 
dysphagia.  
A PEG tube may be utilised as a pre-emptive method to combat weight loss. The proportion 
of patients with MND who use PEG tubes varies between country and institution, with most 
respondents to a survey based in the USA reporting that 50-69% of patients receive PEG 
tubes (Plowman et al., 2017). There is disagreement in the literature regarding whether PEG 
use results in increased length of survival (Mazzini et al., 1995; Mitsumoto et al., 2003). For 
ethical reasons, randomised controlled trials investigating the benefits tube feeding for 
patients with MND do not exist. In a Cochrane review of the literature, Katzberg and Benatar 
(2011) concluded that the evidence for PEG feeding increasing survival in patients with 
MND was positive but weak. Further, a higher BMI has been reported for patients with MND 
who have a PEG compared to those who refuse PEG insertion (Mazzini et al., 1995). As 
randomised controlled trials cannot occur, it is important to consider that the use of PEG 
feeding in these studies was a decision made by the patient. PEG use is associated with 
increased use of other assistive devices, multidisciplinary care, medical assistance in the 
home and more frequent physician visits and hospital admissions (Mitsumoto et al., 2003). 
50 
 
These factors may contribute to the positive outcomes observed for patients who receive 
enteral nutrition.  
In a disease with rapid progressive loss of function, quality of life is an important 
consideration. There is no strong evidence to support increased quality of life following PEG 
insertion. One small study showed no significant effect of PEG tubes on quality of life 
(Zamietra et al., 2012); however this was a retrospective study with no control group and 
only 11 patients in the PEG cohort. Further research investigating a larger cohort of 100 
patients also demonstrated no significant change in quality of life for patients following 
insertion of PEG (Kurien et al., 2017). However, there was no control group so it cannot rule 
out that the use of PEG feeding stopped decline in quality of life with symptom progression. 
Changes in carer quality of life in response to PEG have also been assessed with no 
significant changes observed following PEG insertion (Kurien et al., 2017).  
There are risks involved with the placement of PEG tubes that must be considered. Minor 
complications include tube displacement, tube obstruction, transient laryngeal spasm and 
localised infection. Serious risks include gastric haemorrhage, failure to place the PEG and 
death (R. G. Miller et al., 2009). Mortality in the 30 days following insertion of gastrostomy 
has been reported to be between 4% and 25% (Adriano Chiò et al., 2004; Czell, Bauer, 
Binek, Schoch, & Weber, 2013; Forbes, Colville, Swingler, & Group, 2004). It is 
recommended that PEG tube insertion is completed in the early stages of the disease as 
respiratory failure increases the risk associated with PEG placement (Simon, Huynh, Vucic, 
Talbot, & Kiernan, 2015). Therefore, if a patient’s diagnosis is delayed or they do not decide 
immediately, some patients may not be appropriate for PEG tube insertion. Tube feeding is 
considered a predictor of aspiration pneumonia (Langmore et al., 1998) and the risk of 
aspiration pneumonia is therefore not a sound justification for PEG feeding (R. G. Miller et 
al., 2009). PEG is not an appropriate option for all patients and careful considerations of the 
potential risks and benefits must be made by patients and their carers before undergoing the 
procedure.  
6.2 Cricopharyngeal myotomy 
Both improvement and decline in swallowing function have been reported following 
cricophayrngeal myotomy for patients with MND. Wilson, Bruce-Lockhart, and Johnson 
(1990) performed VFSS on 27 patients with dysphagia secondary to MND, identifying seven 
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patients with cricopharyngeal dysfunction as the predominant factor affecting their 
swallowing. Six of the seven patients underwent cricopharyngeal myotomy and all but one of 
these patients demonstrated improvement in the diet level that they tolerated. The use of diet 
level is a subjective outcome measure and the study would have been strengthened by the 
inclusion of objective quantitative outcome measures pre- and post-surgery. Many studies 
investigating the benefits of myotomy did not use instrumental assessments and outcomes 
were patient perception, which has a large risk of bias due to its subjective nature (David, 
1985; Lebo, Sangü, & Norris, 1976; Loizou, Small, & Dalton; Takasaki, Umeki, Enatsu, 
Kumagami, & Takahashi, 2010). In a single case design, it has been demonstrated that UES 
pressure can decrease at rest and during dry swallowing as a result of cricopharyngeal 
myotomy (Takasaki et al., 2010). However, the functional effects to swallowing were not 
investigated. Further research with the appropriate instrumental assessment is necessary to 
determine the benefits of cricopharyngeal myotomy in the small percentage of patients with 
MND who demonstrate hypertonicity of the cricopharyngeus muscle.  
There are significant risks associated with cricopharyngeal myotomy in this population. The 
mortality rate following the procedure has been reported to be as high as 20% (David, 1985). 
With limited evidence for functional benefits, improvement in quality or quantity of life and 
high risks associated with the surgery, alternative options for managing dysphagia in MND 
are required.  
6.3 Strength-based swallowing treatment 
Treatment strategies aim to induce long term improvements in the safety and efficiency of 
swallowing, resulting in improved nutritional, respiratory and quality of life outcomes. 
Strengthening techniques are the most common and well researched form of dysphagia 
treatment (Clark, 2003). Strength training aims to increase the power, force and/or endurance 
of the targeted muscles (Clark, 2003; D. Jones & Rutherford, 1987); success of strength 
training, therefore, assumes muscle weakness as the underlying cause of dysphagia.  
Common tasks for increasing the strength of the muscles of deglutition include effortful 
swallowing (Bülow, Olsson, & Ekberg, 2001), the Mendelsohn manoeuvre and the Masako 
manoeuvre (Fujiu, Logemann, & Pauloski, 1995). These tasks require the patient to swallow 
in a manner that recruits muscles to a greater extent than in habitual swallowing, thereby 
increasing muscle strength. Strength training exercises also include non-swallowing tasks that 
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recruit the target muscles. Examples of non-swallowing exercises include head-lift exercises 
(Shaker et al., 1997), chin tuck against resistance (Sze, Yoon, Escoffier, & Liow, 2016) and 
expiratory muscle strength training (EMST) (e.g. Pitts et al., 2009; Plowman et al., 2019; 
Plowman, Watts, Tabor et al., 2016; Troche et al., 2010; Wheeler, Chiara & Sapienza, 2007). 
During swallowing, individuals are able to volitionally increase effort with associated 
increased muscle recruitment (Hiss & Huckabee, 2005). During effortful swallowing, 
individuals are simply instructed to swallow with effort. Changes to swallowing timing as a 
result of effortful swallowing have been observed, including longer duration of hyoid 
excursion, laryngeal vestibule closure and UES opening (Hind et al., 2001; Hiss & Huckabee, 
2005). Effortful swallowing also results in pressure changes during swallowing, including 
increased oropharyngeal pressures and decreased pressure at the UES (Hind et al., 2001; Hiss 
& Huckabee, 2005). However, research has demonstrated no change in the amount of 
pharyngeal residue (Bülow et al., 2001) and no increase in amplitude or duration of intrabolus 
pressure (Bülow, Olsson, & Ekberg, 2002). Further, adverse effects of effortful swallowing 
have been reported. In a single case study of a patient with dysphagia following brainstem 
tumour resection, nasal redirection of the bolus developed following training of effortful 
swallowing (Garcia et al., 2004). Nasal redirection persisted with reduction seen only upon 
training of effortless swallowing. In healthy individuals, reduced anterior hyoid movement 
and reduced laryngeal excursion have also been documented as a result of effortful 
swallowing  (Bülow et al., 1999). It is likely that this reduction in hyolaryngeal excursion is a 
result of the lack of specificity of the muscles recruited for the task. It is likely that during 
effortful swallowing the force produced by the large suprahyoid and pharyngeal constrictor 
muscles, which pull the hyoid posteriorly, is greater than that of the submental muscles, 
which facilitate anterior hyoid excursion (Daniels & Huckabee, 2014). Further, research in 
healthy older adults demonstrated increased pharyngeal residue and reduced pharyngeal 
shortening as a result of effortful swallowing (Molfenter et al., 2018). Therefore, although 
effortful swallowing may increase pressures in the distal pharynx and duration of swallowing 
movements, this does not appear to result in functional benefits and there are risks associated 
with this manoeuvre that must be considered.  
The Mendelsohn manoeuvre was originally designed as a compensatory strategy to enhance 
bolus transfer through the UES. To complete the Mendelsohn manoeuvre an individual must 
hold their swallow at the peak of hyolaryngeal excursion. Prolonged hyolaryngeal excursion 
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was suggested as a method of increasing the duration of UES opening and facilitating bolus 
transfer through the UES. In small studies with healthy participants, when compared to 
normal swallowing, the Mendelsohn manoeuvre has been shown to increase the duration of 
anterior and superior hyolaryngeal excursion with subsequent delayed closure of the UES 
(Kahrilas et al., 1991), increased submental muscle contraction (Wheeler-Hegland et al., 
2008) and increased pharyngeal peak contraction and contraction duration (Boden, Hallgren, 
& Witt Hedström, 2006). More recently, the Mendelsohn manoeuvre has been investigated as 
an exercise for patients with dysphagia. Following two weeks of treatment with sEMG 
biofeedback, significant improvement in superior hyoid excursion was observed; however, 
there were no significant changes to anterior hyoid excursion or UES opening (McCullough 
& Kim, 2013). The authors suggested a potential improvement in skill rather than strength 
and as a result, increased coordination in swallowing timing measures (McCullough & Kim, 
2013).  
The Mendelsohn manoeuvre is a very difficult task to explain and comprehend, and if not 
done correctly it may not produce the expected results. One study using VFSS during the 
Mendelsohn manoeuvre reported that 24% of participants were unable to complete the task 
correctly (Wheeler-Hegland et al., 2008). One method of increasing accuracy is the 
implementation of biofeedback. However, consideration of the type of biofeedback is 
essential. In a small group of patients with dysphagia, duration of submental muscle 
activation measured by sEMG had no correlation with duration of maximum hyoid elevation 
or duration of laryngeal vestibule closure, indicating limitations of the use of sEMG for this 
training (Azola et al., 2015). Videofluoroscopy has been demonstrated to be a more effective 
method of training prolonged laryngeal vestibule closure (Azola et al., 2017); however, given 
the limitations of repeated VFSS, it is unlikely to be a feasible training approach.   
The Masako manoeuvre was developed based on an observation that following surgical 
resection of oral cancer, the degree of anterior bulge of the posterior pharyngeal wall 
increased (Fujiu et al., 1995). To mimic the loss of posterior base of tongue movement and 
facilitate bulging of the posterior pharyngeal wall, the Masako manoeuvre involves 
swallowing with the tongue held between the front teeth (Fujiu & Logemann, 1996). 
Importantly, this strategy resulted in increased residual when performed with a bolus, and is 
therefore, recommended for strengthening purposes with saliva swallows only. The Masako 
manoeuvre has been shown to increase hypopharyngeal pressure in patients with base of 
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tongue resections (Lazarus, Logemann, Song, Rademaker, & Kahrilas, 2002) but not in 
healthy volunteers (Doeltgen, Macrae, & Huckabee, 2011; Doeltgen, Witte, Gumbley, & 
Huckabee, 2009). In healthy individuals there were no significant changes to swallowing 
function or biomechanics following four weeks of training (Oh, Park, Cha, Woo, & Kim, 
2012). It therefore remains unknown whether the Masako manoeuvre would benefit patients 
with dysphagia due to reduced base of tongue to posterior pharyngeal wall contact but normal 
anatomy.  
One example of a strengthening task that does not involve swallowing is the head-lift 
exercise. The head-lift exercise was designed to increase floor of mouth muscles to facilitate 
anterior hyoid movement (Shaker et al., 1997). This is done through patients lying supine and 
lifting their head to look at their toes. In healthy elderly individuals, six weeks of the head lift 
exercise has been shown to increase laryngeal excursion and UES opening (Shaker et al., 
1997). Following treatment with the head-lift exercise, patients with dysphagia have 
demonstrated significant improvements in UES opening and anterior laryngeal excursion 
with resultant return to oral feeding in all 27 participants (Shaker et al., 2002). Compliance to 
this task has been reported to be a barrier with up to 50% of patients of individuals dropping 
out in the first two weeks of training (Easterling, Grande, Kern, Sears, & Shaker, 2005). 
Reported reasons for drop out included neck muscle soreness and dizziness (Easterling et al., 
2005). The participants included in this trial were healthy elderly individuals and may, 
therefore, have had little motivation for continuing the trial. In the patient trial, participants 
also reported minor neck muscle discomfort; however, this discomfort was not significant 
enough to result in discontinuation of treatment (Shaker et al., 2002).  
Adaptations have been made to the head-lift exercise to reduce the risk of dizziness and 
muscle aches. The chin tuck against resistance (CTAR) is one example. To complete the 
CTAR an individual places a rubber ball under their chin and presses down against the ball 
into a chin tuck position (Yoon, Khoo, & Liow, 2014). Subjective ratings by healthy 
individuals indicate that the CTAR is perceived to be less strenuous than the head lift 
exercise (Sze et al., 2016). However, the CTAR has not yet been systematically evaluated in 
a patient population. Measurement of fatigue with sEMG analysis of the submental muscles 
has been used to determine the specific muscles using during the head lift exercise and CTAR 
(Sze et al., 2016). Levels of submental muscle use and subsequent fatigue were equal during 
the CTAR and head-lift in healthy older participants. However, the CTAR was more specific 
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to this target muscle group, as greater fatigue was recorded in the sternocleidomastoid 
muscles during the head-lift exercise. This indicates that the CTAR may be a more 
appropriate task for improving dysphagia in patients with submental muscle weakness. 
However, sEMG signals during the CTAR may have been distorted due to contact between 
the ball that provided resistance for the exercise and the submental sEMG electrodes, 
indicating the need for further research investigating the potential use of this less strenuous 
alternative to the chin tuck exercise.  
Expiratory muscle strength training (EMST) was originally investigated in the respiratory 
literature to assist with cough production (Smeltzer, Levietes, & Cook, 1996). However, this 
approach may have cross system benefits for swallowing. In addition to recruiting the 
muscles of expiration, when the EMST device is set to 75% of an individual’s maximum 
expiratory pressure, the submental and palatal muscles are activated with a longer duration 
and higher amplitude than during water swallowing (Hutcheson, Hammer, Rosen, Jones, & 
McCulloch, 2017; Wheeler-Hegland et al., 2008; Wheeler, Chiara, & Sapienza, 2007). The 
most commonly used device in the dysphagia literature is the EMST150. It is a device with a 
one-way spring-loaded valve that provides resistance to forced expiration. The device is 
adjustable and can be set to a resistance that is appropriate for a given patient, allowing for 
increased or decreased difficulty as the resistance is changed. Patients are instructed to blow 
into the device such that the valve opens. In addition to healthy individuals, EMST has been 
investigated in many patient populations, including patients with neurodegenerative disease. 
One large randomised controlled trial has investigated the use of EMST in patients with 
Parkinson’s disease (Troche et al., 2010). Sixty participants with mild to moderate dysphagia 
were recruited and randomised into receiving either the sham or active treatment. Patients in 
the active EMST group demonstrated increased hyoid excursion and decreased penetration 
aspiration scores measured by VFSS. This study demonstrated the potential benefits of 
EMST for facilitating airway protection in patients with mild to moderate dysphagia due to 
neurodegenerative disease. The use of EMST in patients with MND is discussed in the 
chapter 6.3.1.  
The theory behind non-swallowing strengthening exercises is that if a patient is not able to 
achieve adequate muscle contraction for safe and efficient swallowing due to weakness, 
isolated strengthening of targeted muscles may translate to the functional task. However, 
sport and exercise literature has demonstrated that increases in muscle strength following 
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training are greater in the task that was trained than in other tasks that recruit similar muscles 
in a different manner (Rasch & Morehouse, 1957). Further, sport and exercise literature 
suggests that generally increasing the strength of a muscle group is not likely to be beneficial 
in improving performance in a specific task (Burkhead, Sapienza, & Rosenbek, 2007), 
highlighting the importance of task specificity.  
There has been little research investigating the required intensity for strength training to 
improve swallowing function. Information from sport and exercise science indicates that to 
achieve muscle hypertrophy and increase force generation, the task must include repetitive 
execution at a magnitude above the habitual level (Rasch & Morehouse, 1957; Zatsiorsky & 
Kraemer, 2006). It is recommended that a task is initially at an intensity of at least 60% of a 
one rep maximum, but 70-85% is preferable for inducing high rates of muscle hypertrophy 
(Burkhead et al., 2007; Porter, 2000; Wernbom, Augustsson, & Thomeé, 2007). Research has 
not indicated the most beneficial intensity for hypertrophy of bulbar muscles; however, 
progressive strength training regimes with loads above 60% have demonstrated beneficial 
effects for patients (e.g. Robbins et al., 2007; Troche et al., 2010).  
Although, in the past, strength training was the only option for dysphagia treatment, evidence 
is emerging that it might not be appropriate for all patients. Potential adverse effects have 
been identified following the effortful swallowing technique, including nasal redirection 
(Garcia et al., 2004) and reduced hyoid excursion (Bülow et al., 1999). In sport and exercise 
literature, strength training has been shown to result in impaired performance due to fatigue 
(Ament & Verkerke, 2009; Grandou, Wallace, Impellizzeri, Allen, & Coutts, 2020). Further, 
effects from a period of strength training are not permanent; following the offset of strength 
training exercises, detraining effects are a well-recognised phenomenon in respiratory and 
bulbar muscles (Baker, Davenport, & Sapienza, 2005; Burkhead et al., 2007; Clark, O’Brien, 
Calleja, & Corrie, 2009; Oh, 2015; Troche, Rosenbek, Okun, & Sapienza, 2014). 
6.3.1 Strength training for individuals with MND 
Exercise is not a common treatment approach in patients with MND. This is due to the belief 
that exercise will result in overuse of muscles, leading to increased levels of fatigue, and 
consequently, more rapid decline in function (Bennett, 1958). There is basis behind this 
concern as Carreras et al. (2010) demonstrated, through a mouse model of MND, that mice 
who underwent high intensity treadmill exercise had an earlier onset of motor symptoms than 
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sedentary controls. However, the same study showed that moderate intensity exercise was 
beneficial when compared to no exercise. Improvements were observed in body weight, 
motor performance and motor neuron counts of mice in the moderate intensity group 
(Carreras et al., 2010). In this study, moderate intensity differed from high intensity exercise 
based on the duration (30 vs. 60 mins), sessions per week (3 vs. 5) and speed (10 vs 20 
meters/min) of exercise. Therefore, it remains unknown if one or a combination of these 
factors contributed to the differences observed between the groups.  
Studies that have investigated exercise in patients with MND range from single case studies 
(Bohannon, 1983; Dworkin & Hartman, 1979; Watts & Vanryckeghem, 2001) to randomised 
controlled trials (Cheah et al., 2009; Clawson et al., 2018; Dal Bello-Haas et al., 2007; Drory, 
Goltsman, Reznik, Mosek, & Korczyn, 2001; A. C. Pinto et al., 1999; Plowman et al., 2019). 
The exercises that have been investigated include limb resistance training (Bohannon, 1983; 
Clawson et al., 2018; Dal Bello-Haas et al., 2007; Drory et al., 2001) treadmill training 
(Braga, Pinto, Pinto, & de Carvalho, 2018; S. Pinto, Swash, & de Carvalho, 2012; 
Mohammed Sanjak, Bravver, Bockenek, Norton, & Brooks, 2010), inspiratory muscle 
strength training (Cheah et al., 2009; S. Pinto & de Carvalho, 2013; S. Pinto et al., 2012) oral 
motor exercises (Dworkin & Hartman, 1979), Lee Silverman Voice Treatment (Watts & 
Vanryckeghem, 2001) and expiratory muscle strength training (EMST) (Plowman et al., 
2019; Plowman, Watts, Tabor, et al., 2016).  
The primary goal of resistance exercise is to increase or maintain the force that is able to be 
produced by the trained muscle through muscle hypertrophy. One of the first studies to 
investigate resistance exercises in patients with MND was a case report by Bohannon (1983).  
This study investigated the use of an isometric strength training protocol using a latex band 
for resistance when performing elbow flexion and extension exercises over 75 days. This 
patient increased strength in the trained muscle groups; however, this did not transfer to 
functional improvements. Further research in larger cohorts has examined changes in 
functional measures. Drory and colleagues (2001) investigated the use of individualised 
programmes for increasing strength of the limbs and trunk in 14 patients with MND 
compared to 11 patients who performed only their usual daily activities. The exercise 
programme aimed to work individuals against a moderate load for 15 minutes, twice daily. 
Patients were assessed at three, six, nine and twelve months. Drop-out rates were high in both 
the treatment and control groups so only three- and six-month assessments could be 
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compared. Participants in the treatment group had less decline in the ALSFRS-R compared to 
those in the control group at three months but there was no significant difference at the six-
month assessment. ALSFRS-R is a common method of measuring functional change in this 
population. However, it is a subjective assessment that provides scores on broad categories of 
function, and therefore, may not be appropriate as a primary outcome measure in research 
trials. This is the only study that has investigated the impacts of exercise on spasticity in 
patients with MND. Significant differences were observed between the treatment and control 
group on the Ashworth scale at the three month assessment (Drory et al., 2001). However, 
this was not significantly different at the six-month assessment. Although it is widely used 
for measuring spasticity, the Ashworth scale is subjective, and scores are not significantly 
associated with electromyographic parameters in patients with upper motor neuron 
syndromes (Fleuren et al., 2010). Therefore, changes in spasticity as a result of exercise have 
not been well investigated for patients with MND.  
One major barrier to participation in treatment is travelling to the clinics. Therefore, home 
based resistance exercise was investigated in 27 patients who were assigned to either the 
treatment or the usual care control group (Dal Bello-Haas et al., 2007). Again, the primary 
outcome measure was the ALSFRS-R. As in previous research there was a high drop-out rate 
with eight participants in the treatment group and 10 in the usual care group finishing the 
trial. Of the participants that did not drop-out, overall treatment compliance was reported to 
be high. ALSFRS-R and quality of life scores were higher in the treatment group than the 
control at the three- and six-month assessments. Additionally, measures of maximum 
isometric contraction declined significantly less in the treatment group at the six-month 
assessment, indicating potential benefits of long term use of exercise to maintain function. 
Kitano et al. (2018) investigated the use of an unsupervised home-based treatment 
programme that included strength training and stretching of both the upper and lower limbs 
and functional training exercises such as standing from a chair. Of the 21 participants 
recruited, 15 completed six months of home-based exercises and outcomes were compared to 
a historical control group of 84 patients who had participated in six months of supervised 
treatment. No adverse effects were observed in the at home treatment group, indicating that 
this is a safe method of exercise provision. However, there was still a high rate of drop out. 
Interestingly, when compared to historical controls, patients in the at home treatment group 
had a significantly higher respiratory function subscore and total score on the ALSFRS-R 
following treatment. This is likely a result of different exercises performed between patients 
59 
 
in the treatment group and historical controls. Specific information is not provided regarding 
the exercises completed by either group. It is also important to consider changes in healthcare 
systems over time when comparing a group to a historical control group. The dates that data 
was collected from the historical group were not reported and neither were factors such as 
medications taken by participants.  
High drop-out rates are a significant factor of all resistance exercise regimes completed in the 
MND population. Clawson et al. (2018) compared the tolerability and effects of range of 
motion, endurance and resistance exercises in home-based training programmes on 59 
patients. The training programmes were individually designed by a physical therapist and 
lasted six months. At the six-month point, 19 participants remained in the range of motion 
group, 14 in the resistance exercise group and 11 in the endurance exercise group. 
Compliance to the task was lowest in the endurance exercise group and highest in the range 
of motion group. None of the exercises were deemed to be harmful and there were no 
significant differences between groups in any of the outcome measures assess including 
fatigue, ASLFRS-R or quality of life. However, a trend towards fewer falls was noted in the 
resistance and endurance exercise groups. This study demonstrates safety of a range of 
exercise types but reduced compliance in endurance tasks.  
One study (n = 5) has demonstrated potential negative effects of resistance training with loss 
of strength and power following a 12-week training period (L. Jensen et al., 2017). 
Interestingly, despite this, an improvement was observed in a functional chair rise task. In 
this study, a range of strengthening exercises targeting the upper and lower body were 
completed on non-consecutive days, two to three times per week with supervision from a 
clinician. In the absence of a control group, it is difficult to determine whether the observed 
negative changes were a result of disease progression or the exercise regime.  
A pilot study investigating the safety of treadmill exercise recruited nine participants 
(Mohammed Sanjak et al., 2010). Exercise consisted of five-minute training blocks with five-
minute breaks, for thirty minutes total. This was performed three times per week for a total of 
eight weeks. Of the original nine participants, one third dropped-out prior to finishing the 
protocol. For the participants who completed the protocol, gait speed, distance and stride 
length increased significantly in a six-minute walking test at both four and eight months of 
training. This study concluded that repetitive rhythmic exercise is well tolerated and indicated 
the need for further research.  
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As intensity is a limitation for exercise in patients with MND, Braga et al. (2018) investigated 
the effects of aerobic treadmill exercise with cardiopulmonary exercise testing to determine 
the intensity. All participants (n = 48) participated in range of motion exercises, limb 
relaxation, trunk balance and gait training and those in the treatment group had two additional 
sessions of moderate intensity aerobic exercise per week, with cardiopulmonary testing. 
Participants were selected to participate in the training or control group based on proximity of 
living to the hospital. Decline in ALSFRS-R score was observed in both patient groups; 
however, greater decline was observed in the control group. Importantly, although not 
statistically significant, patients in the control group had a higher mean age, had a higher 
percentage of women and a higher percentage of bulbar onset disease type, all predictors for a 
faster rate of decline. To account for this difference, the authors used a multiple linear 
regression model that included disease onset type, age and gender and with this demonstrated 
that the intervention group was an independent predictor of decline in ALSFRS-R score. This 
demonstrates that monitoring muscle fatigue during aerobic exercise may be beneficial to 
prescribing appropriate intensity exercise.  
Inspiratory muscle strength training has been investigated by a number of authors with 
inconclusive results (Cheah et al., 2009; S. Pinto & de Carvalho, 2013; S. Pinto et al., 2012). 
Cheah et al. (2009) investigated the effects of 12 weeks of training with resistance gradually 
increased from 15% to 60% of a participant’s maximal sniff nasal inspiratory pressure. 
Participants in both the treatment (n = 9) and sham groups (n = 10) demonstrated an increase 
in inspiratory muscle strength following the 12 weeks. This increase in strength was greater 
in the treatment group, but between group differences were not statistically significant. None 
of the improvements in strength remained following the offset of training. S. Pinto et al. 
(2012) investigated the effects of twelve weeks of inspiratory pressure training set at 30-40% 
of a participant’s maximal inspiratory pressure using a randomised delayed-start design trial. 
No significant differences were observed between the treatment and the placebo groups in 
this trial. S. Pinto and de Carvalho (2013) then investigated longer term use of inspiratory 
muscle training set at 30-40% of an individual’s maximum inspiratory pressure. Eighteen 
participants from the previous trial continued training for at least eight months. Outcomes 
from this group were compared to historical patient data that were matched for gender, age at 
onset, bulbar vs spinal onset, diagnostic delay, ALSFRS and respiratory test outcomes. There 
was a significant increase in survival time of approximately 12 months in the treatment group 
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compared to controls. However, it is important to consider the limitations of a historical 
control group when compared to a group that are motivated to participate in treatment.  
In the studies that investigated outcomes after a period of no treatment, no differences 
between control and treatment groups were found at follow-up assessments two to six months 
following treatment (Cheah et al., 2009; Drory et al., 2001). These findings are consistent 
with literature that suggests that increases in muscle strength are not maintained following the 
conclusion of strength training.  
Research investigating treatment for dysarthria includes two case studies (Dworkin & 
Hartman, 1979; Watts & Vanryckeghem, 2001). In these studies, a reduction in function 
following treatment was reported. However, both of these studies were single case designs 
with no manner of controlling for disease progression. Watts and Vanryckeghem (2001) 
investigated the outcome of oral motor strengthening, voice and articulation treatment, 
including Lee Silverman Voice Treatment, on a patient with MND. The voice of this patient 
was reported to be hoarse, strained and pressed, with ventricular fold phonation. There was 
not a strong rationale for the choice of treatment approach. Following completion of the 
protocol, the patient demonstrated decreased vocal quality and increased frequency of voice 
breaks. This study did not have controls and, as MND is degenerative, it is difficult to 
separate whether the negative results were in response to the treatment or natural disease 
progression. Dworkin and Hartman (1979) investigated the effects of lingual resistance 
exercises and a palatal lift on a patient with moderately impaired speech and swallowing. The 
treatment protocol was not well defined, with no indication of timing, number of sessions or 
specific exercises completed. They found continued decline in articulation and phonation, 
which was attributed to the progressive nature of the disease. The authors concluded that 
because of the rapid deterioration associated with MND, they were unable to confirm or deny 
the effects of the treatment protocol. 
Strength training has also been assessed to treat dysphagia with the use of EMST (Plowman 
et al., 2019; Plowman, Watts, Tabor, et al., 2016). Plowman and colleagues (2016) initially 
investigated the feasibility of an EMST protocol in 15 patients. To ensure the exercise was at 
a mild to moderate intensity, the device was set at 50% of an individual’s maximum ability. 
Other aspects of training intensity such as number of repetitions per session and number of 
sessions per week remained consistent with previous EMST literature, with five sets of five 
repetitions per day, five days per week (Hegland, Davenport, Brandimore, Singletary, & 
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Troche, 2016; Park, Oh, & Chang, 2017; Troche et al., 2010). EMST was well tolerated and 
resulted in improved respiratory and swallowing outcomes as measured by maximum 
expiratory pressure and anterior hyoid displacement.  
In a subsequent randomised controlled trial, 48 patients with MND received eight weeks of 
treatment with either an EMST150 or a sham device (Plowman et al., 2019). Other training 
parameters remained the same as the pilot study, with one visit from a clinician per week and 
the remainder of the sessions performed independently. Patients in both the EMST and sham 
groups demonstrated increased maximum expiratory pressure (MEP) at the end of the 8-week 
treatment period, likely associated with a learning effect. However, patients in the active 
treatment group had a significantly greater increase in MEP than those in the sham group, 
indicating that there was a positive effect of the treatment on respiratory function. 
Swallowing safety was dichotomised into “safe” and “unsafe” with a cut-off score on the 
PAS of  ≥ 3. Swallowing efficiency was dichotomised into “efficient” and “inefficient” with 
a cut-off score  ≥ 1 on the efficiency subscale of the DIGEST indicating inefficient. Patients 
were also classed as “dysphagic” and “non-dysphagic” depending on whether total DIGEST 
total score was  ≥ 1. This method of analysis may have led to some bias in the results as the 
variability in the data was reduced (Altman & Royston, 2006; Steele & Grace-Martin, 2017). 
Following treatment, decline in swallowing function was observed in both groups. However, 
there was a statistically significant difference reported between groups for swallowing 
efficiency. Significantly greater decline was reported in the sham group compared to the 
active treatment group. However, this change may not be clinically significant as pre-
treatment both groups had two inefficient swallowers (pharyngeal residue  > 10% of bolus) 
and following the eight-week protocol, the treatment group had three inefficient swallowers 
and the sham group had five inefficient swallowers, from 23 individuals in each group. 
Further, while only one patient demonstrated improvement in safety in the active treatment 
group, four patients demonstrated improvement in safety in the sham group; however, this 
was not statistically significant. Data from all of the 23 participants in each group who were 
reported to complete the protocol, were not included in all analyses. In the sham group, 
analysis of swallowing efficiency was performed on only 19 participants pre-treatment and 
21 participants post-treatment. The authors do not describe the reasons for participants not to 
be included in the analyses. Considering that the difference in the number of patients moving 
from efficient to inefficient was only two patients, it may have made a significant difference 
to the outcome if the results from all patients were reported. Despite improvements in hyoid 
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displacement during the pilot study, changes in hyoid excursion were not reported for the 
randomised control study.  
Although the submental muscles are used to complete EMST, swallowing is not involved in 
the task. As previously discussed, sport and exercise literature suggests that generally 
increasing the strength of a muscle group is not likely to improve performance in a task that 
is not trained (Burkhead et al., 2007). This could have contributed to change in outcomes for 
maximum expiratory pressure, the task that was trained, being more compelling than 
swallowing outcomes. These studies provide some evidence that EMST may be beneficial at 
prolonging swallowing function and improving respiratory outcomes in patients with MND, 
but more research with a larger sample size and continuous outcome measures would be 
beneficial.  
Lingual strengthening has also been investigated in a small study of two participants with 
MND (Robison, 2015). This study demonstrated an increase in lingual endurance but not in 
lingual strength following the eight-week treatment program and there was no transfer to 
functional speech or swallowing tasks. Due to concern for over exertion, the strengthening 
load was at 50% of the initial one rep maximum, whereas the duration of the endurance task 
increased weekly. This study suggests that five repetitions of a 50% maximum task are not 
sufficient for increasing lingual muscle strength in patients with MND, investigations in a 
larger cohort would be necessary to confirm this.  
Although evidence exists that strength training may be beneficial for patients with MND in 
improving respiratory and limb muscle function, there is currently no compelling evidence 
that it results in beneficial changes to swallowing. It is possible that due to the heterogeneity 
of dysphagia within this population there will be no one answer that facilitates improvement 
in all patients. Further research is needed to investigate outcomes of various treatment options 
for swallowing in this population. 
6.4 Skill-based training for swallowing 
Swallowing is a task performed at a submaximal strength. Therefore, although a patient may 
demonstrate muscle functioning at a level that is below what is considered normal, this may 
not cause dysphagia. Skill training is an emerging approach in the dysphagia literature that 
targets cortical modulation of swallowing. Although it is a recent addition to the dysphagia 
literature, skill training is not a new concept; it has been investigated for decades in the limb 
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literature. Skill learning is the process of increasing the spatial and temporal precision of a 
movement through practice (Willingham, 1998). Skill acquisition is the systematic 
improvement in performance accuracy without an associated decrease in speed (Kitago & 
Krakauer, 2013). There is some overlap between strength and skill training as there are 
aspects of both strength and skill involved in most tasks. Skilled learning and neural 
adaptation occur within many strength training paradigms, especially during the early stages 
as individuals learn the motor sequence and to maximally activate the antagonist muscles 
with minimal activation of agonist muscles (Folland & Williams, 2007). Conversely, 
repetition of a skilled task may increase the strength and endurance of muscles. However, the 
aim of the systemic adaptation differs between strength and skill training. While strength 
training aims to increase the size and strength of the peripheral muscle, skill training involves 
increasing precision of performance, and shifts focus to adaptation of central control of task 
completion (J. L. Jensen, Marstrand, & Nielsen, 2005).  
Although an individual may have the capacity to perform an activity, ‘skill’ implies a quality 
of performance that must be acquired (Adams, 1987). Improvement at a skilled task is 
attained by increasing the accuracy of the task while increasing or maintaining the speed of 
performance; this is achieved through task repetition and refinement (Adkins, Boychuk, 
Remple, & Kleim, 2006; Kitago & Krakauer, 2013). To increase skill, a task must be 
challenging due to the complexity of the action, rather than the required muscle strength. 
Progression in the level of difficulty upon mastery results in improved learning and continued 
motivation (C. S. Green & Bavelier, 2008).  
Skill learning occurs in multiple phases: an initial period of rapid improvement, followed by 
a consolidation period and continued improvement of the skill at a slower rate (Karni et al., 
1998). Depending on the complexity of the task, skill mastery can take from several days to 
several years (Kitago & Krakauer, 2013; Nudo, Milliken, Jenkins, & Merzenich, 1996). One 
benefit of skill learning is that often, a learned skill remains producible following a period of 
no training. This indicates that there are long-term, experience-specific neural changes 
associated with skill learning, rendering the skill more resistant to detraining effects over time 
than strength training (Tyč, Boyadjian, & Devanne, 2005; Ungerleider, Doyon, & Karni, 
2002).  
It is known that the cortex plays an important role in swallowing and damage to the cortex 
can lead to dysphagia. Skill training is targeted to recruit cortical mechanisms to alter the 
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impaired response. Plasticity allows for reorganisation of neural regions to modify function 
and improve task performance (Bhatnagar, 2013; Kleim & Jones, 2008; Nudo, 2006b). This 
is evidenced by a larger cortical representation present in skilled individuals than novices 
(Elbert, Pantev, Wienbruch, Rockstroh, & Taub, 1995; Remple, Bruneau, VandenBerg, 
Goertzen, & Kleim, 2001). In patients with dysphagia, increased cortical representation of 
pharyngeal swallowing has been associated with recovery (Hamdy et al., 1998; Teismann et 
al., 2008).  
As well as greater cortical activation, skill learning also helps individuals to modulate 
neurotransmitters, alters synaptic morphology and facilitates synaptogenesis (Adkins et al., 
2006; Browne, Morley, & Parsons, 2012; Rioult-Pedotti, Friedman, Hess, & Donoghue, 
1998). Rats trained in a skilled reaching task were found to have more synapses per neuron 
than untrained rats in the neural regions associated with the task in both the motor cortex and 
cerebellum (Black, Isaacs, Anderson, Alcantara, & Greenough, 1990; Kleim et al., 2002; 
Kleim et al., 2004). Dendritic complexity relates to the number of dendritic branches; a 
greater number of branches results in greater synaptic connectivity, and therefore, greater 
potential for recovery. The length and complexity of dendrites has been shown to increase 
following skill training of both the unimpaired and the impaired limb in lesion studies (Allred 
& Jones, 2004; Biernaskie, Chernenko, & Corbett, 2004; T. A. Jones, Hawrylak, Klintsova, 
& Greenough, 1998). As the cortex has a modulatory role in swallowing, if skill training can 
adapt the cortical representation and neuronal structures associated with swallowing, it may 
be an approach that facilitates safe swallowing in patients with neurological damage or 
disease. However, transfer of the previously discussed limb and animal studies to swallowing 
skill training is not guaranteed and more research regarding neural adaptation as a result of 
swallowing skill training is required.  
Plasticity may be adaptive or maladaptive (Humbert & German, 2013); it is therefore critical 
that treatment techniques target beneficial behaviours. Behavioural intervention following 
neurological injury is believed to be an effective contributor to adaptive plasticity (Nudo, 
2006b). Several principles of neuroplasticity have been described, which provide information 
about how to maximise outcomes of skill training. These principles of neuroplasticity include 
use it or lose it, use it and improve it, experience specific, task repetition, task time, task 
specificity, task intensity, task salience, age, transference and interference (Robbins, Butler, 
et al., 2008). Four of the principles of neuroplasticity that are especially relevant to the 
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planning and implementation of swallowing skill training are the concepts of plasticity being 
experience specific, plasticity being dependent on the intensity of training, the importance of 
task salience and using and improving a skill. As plasticity is experience specific, it is 
important that the targeted task is a reflection of the behaviour that requires improvement. 
The cortical pathways associated with the task that is trained are likely to be the only 
pathways that are affected by practice (Nudo, 2006a). The intensity at which a task is 
performed is crucial as it is non-linearly related to neural change. Robbins and colleagues 
(2008) suggest that there is an intensity threshold that is necessary to induce changes to the 
neural substrates. When considering intensity of the sessions, it is also important to consider 
the structure of training, as continuous bursts of training are more beneficial for inducing 
neural change than intermittent training periods.  
Practising and adapting a skill to refine motor movements is thought to increase neural 
representation when performing the task, this is related to the use it and improve it principle 
of neuroplasticity. Cortical neural plasticity is the intrinsic functional reorganisation of the 
cerebral cortex in response to new learning or retraining of a skill (Pascual-Leone, Amedi, 
Fregni, & Merabet, 2005; Tyč et al., 2005). For cortical change to occur the task cannot be a 
task that is performed optimally from the initial attempt; there must be the opportunity for 
skilled improvement with increasing task difficulty over time (Kleim, Barbay, & Nudo, 1998; 
Nudo et al., 1996; Perez, Lungholt, Nyborg, & Nielsen, 2004; Plautz, Milliken, & Nudo, 
2000; Ungerleider et al., 2002). As swallowing is a concept that is often difficult for 
individuals to visualise and adapt, the topic of task salience is best address with the use of 
biofeedback. Biofeedback is discussed in greater detail below.  
6.4.1 Biofeedback 
The use of biofeedback has been researched since the 1940’s, when it was found to enable 
participants to elicit change in processes that would otherwise not be considered to be under 
conscious control, such as their heart rate and blood flow (McKee, 2008). As swallowing is 
an abstract concept, it likely falls into this group of processes. Biofeedback may the patient to 
visualise minute changes to swallowing timing or intensity, allowing increased conscious 
control. Importantly, it is not only the patient who is able to visualise their swallowing but 
also the clinician. Biofeedback allows for specific feedback into the areas of swallowing that 
require adaptation to perform the task precisely. Biofeedback can increase the salience of a 
task as it can make an abstract task more concrete. Tasks that are purposeful and related to 
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the movement that is being trained facilitate neural reorganisation (Robbins, Butler, et al., 
2008). For successful biofeedback, the feedback must be simple to understand, to allow 
modifications to occur in real time. To ensure that the feedback is easy to understand, it is 
usually presented in an auditory or visual modality.  
The uses of biofeedback have expanded with the invention of new instrumentation, allowing 
an increase in the number of physiologic processes to be visualised and altered. Early 
research into biofeedback modalities for swallowing investigated the use of VFSS 
(Logemann & Kahrilas, 1990), sEMG (Bryant, 1991) and videoendoscopy (Denk & Kaider, 
1997). These studies highlighted the benefits of biofeedback in providing objective 
information to increase a patient’s comprehension and expectations of therapy tasks, to 
improve outcomes, especially during the early learning phase. However, limitations were also 
acknowledged. Feedback from VFSS was time restricted due to the need for ionising 
radiation (Logemann & Kahrilas, 1990). Discomfort associated with invasive endoscopic 
methods of biofeedback resulted in several cases of early cessation of treatment (Denk & 
Kaider, 1997). These early studies demonstrated the potential positive effects of biofeedback 
for swallowing and highlighted the need for further investigation.  
Since these early studies, research has investigated various alternative methods for providing 
biofeedback to patients. Measurement of lingual pressure is a non-invasive method of 
providing biofeedback to patients regarding the force produced during by the lingual muscles. 
In a series of two studies, Svensson and colleagues investigated the potential for a lingual 
training task with biofeedback to induce cortical plasticity (Svensson, Romaniello, Arendt-
Nielsen, & Sessle, 2003; Svensson, Romaniello, Wang, Arendt-Nielsen, & Sessle, 2006). 
Healthy participants completed a training protocol during which they protruded their tongue 
against a transducer that measured force. Participants were instructed to produce exactly one 
Newton of force on the transducer. It is likely that changes as a result of this task were due to 
skill, and not strength, as one Newton is only 3 – 18% of what would be expected during a 
maximal tongue protrusion task (Blumen et al., 2002; Sha, England, Parisi, & Strobel, 2000). 
Following only one hour of training, participants demonstrated evidence of neuroplasticity, 
with increased excitability in the primary motor cortex (Svensson et al., 2003; Svensson et 
al., 2006). This highlights the potential for neuroplasticity as a result of bulbar skill training. 
Further research investigated transference of lingual skill training to functional outcomes in 
dysphagic patients. Patients in this study participated in 24 sessions of a combination of 
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lingual strength and skill training protocol (Steele et al., 2013). This training regime resulted 
in increased lingual pressure, improved accuracy of lingual pressure generation, reduced 
airway invasion and improved bolus control. However, as training included aspects of 
increasing strength as well as skill, the observed improvements cannot be attributed to skill 
training alone.  
Respiratory swallow training has been investigated as a method of skill training to improve 
swallowing outcomes in patients with dysphagia due to head and neck cancer (Martin-Harris 
et al., 2015), Parkinson’s disease (J. A. Curtis, Dakin, & Troche, 2020) and anoxic brain 
injury (J. A. Curtis, Seikaly, & Troche, 2020). In 30 patients with head and neck cancer, 
respiratory phase and volume during swallowing was visualised using nasal airflow and 
signals from the rib cage and abdomen (Martin-Harris et al., 2015). The targeted swallowing 
behaviour was swallowing mid-expiration with a mid to low lung volume. The treatment 
protocol was split into three training modules: identification, acquisition and mastery. 
Progression through the levels was dependent on the participant achieving success at the 
previous level and training continued until the participant achieved success at all levels. 
During the identification phase, participants identified the target respiratory pattern and lung 
volume on simulated tracings and while swallowing. During the acquisition phase, 
participants aimed to complete the target swallowing pattern with a bolus with biofeedback. 
For the mastery phase, participants aimed to complete the target swallowing pattern with a 
bolus but without biofeedback. All patients were able to master the task within eight sessions. 
Significant improvement in laryngeal vestibule closure, tongue base retraction, pharyngeal 
residue and airway invasion were noted post treatment with maintenance of improvement at 
one-month post-treatment. The improvements in untrained aspects of swallowing, such as 
tongue base retraction, indicate transference of the learned skill to other aspects of 
swallowing. In single case studies in patients with Parkinson’s disease and anoxic brain 
injury, improvements in respiratory swallow coordination, airway invasion and pharyngeal 
residue were observed following training of respiratory swallow coordination with clinician 
feedback but without the use of biofeedback (J. A. Curtis, Dakin, et al., 2020; J. A. Curtis, 
Seikaly, et al., 2020). Swallowing pattern without biofeedback may be observable by the 
clinician but further research is necessary to investigate accuracy of clinician feedback in the 




Huckabee, Lamvik, and Jones (2014) identified a group of 16 patients with dysphagia that 
was characteristic of mis-sequencing of pharyngeal contraction. Low-resolution pharyngeal 
manometry provided visualisation of the deficit to the patients. Participants were instructed to 
increase the temporal separation between contractile waves produced by the proximal and 
distal pharynx. Following twice-daily treatment sessions for a minimum of one week, patients 
achieved success at the task. The average time between peak pressure in the proximal and 
distal pharynx increased from 15 ms to 137 ms. As a result, 11 patients were able to return to 
a full oral diet following treatment and subjectively reported reduced nasal redirection. 
However, these findings were not confirmed with instrumental assessment and further 
research including VFSS post-treatment would be beneficial. Importantly, patients in this 
group demonstrated effective learning when modulating the pharyngeal phase of swallowing 
in a task that, without the use of biofeedback, would likely be impossible for the clinician to 
explain, provide feedback of success or measure progress.  
Biofeedback in Strength and Skill Training (BiSSkiT) is a software-enabled training protocol 
that uses submental sEMG to provide biofeedback of timing and amplitude of muscle 
activation. During the skill training protocol, individuals swallow such that the peak of the 
sEMG waveform lands within a target box. The target box is randomly placed on the screen 
to increase variability in the timing and amplitude of swallowing. The size of the box varies 
to make the task easier or more difficult depending on levels of success. A small pilot study 
investigated the effects of skill training using the BiSSkiT software for patients with 
Parkinson’s disease. Ten participants completed two weeks of daily skill training with 100 
swallows per session. Following two weeks of skill training, improvement in swallowing 
efficiency (TWST) and quality of life (Swal-QOL) scores, and a reduction in lingual 
movements prior to swallowing onset were observed, demonstrating transference of the 
trained task to functional swallowing (Athukorala, Jones, Sella, & Huckabee, 2014). These 
improvements were maintained across a two-week no-treatment phase, indicating skill 
retention. However, there were no instrumental assessments completed to determine if 
changes in swallowing safety or biomechanics occurred. In a further case study of a patient 
with multiple system atrophy, six sessions of skill training with the BiSSkiT software, with a 
modified home practice task resulted in increased swallowing safety as indicated on FEES (S. 
E. Perry, Sevitz, Curtis, Kuo, & Troche, 2018). Further research is necessary to determine the 
appropriate intensity of skill training and the additional effects of home-based tasks without 
biofeedback. However, these early studies demonstrate the potential for maintenance or 
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improvement in swallowing function in patients with neurodegenerative disease as a result of 
skill training.  
6.4.2 Skill training for individuals with MND 
Neuroplasticity is a critical aspect of skill training, and it is therefore important to consider 
whether neuroplasticity is possible for patients with this rapidly degenerative disease that is 
neurological in origin. Early research in limb literature identified a difference in neural 
activation between individuals with MND and healthy controls when performing a simple 
motor task (Konrad et al., 2002; Konrad et al., 2006; Schoenfeld et al., 2005). During a 
simple hand movement task, individuals with MND demonstrated greater activation in areas 
of the brain that are involved in higher level motor tasks and motor planning than control 
subjects (Konrad et al., 2002; Stanton et al., 2007). Individuals with weakness due to 
peripheral lesions were compared to the patients with MND. The weakness matched controls 
did not demonstrate the same increases in cortical activation as was seen in the MND 
patients, indicating that the neural change was not a result of muscle weakness or task 
difficulty, but exclusive to those with weakness secondary to MND (Stanton et al., 2007).  
Mohammadi, Kollewe, Samii, Dengler, and Münte (2011) propose two distinct phases of 
neuroplastic change in individuals with MND when performing limb motor tasks. These 
phases consist of: 1) an initial phase of increased cortical activation associated with 
maintained function and 2) a later phase in which further loss of motor neurons occurs with 
concomitant reduction in strength. To investigate this, 22 participants were divided into three 
groups depending on hand weakness: no weakness (n = 11), mild weakness (n = 17) or 
marked weakness (n = 19). Participants were included in multiple groups as their function 
declined. FMRI was used to gather information about neural activation during a finger 
flexion and extension task with the right hand. As in previous research, patients in the no 
weakness group demonstrated an increase in areas of neural activation during the task 
compared to healthy controls. In patients with mild and marked weakness the activated area 
was the same as the ALS patients with no weakness; however, there was evidence of 
progressive decline in percent signal change. The authors suggest that this may be due to 
progressive loss of pyramidal cells. The first proposed phase of neuroplastic change was 
during the time in which no weakness was observed in the limb, but the size of the 
sensorimotor cluster in the ipsilateral region was increased compared to healthy controls. 
Further research has also demonstrated increased activation in the primary motor cortex, and 
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supplementary motor areas during limb tasks, suggesting that neural changes in the early 
phase are a result of compensatory cortical plasticity (Konrad et al., 2002; Schoenfeld et al., 
2005; Shen et al., 2015). As muscle strength decreased, mean signal change and beta weights 
decreased, indicating decreased neural activity compared to those with no weakness. This 
indicates that weakness may occur as a result of further loss of motor neurons and inability to 
further compensate by recruiting additional cortical regions.  
There is speculation that the presence of cortical reorganisation in response to 
neurodegeneration differs between spinal and bulbar tasks. Although increased cortical 
activation has been observed in patients with MND during hand movement tasks, Kollewe et 
al. (2010) found reduced cortical activation in patients with MND when performing a vertical 
tongue movement task. Twenty patients with MND and healthy age matched controls were 
recruited. Patients were separated into groups based on the presence of bulbar function and 
hand muscle weakness. The presence of bulbar symptoms was based on the bulbar function 
section of the ALSFRS-R; however, it is not stated what the cut-off was for the patients in the 
“showed bulbar signs” group. The grouping for muscle strength was based on the Medical 
Research Council Scale for testing muscle strength in patients with radial palsy (Paternostro-
Sluga et al., 2008), which split patients into three groups based on severity of muscle 
weakness of the hand. The task consisted of either right hand movements or vertical tongue 
movements during fMRI. Four blocks of 20 seconds of task performance were performed, 
with each block followed by 20 seconds of rest. As in previous research, patients with no 
muscle atrophy of the right hand demonstrated increased cortical activation compared to 
healthy controls during the finger flexion task. However, during the lingual task, patients with 
no bulbar symptoms did not demonstrate a significant change in cortical activation compared 
to healthy controls, but those with bulbar symptoms demonstrated decreased cortical 
activation. The authors concluded that “this suggests that neurodegeneration of the bulbar 
system cannot be compensated and may explain the faster progress of the bulbar-onset form 
of ALS” (Kollewe et al., 2010, p. 808). However, there are limitations to this study. The 
separation of patients into bulbar symptoms and no bulbar symptoms was not specific as the 
ALSFRS-R investigates changes to functional activity rather than muscle weakness. This 
means that a patient could be experiencing muscle weakness in the absence of functional 
change and placed within the no bulbar symptoms group. Further, unlike finger flexion which 
is commonly used to grasp items, vertical tongue movements are not a functional task and it 
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is possible that patients do not perform this task frequently enough to induce compensatory 
neuroplasticity in response to subtle changes in task performance.  
Further research has investigated cortical activation during swallowing in patients with MND 
compared to healthy controls with the use of functional magnetic resonance imaging (fMRI) 
and magnetoencephalography (MEG) (Li et al., 2009; Teismann et al., 2011). Li and 
colleagues (2009) used FEES to identifying dysphagia in patients. Interestingly, both Li et al. 
(2009) and Teismann et al. (2011) demonstrated a hemispheric shift, with greater activation 
of the right hemisphere when compared to the left in patients with dysphagia. Teismann et al. 
(2011) hypothesised that this was due to increased resources being provided to the 
pharyngeal phase of swallowing, under the assumption that this phase is right hemisphere 
dominant. However, as previously discussed, there is conflicting evidence in the literature 
regarding hemispheric dominance for different phases of swallowing. In an fMRI study in 
which participants completed saliva swallows, Li et al. (2009) demonstrated bilateral 
increased activation in the sensorimotor cortex for patients with MND without dysphagia 
compared to healthy controls, indicating functional neural reorganisation to prolong safe and 
efficient swallowing. When compared to healthy controls, reduced cortical activation during 
swallowing was observed for MND patients with mild dysphagia and further reduction in 
those with severe dysphagia (Li et al., 2009; Teismann et al., 2011). These findings align with 
the phases of neuroplasticity proposed by Mohammadi et al. (2011). 
Cortical reorganisation has been demonstrated in patients with MND for limb and functional 
swallowing tasks prior to the presence of functional decline (Konrad et al., 2002; Konrad et 
al., 2006; Li et al., 2009; Schoenfeld et al., 2005). Increased cortical excitement in response 
to early motor changes in MND demonstrate the potential for neural adaptation to occur in 
patients with this neurogenic disease. As previously discussed, in the limb literature skill 
training has been linked to increased corticomotor excitability, neuroplasticity and functional 
improvement (J. L. Jensen et al., 2005; Remple et al., 2001). However, to date, the potential 
for skill training to further facilitate the observed spontaneous changes in MND has not been 
investigated. It is possible that with the addition of skill training and visual feedback, 
increased plasticity may be facilitated, with the potential for improvement or maintenance of 
function.  
One recent study investigated skill training with biofeedback in patients with MND. In a non-
randomised controlled trial, J. Tomik et al. (2020) investigated the use of low resolution 
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oesophageal manometry as biofeedback to improve dysphagia. This study recruited 20 
participants with MND, 10 of whom agreed to participate in treatment. Patients in the 
treatment group participated in five sessions of biofeedback training, with a five-day break 
between each session. During treatment, patients were taught about primary, secondary and 
non-peristaltic oesophageal contractions and oriented to their swallows displayed on a screen. 
Ten bread and ten liquid swallows were completed per treatment session; however, further 
information about the training protocol and feedback provided by the researcher during 
training is not discussed in the journal article. There was no assessment session immediately 
following treatment to determine the presence of immediate treatment effects or success in 
task learning during the treatment protocol. One year following treatment, patients who 
underwent skill training demonstrated a significant increase in primary peristaltic wave 
frequency (the peristaltic waves initiated in response to swallowing and provide the main 
force for bolus propulsion). Patients who underwent skill training also demonstrated a 
reduction in non-peristaltic waves (oesophageal waves in which no peristaltic wave occurs in 
the distal smooth muscle oesophagus after proximal oesophageal peristalsis and indicate 
abnormalities in oesophageal peristalsis). No significant changes in these outcomes were 
observed in the control group. BMI was also monitored, with less decline in BMI in the 
treatment group compared to the control group. A reduction in decline of BMI may indicate 
improved nutritional outcomes; however, there are other factors that may contribute to BMI 
including muscle wasting, which is common in patients with MND. There were significant 
limitations to this study. Patients were not randomised to a group, the patients who agreed to 
treatment are the patients who underwent the treatment. This could have created a bias, with 
patients in the treatment group being those who are more proactive and involved in their care 
or those with fewer symptoms making it easier to get to the treatment sessions. Information 
about group differences between the treatment and control group are not provided, including 
time since diagnosis, severity of dysphagia and symptom onset type. It may, therefore, be 
possible that there are unreported inherent differences between groups that account for the 
observed changes. Finally, immediate treatment effects are not reported. It is therefore, 
difficult to conclude that the observed differences are a result of the treatment. Definitive 
conclusions about the effectiveness of the treatment protocol cannot be gleaned from the 
reported outcomes. Further research investigating skill training for patients with MND to 
improve swallowing and nutritional outcomes would be beneficial to determine if the positive 
outcomes in the treatment group can be attributed to skill training. It would be imperative that 
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this research investigate changes immediately following training in addition to longer term 
follow-up.  
7. Summary of evidence 
Dysphagia presents in 86% to 98% of patients with the corticobulbar subtype of MND, and in 
approximately 73% of patients with the corticospinal subtype (A. Chen & Garrett, 2005; 
Kühnlein et al., 2008; Onesti et al., 2017). Both the oral and pharyngeal phases of swallowing 
are affected, with resulting negative impacts on quality of life and survival (Burkhardt et al., 
2017; Paris et al., 2013; Tabor et al., 2016). Common clinical methods of managing 
dysphagia include diet modification and postural adaptations; however, these strategies do 
not alter the course of dysphagia progression and can negatively impact quality of life.  
Although historically avoided in this population, short term beneficial effects of mild to 
moderate intensity strength training have been demonstrated in the limb and respiratory 
literature (Plowman, 2015). To date, little research has been conducted investigating the 
optimal intensity of swallowing treatment and there are no clinically friendly methods of 
identifying fatigue of bulbar muscles during exercise. It would be of benefit to investigate a 
non-invasive and simple to use method of quantifying muscle fatigue to ensure that treatment 
is at an appropriate intensity for patients with MND to optimise training intensity without 
producing harmful levels of fatigue.  
Expiratory muscle strength training (EMST) has been investigated in patients with MND. 
Increased maximum expiratory pressure and potential improvements in swallowing 
physiology have been demonstrated as a result of treatment (Plowman et al., 2019; Plowman, 
Watts, Tabor, et al., 2016). However, the improvement in swallowing was not compelling 
and more research with a large sample size and continuous outcome measures is necessary to 
further investigate this. The resistance set during this task was reduced to 50% of a 
participant’s maximum expiratory pressure to ensure that training was not at an intensity that 
could cause harm. This is less than the minimum recommendations made in sport and 
exercise science for training to be greater than 60% of an individual’s one rep maximum and 
far below the reported ideal of 70-85% of one repetition maximum for muscle hypertrophy 
(Burkhead et al., 2007; Porter, 2000; Wernbom et al., 2007). This may have contributed to 
the limited transference of effects from EMST task to swallowing but may be necessary in 
this population. Long term outcomes of EMST have not been investigated; however, other 
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forms of strength training in MND have demonstrated a detraining effect following the offset 
of treatment (Cheah et al., 2009; A. C. Pinto et al., 1999). Because of these limitations, 
strength training may not be the most appropriate form of dysphagia treatment for patients 
with MND.  
Skill training is an alternative form of treatment that is emerging in the dysphagia literature. 
In the limb literature, successful skill training has been shown to result in increased 
neuroplasticity and cortical excitability associated with the trained task  (J. L. Jensen et al., 
2005; Remple et al., 2001). In patients with Parkinson’s Disease, a skill training protocol 
using sEMG hardware and BiSSkiT software for biofeedback of submental muscle activation 
during swallowing was found to have beneficial effects on both functional swallowing 
outcomes and quality of life following two weeks of daily treatment (Athukorala et al., 2014). 
As dysphagia is also progressive and neurological in origin for patients with MND, it is 
reasonable to hypothesise that functional swallowing improvement may be observed in this 
patient group. However, the use of skill training to enhance neural functioning has not been 
assessed in patients with MND and it therefore remains unknown if plasticity can be elicited 
through behavioural changes. Evidence of increased cortical recruitment during swallowing 
exists in this population prior to functional decline (Li et al., 2009). However, with 
progressive neural degeneration over the course of the disease progression, cortical 
recruitment decreases and functional decline occurs. It has not yet been investigated whether 
skill training can facilitate a prolonged period of cortical plasticity, leading to improved 
functional outcomes in this population. Investigation of BiSSKiT at a mild to moderate 
intensity in patients with MND would be a valuable first step in understanding the potential 














PART II: EXPERIMENTAL STUDIES 
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8. Objectives and Hypotheses 
8.1 Fatigue of submental muscles during a lingual endurance task in healthy 
participants 
8.1.1 Research question 
Does average sEMG output reflect bulbar muscle fatigue during a lingual pressure task?  
8.1.2 Objective 
To determine whether simple sEMG amplitude can be used to indicate muscle fatigue during 
a lingual endurance task. 
8.1.3 Hypotheses 
1. The endurance time of a sustained lingual press at 50% maximum capacity will decrease in 
the final trial compared to the initial trial as a result of fatigue.  
2. Area under the curve when adjusted for time will increase in the final trial compared to the 
initial trial as a result of fatigue.  
8.1.4 Rationale 
Fatigue is expected to occur during isometric contractions that are greater than 30% of an 
individual’s maximum voluntary contraction (De Luca, 1997). As the maximal lingual 
endurance task is set at 50% of an individual’s maximum voluntary contraction, fatigue is 
expected. As muscles fatigue, additional motor units are recruited, firing frequency increases 
and discharges are synchronised to sustain the force produced. Electromyography of a 
fatiguing muscle with a stable force output should reflect muscle fatigue with an increase in 
amplitude of the waveform (Chang et al., 2016).  
8.1.5 Significance 
An assessment of fatigue of bulbar muscles would help in the development of exercise 
programmes for patients with MND as it is recommended that exercise is targeted at a mild to 
moderate intensity. If exercise programmes can be tailored and implemented at an intensity 
that is shown to be mild to moderate for an individual, dependent on their personal fatigue 
levels, this may help to reduce adverse effects associated with high intensity exercise, and 
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therefore, increase ability to offer safe treatment options to patients. Current methods of 
quantifying fatigue are invasive or involve complex equipment and algorithms, which are not 
often clinically accessible. This methodological study is an important first step in developing 
a simple, non-invasive quantitative assessment for fatigue of bulbar muscles. 
8.1.6 Proposed study 
Twenty-four healthy participants will be recruited with three males and three females in each 
of the following age groups: 20-39, 40-59, 60-79 and over 80. Each participant will complete 
eight repetitions of a maximum lingual endurance task. The lingual endurance task will be 
completed at 50% of an individual’s pre-determined maximum pressure. During each trial, 
participants will press the anterior surface of their tongue against a lingual pressure bulb with 
concurrent sEMG over the submental muscles to measure muscle activity. Outcome measures 
will be the time that a lingual endurance trial is sustained and the average sEMG output. 
Linear mixed effects models will be used to investigate the effect of fatigue over trials on the 
outcome measures.   
8.2 Pilot study investigating the feasibility of skill training for patients with dysphagia 
secondary to MND 
8.2.1 Research questions 
 Is skill training for swallowing a feasible treatment option for patients with MND? 
 Would it be feasible to perform a larger scale treatment study in patients with MND in 
Christchurch, NZ? 
8.2.2 Objectives  
 To determine the feasibility of participating in a skill-based swallowing task with 
surface electromyography as biofeedback in patients with dysphagia secondary to 
MND.  
 To determine if skill training results in potential improvement in swallowing 
outcomes and quality of life for patients with MND, indicating the need for further 
research. 
 To investigate rates of recruitment to determine the feasibility of conducting a large-




 Participants will be able to participate in skill training with surface electromyography 
as biofeedback as evidenced by the participants completing 80 swallows per session 
and a drop-out rate less than 10%. 
 Participants will demonstrate improvement in functional swallowing outcomes as 
evidenced by: 
- Increased volume per swallow at the end of the treatment period compared to 
baseline as measured by the TWST  
- Decreased time per swallow at the end of the treatment period compared to 
baseline as measured by the TWST 
- Increased volume per sec at the end of the treatment period compared to 
baseline as measured by the TWST 
- Decreased time to complete the TOMASS following treatment compared to 
baseline. 
- Decreased number of swallows to complete the TOMASS following treatment 
compared to baseline. 
 Participants will demonstrate improvement in quality of life as evidenced by: 
- Increase in swallowing related quality of life total score following treatment 
compared to baseline as measured by the Swal-QOL. 
- Decrease in EAT-10 score following treatment compared to baseline. 
 Participants will demonstrate improvement on speech related outcomes as 
demonstrated by: 
- An increase in syllable repetition following treatment compared to pre-
treatment 
- An increase in prolonged vowel duration following the treatment period when 
compared to the pre-treatment assessment.  
 Improvements in functional swallowing ability, quality of life and speech outcomes 
will be maintained over the follow-up period.  
8.2.4 Rationale 
It is hypothesised that participants will be able to participate in this study as sEMG treatment 
has no known side effects and this protocol will be presented at an intensity that is not likely 
to result in muscular fatigue. For patients with MND, low to moderate intensity exercise is 
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recommended as high intensity exercise may cause fatigue and increase the rate of functional 
decline (Carreras et al., 2010; Plowman, 2015). As targets are placed between 40% and 70% 
of a patient’s maximal contraction, skill training using the BiSSkiT software is likely to fall 
within the mild to moderate intensity category. For patients with MND and no evidence of 
dysphagia, cortical activation is increased during swallowing compared to healthy controls, 
likely as a result of compensatory plasticity (Li et al., 2009). Skill training using the BiSSKiT 
software is a swallowing specific task with the potential to increase positive neuroplasticity 
with transference of skill to functional swallowing outcomes in patients with 
neurodegenerative diseases (Athukorala et al., 2014; S. E. Perry et al., 2018).  
8.2.5 Significance 
As no previous research has been conducted using skill training for swallowing outcomes in 
patients with MND, this pilot study is a necessary first step to determine the relevance of 
further research.  
8.2.6 Proposed study 
This pilot study aims to recruit six to ten participants in the Christchurch region. If 
recruitment within Christchurch is not possible, recruitment will expand to include other 
centres within NZ. Participants will undergo four weeks of skill training for swallowing using 
the BiSSkiT software. These four weeks of active treatment will be preceded by a four-week 
period of no treatment to assess natural decline and followed by a four-week period of no 
treatment to assess maintenance effects. Functional swallowing will be assessed by the 
TOMASS and TWST, and patient perception of impairment by the Swal-QOL and EAT-10. 
Speech outcomes will be assessed by vowel prolongation, alternating motion rate and 
sequential motion rate. Due to the small number of participants, descriptive statistics will be 
used to describe observed changes in outcome measures.  
8.3 Exploratory study investigating the effects of skill training on swallowing and 
quality of life in patients with MND 
8.3.1 Research question 
Does skill training for swallowing improve swallowing and quality of life outcomes for 




To determine if a two-week skill training protocol is beneficial for swallowing and quality of 
life outcomes for individuals with MND.  
8.3.3 Hypotheses 
 Participants will increase temporal accuracy in the treatment task over the treatment 
period. 
 Participants will increase amplitude accuracy in the treatment task over the treatment 
period. 
 Swallowing skill will be maintained over the follow-up period. 
 Participants will demonstrate a reduction in the rate of decline in swallowing related 
quality of life over the treatment period when compared to the baseline period. This 
will be demonstrated by: 
- Reduced rate of decline in total swallowing symptom frequency as measured 
by the Swal-QOL 
- Reduced rate of decline in pharyngeal symptom frequency as measured by the 
Swal-QOL 
 Improvements in swallowing related quality of life will be maintained over the 
follow-up period.  
 Participants will demonstrate increased speed of swallowing initiation on VFSS 
following treatment compared to the baseline period as demonstrated by a decrease in 
OPTT. This will be observed for: 
- Five cc water boluses 
- Five cc puree boluses 
- Boluses of a bite of cracker   
 Participants will demonstrate an increased speed of pharyngeal bolus transit following 
treatment when compared to pre-treatment as measured by 
- Decreased HPTT with 5 cc water boluses measured by VFSS 
- Decreased HPTT with 5 cc puree boluses measured by VFSS 
- Decreased HPTT with a bite of cracker measured by VFSS 
- Decreased TPTT with 5 cc water boluses measured by VFSS 
- Decreased TPTT with 5 cc puree boluses measured by VFSS 
- Decreased TPTT with a bite of cracker measured by VFSS 
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- Decreased hypopharyngeal bolus presence time with 5cc saline boluses 
measured by HRIM 
- Decreased hypopharyngeal bolus presence time with 5cc puree boluses 
measured by HRIM 
 Improvements in swallowing timing will be maintained over the follow-up period.  
 Participants will demonstrate a reduction in rate of decline in pharyngeal pressure 
generation over the treatment period when compared to the baseline period for: 
- Pharyngeal constriction ratio (PCR) of five cc water boluses measured by 
VFSS 
- PCR of five cc puree boluses measured by VFSS 
- PCR of a bite of cracker measured by VFSS 
- Hypopharyngeal peak pressure (PeakP) measured by HRIM for 5 cc thin 
liquid boluses 
- Hypopharyngeal peak pressure (PeakP) measured by HRIM for 5 cc puree 
boluses 
 Participants will demonstrate a decrease in rate of decline in extent of UES opening 
measured by VFSS over the treatment period when compared to the baseline period 
for: 
- Five cc water boluses 
- Five cc puree boluses 
- Boluses of a bite of cracker 
 Participants will demonstrate an increase in hyoid excursion measured by VFSS 
following treatment compared to pre-treatment for: 
- Five cc water boluses 
- Five cc puree boluses 
- Boluses of a bite of cracker 
 Participants will demonstrate an increase in hyoid excursion measured by US 
following treatment compared to pre-treatment for: 
- Five cc water boluses 
- Five cc puree boluses 
- Dry swallows 
 Participants will demonstrate improvement in functional swallowing outcomes over 
the treatment period compared to the baseline period as demonstrated by: 
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- Decreased number of swallows measured by the TOMASS 
- Increased volume per swallow measured by the TWST 
- Decreased time per swallow measured by the TWST 
- Increased volume per sec measured by the TWST 
 There will be no significant muscle hypertrophy over the treatment period as 
measured by CSA of the geniohyoid+ muscle complex (GH+), and anterior belly of the 
digastric muscles.  
8.3.4 Rationale 
Improvements in functional swallowing outcomes were observed in the pilot study for 
patients with mild to moderate dysphagia. These signs of improvement suggested that further 
research would be beneficial to investigate the physiology associated with functional 
changes. Many outcome measures will be assessed as the research is exploratory.  
It was hypothesised that no significant muscle hypertrophy would be observed as peripheral 
muscle hypertrophy occurs as a result of exercises that are conducted above the habitual level 
(Rasch & Morehouse, 1957; Zatsiorsky & Kraemer, 2006) and the skill training protocol will 
occur at 30 – 70% of an individual’s effortful swallow, which is within the range of normal 
swallowing. 
8.3.5 Significance  
Treatment options are currently limited for patients with MND due to the historical belief that 
exercise would result in negative outcomes for this patient group. With emerging evidence 
that exercise may be beneficial for patients at a mild to moderate intensity, it is crucial that 
various options for this group are investigated. Effective swallowing treatment for patients 
with MND could increase life expectancy and quality of life by prolonging the time patients 
are able to eat orally and by reducing sequelae associated with dysphagia that can result in 
mortality such as malnutrition and aspiration pneumonia.  
8.3.6 Proposed study 
Twenty-four patients with dysphagia secondary to MND will be recruited across sites in NZ 
(Auckland and Christchurch) and the USA (New York City). The study will be an A-B-A 
trial with a baseline period, treatment period and follow-up period, each two weeks. During 
the treatment period, individuals will participate in a two-week skill training protocol using 
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sEMG as biofeedback through the BiSSkiT software. For all participants, quality of life will 
be assessed with the Swal-QOL questionnaire and swallowing will be assessed by the 
TOMASS, TWST, and Ultrasound. To provide more information about swallowing 
physiology and how this is affected by a period of skill training, participants in Auckland will 
additionally undergo VFSS and participants in Christchurch will additionally undergo VFSS 
and HRIM. Data will be analysed using linear mixed effects models to determine if there is a 
difference between each of the assessment points and to compare the amount of change 










9. Fatigue of submental muscles during a lingual endurance task 
in healthy participants1 
9.1 Introduction 
Research has demonstrated that while mild to moderate exercise may be beneficial for 
patients with MND, high intensity exercise has been reported to be detrimental (Carreras et 
al., 2010; Plowman, 2015). This theory is based on the premise that high intensity exercise 
leads to fatigue of bulbar muscles and a faster rate of decline. However, degree of muscle 
fatigue as a result of the exercise was not documented during these studies. More information 
about muscle fatigue of patients with MND during exercise may help to increase 
understanding of the mechanism that results in poorer outcomes for patients following high 
intensity exercise and to individualise exercise regimes. 
Mechanisms of muscle fatigue are dependent on the type, intensity and frequency of exercise, 
and demographic factors such as age, sex, degree of general fatigue and health status. This 
includes a faster rate of muscular fatigue during isometric limb tasks in patients with MND 
compared to healthy controls (Finsterer & Drory, 2016; Palacios et al., 2015; M Sanjak et al., 
2004; Sharma & Miller, 1996; Skurvydas et al., 2006). As there are many factors contributing 
to degree of muscular fatigue, it would be beneficial to tailor treatment programmes to an 
intensity that is the appropriate level by quantifying fatigue in an individual. However, a 
clinically applicable method of determining levels of bulbar muscle fatigue is not currently 
available. There are many biological and mechanical methods for measuring muscle fatigue, 
including measuring lactic acid build up, force produced and muscle activity through EMG 
(Finsterer & Drory, 2016). These have been used in limb muscles to quantify fatigue during 
and following different exercise regimes (Al-Mulla, Sepulveda, & Colley, 2012).  
The most common non-invasive method for assessing muscular fatigue is sEMG (Al-Mulla et 
al., 2012). Benefits of using sEMG to measure muscle fatigue are that it can measure muscle 
activity as the task is performed and it has been found to be correlated with both biochemical 
                                                 
1 This study is somewhat peripheral, but related, to the scope of the overall thesis. It was 
designed as a community school engagement project to introduce two 13 year old high school 
students to research methods. The students were tutored in research methods and assisted 




and physiological muscle changes associated with the fatiguing process (Cifrek, Medved, 
Tonković, & Ostojić, 2009; del Toro et al., 2019). SEMG works by measuring the activity of 
motor units. When muscles become fatigued, additional motor units are recruited, firing 
frequency increases and discharges are synchronised to produce continual power output at a 
stable level; this is reflected in sEMG output. SEMG is not specific to one muscle, it detects 
signals from all nearby muscles with motor units that are closer to the electrode producing a 
higher amplitude waveform than those that are further away (Stepp, 2012). Therefore, sEMG 
is best at providing information about the activation of superficial muscles. 
Mean and median frequency are the gold-standard for measuring fatigue using sEMG; a 
decrease in frequency indicates fatigue (Al-Mulla et al., 2012; Phinyomark, Thongpanja, Hu, 
Phukpattaranont, & Limsakul, 2012). Measurement of fatigue using sEMG analysis of the 
submental muscles has been used to compare levels of muscle fatigue between the head lift 
exercise and chin tuck against resistance (CTAR) (Sze et al., 2016). Fatigue was assessed 
using maximum muscle activation, frequency values and recurrence values. This method of 
assessment differentiated the levels of fatigue between the two exercises, demonstrating that 
although submental muscle activation was similar, the level of fatigue of the 
sternocleidomastoid muscles was greater during the head lift exercise than CTAR. However, 
there was a large confounding variable with this method of fatigue analysis as there was 
contact between the sEMG electrodes and the ball used for the exercise. Further investigation 
of methods for identifying levels of fatigue of bulbar muscle fatigue is required. However, it 
is important that note that although frequency measurements are the gold standard, access to 
measures of frequency is not always achievable from basic equipment without the use of 
complex algorithms, making them difficult to access in clinical situations. 
Root mean square (RMS) is a measure of the square root of the average voltage measured by 
sEMG for a given period of time. It creates a smooth waveform that allows sEMG data to be 
easily interpreted and is a common method for smoothing the waveform. An alternative 
smoothing method is to rectify and filter the raw data. These processes allow the sEMG data 
to be easily interpreted. When the power output produced by the muscle remains stable, an 
increase in sEMG amplitude is expected as fatigue increases (Chang et al., 2016). Therefore, 
following smoothing, sEMG amplitude may be used as another method for identification of 
muscular fatigue. One of the disadvantages of using an average sEMG amplitude is that a 
change in power produced by the muscle will also influence the amplitude. This limits the use 
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of this strategy in maximum pressure trials as force usually decreases as fatigue increases 
(Chang et al., 2016). However, fatigue is expected to be observed via average amplitude 
when a constant force is generated by isometric muscle contraction that is greater than 30% 
of an individual’s maximum voluntary contraction (De Luca, 1997). Calculating an average 
amplitude from sEMG output during a sustained isometric task can be achieved with basic 
equipment that provides a rectified and filtered time by amplitude waveform of sEMG. This 
method may, therefore, be more accessible for clinicians and it would be valuable to 
determine whether using average amplitude is an effective method of measuring fatigue of 
submental muscles.  
This study aims to investigate if average submental sEMG output that has been smoothed and 
filtered will increase as a result of fatigue over multiple trials of a lingual endurance task. As 
the submental muscles are known to be recruited during a tongue to palate press task (P. M. 
Palmer et al., 2008), one might expect that these muscles would become fatigued during a 
repeated 50% of maximum isometric pressure (MIP) lingual endurance task. It is 
hypothesised that this would be reflected by a decrease in lingual endurance time and an 
increase in average sEMG amplitude.  
9.2 Methods 
9.2.1 Participants 
Twenty-four healthy participants were recruited with three men and three women in each of 
the following age bands: 20-39, 40-59, 60-79 and 80+. Participants were recruited through 
convenience sampling from the general population via written and verbal advertisements.  No 
participant reported a history of muscular or neurological conditions or swallowing 
impairment. Informed consent was gained prior to participation. Ethical approval for this 
study was granted through the University of Canterbury Human Ethics Committee.  
9.2.2 Materials 
The KayPentax Digital Swallowing Workstation (KayPentax, Lincoln Park, NJ, USA) was 
used to collect and display both lingual pressure and sEMG data. A three-sensor pressure 
bulb was modified to contain only one air-filled bulb to measure lingual pressure. During the 
task, lingual pressure was displayed as a time (secs) by pressure (mmHg) waveform on the 
monitor (figure 9.1). Single channel sEMG was used with TriodeTM silver-silver chloride 
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electrodes with 2 cm spacing secured with an adhesive patch (Thought Technology Ltd., 
Canada). Raw sEMG signals were sampled at 250 Hz, bandpass filtered (50 – 250 Hz), 
integrated (50ms time constant), and rectified. The resulting signal was display as a time 
(secs) by amplitude (µV) waveform (figure 9.1).  
 
Figure 9.1. Monitor viewed by participants. Red line represents lingual pressure, blue line 
represents submental muscle activity. A- 50% of participant’s MIP, B- line indicating start of 
trial, C- line indicating end of trial. 
9.2.3 Experimental procedure 
Calibration of the lingual bulb to atmospheric pressure occurred prior to the session, this was 
done as per the standard Kay Pentax operating instructions, using the internal calibration of 
the system. Prior to electrode placement, the skin was prepared with an alcohol wipe to 
remove oils from the skin surface to reduce impedance from the sEMG signal. The self-
adhesive triode electrode patch was positioned over a participant’s submental muscles with 
the two recording electrodes at midline and the ground electrode lateral. The patch was held 





alveolar ridge, ensuring that all parts of the bulb were posterior to the central incisors so the 
participants could not use their teeth to produce pressure on the bulb. Participants were 
instructed to hold this in place using their hands, holding the connecting tubes just anterior to 
the lips. Participants were seated comfortably and it was ensured that they were able to view 
the monitor of the swallowing workstation.  
To determine an individual’s MIP, participants were asked to press their tongue against the 
bulb as hard as possible for three seconds, and the peak of the pressure produced was 
recorded. The researcher used the software to place a threshold line on the screen at 50% of a 
participant’s MIP (line A, figure 9.1). In the lingual endurance task, participants were 
instructed to press their tongue against the bulb such that the pressure waveform remained 
just above the threshold line for as long as possible. As in previous research, if lingual 
pressure dropped below the 50% MIP line for two seconds or below 40% of MIP for more 
than 0.5 seconds the trial concluded (Kays, Hind, Gangnon, & Robbins, 2010; Vanderwegen, 
Guns, Van Nuffelen, Elen, & De Bodt, 2013). Participants were given a 15 sec break between 
trials, during which they were instructed not to talk or apply any pressure to the bulb. The 
researcher monitored this time on a stopwatch and after 12 seconds, participants were given a 
three second countdown and instructed to complete the task again. This task was repeated for 
a total of eight trials. During each trial, participants were given verbal encouragement to keep 
the waveform above the threshold line for as long as possible, as encouragement has been 
shown to increase performance (Andreacci et al., 2002). Although the sEMG waveform was 
not hidden, participants were oriented towards the lingual pressure waveform and were told 
to focus on keeping lingual pressure just above the line.  
9.2.4 Outcome measures 
Muscle activity for each trial was measured by sEMG in microvolts (µV) and lingual 
endurance time was measured in seconds (s). The Kay Pentax Digital Swallowing 
Workstation produces a rectified waveform and therefore true root mean square could not be 
calculated. To produce an average amplitude from the sEMG waveform, the area under the 
curve of the rectified sEMG waveform (µV s) was divided by the lingual press duration (s). 
Each trial was measured from the point in which the lingual pressure first crossed the line 
indicating 50% of MIP (see line A. figure 9.1). The trial concluded at the point when lingual 
pressure crossed the 50% MIP line before it dropped below 50% of MIP for 2 seconds or 
below 40% of MIP for 0.5 seconds (see line B in figure 9.1).  
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Inter-rater reliability of measurement was completed for 20% of trials selected by a random 
number generator. Inter-rater reliability was calculated for the time of a trial and for the area 
under the curve of the sEMG waveform. The second rater was a trained speech-language 
pathologist with no experience using lingual pressure or sEMG as outcome measures. Rules 
regarding when an attempt commenced and concluded were provided in written format and 
training of the second rater was completed through practice on data that were not selected for 
inter-rater reliability. 
9.2.5 Statistical analyses 
All statistical analyses were completed using RStudio software (version 1.2.5033) with R 
(version 3.6.2 for windows). Assumptions of normality and equality of variance were 
assessed. If the assumption of normality or equality of variance was not met, the non-
parametric Friedman’s tests were used to determine if there was an effect of multiple 
attempts. If a Friedman’s test highlighted a significant change across attempts then Wilcoxon 
signed ranks tests were used post-hoc to assess the comparisons of interest. Comparisons 
were selected a priori. Each attempt was compared to the previous attempt to determine if 
there was gradual change in measures of fatigue and the first attempt compared to the final 
attempt to determine if there was an overall fatigue effect across sessions. Bonferroni 
corrections were used to correct for multiple comparisons. As there were eight comparisons 
made, the p-value indicating significance was adjusted to be 0.00625. 
Inter-rater reliability was calculated using intra-class correlation coefficients (ICCs) derived 
from a linear mixed models analysis. A two-way random effects model based on single 
measures (ICC[2,1]) was used. Participant and rater were random effects in the model with 
only an intercept as a fixed effect. When assessing inter-rater reliability, each attempt at the 
task was considered independent. 
9.3 Results 
Inter-rater reliability was excellent for both task duration (ICC = 99.8 [95% CI = 99.7, 99.9]) 
and sEMG amplitude (ICC = 99.28 [95% CI = 98.7, 99.6]). 
The data for duration of lingual endurance did not meet the assumptions of normality and 
equality of variance, therefore a Friedman’s test was performed. There was a significant 
effect of gender (X2 [1] = 4.5, p = .033) but not age group (X2 [1] = 2, p = .157) on lingual 
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endurance time. Over all trials, females produced a median endurance time of 19.75 seconds 
and males produced a median endurance time of 15.46 seconds.  
There was a significant effect of trial (X2 [7] = 41.826, p < .001) on duration of lingual 
endurance. Median endurance time was 34.6 seconds for the initial attempt and 13.9 seconds 
for the final attempt. Post-hoc analysis showed that duration of lingual pressure was 
significantly shorter on the final attempt compared to the initial attempt (V = 255, p < .001). 
When comparing each attempt to the previous attempt, there was no significant change (p > 
.006).  
 
Figure 9.2. Boxplot of duration of lingual endurance over eight trials. 
The average sEMG amplitude data did not meet the assumptions of normality and equality of 
variance; therefore, a Friedman’s test was performed. There was a significant difference in 
average sEMG amplitude between trials (X2 [7] = 14.30, p = .046). None of the pairwise 
comparisons were significant at the a priori determined level of significance following 
adjustment for multiple comparisons (p < 0.006; details in appendix). The difference between 
attempt seven and eight was approaching significance with attempt eight demonstrating a 




Figure 9.3. Boxplot of average activation of submental muscles over eight trials. 
9.4 Discussion 
The gold standard method for measuring muscle fatigue requires complex equipment and 
algorithms, which are not likely to be used in a clinical setting. This study represents an 
exploratory investigation into the use of a simple average sEMG amplitude to determine 
bulbar muscle fatigue. The methods used in the current study were not sufficient to document 
an increase in sEMG amplitude over trials, which would have indicated increasing fatigue. 
Therefore, further research is necessary to refine methods of measuring fatigue of submental 
muscles using non-invasive, clinically accessible means.  
The results demonstrated a significant reduction in lingual endurance time between the first 
and final attempts; this likely indicates fatigue as a result of task repetition. A reduction in 
lingual endurance as a result of fatigue has been demonstrated in previous research (Kays et 
al., 2010). Kays et al. (2010) recruited 22 healthy participants and assessed lingual endurance 
at 50% of MIP both before and after a meal using the Iowa Oral Performance Instrument 
(IOPI). Both young and older participants demonstrated a reduction in anterior lingual press 
endurance time following the meal compared to the baseline condition. In the current 
research, significant changes in lingual endurance time were not observed between 




Levels of patient motivation may have also contributed change in endurance time over trials. 
During the current study, participants received immediate visual biofeedback of their 
performance, as well as verbal encouragement, which has been shown to increase task 
performance (Andreacci et al., 2002). However, a limitation of all isometric endurance tasks 
is that factors such as a participant’s motivation, tolerance to discomfort and competitive 
spirit can contribute to their performance (Solomon, 2004). If participants were to lose 
motivation by the later trials, despite no change in fatigue, this could have contributed to the 
significant findings for a reduction in time and lack of significant findings for increase in 
average sEMG amplitude. 
There was no significant change in average sEMG amplitude between trials. This is contrary 
to the hypothesis that increasing levels of fatigue due to task repetition would result in an 
increase in sEMG amplitude. There are multiple possible explanations for this finding. The 
lack of significant change in average amplitude may be due to the fact that sEMG is not 
specific to a single muscle and the contribution of each muscle to the output is dependent on 
the proximity to the recording electrodes. Anterior tongue to palate pressure is produced by 
the genioglossus, mylohyoid, anterior bellies of the digastric, medial pterygoid and intrinsic 
tongue muscles (P. M. Palmer et al., 2008). The intrinsic tongue muscles, anterior portion of 
the geniohyoid and the submental muscles are all primarily made up of type II muscle fibres 
(Korfage, Schueler, Brugman, & Van Eijden, 2001; Saigusa, Niimi, Gotoh, Yamashita, & 
Kumada, 2001; Stål, Marklund, Thornell, De Paul, & Eriksson, 2003), which are designed for  
fast, frequent bursts of activity but not for endurance tasks. Therefore, these muscles fatigue 
quickly. With the electrode placement that was used, the submental muscles produce the 
majority of the electrical signal picked up by sEMG (P. M. Palmer et al., 1999). If other 
contributing muscles become fatigued prior to the submental muscles, it could result in the 
observed decrease in lingual endurance time without evidence of submental muscle fatigue 
identified by sEMG.  
For many participants, the amplitude of the sEMG waveform appeared to increase within the 
trial as lingual pressure begins to drop (figure 9.1). It is possible that this indicates fatigue of 
submental muscles within a trial that was not observed between trials. Participants were given 
a 15 sec break following each trial, this may have allowed muscle recovery and have limited 
the findings of increasing sEMG amplitude between trials. Alternatively, this could indicate a 
pattern of muscle activation in which intrinsic lingual muscles are primarily recruited to 
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achieve tongue to palate approximation. However, as intrinsic lingual muscles begin to 
fatigue, extrinsic muscle activation occurs to compensate for fatiguing intrinsic lingual 
muscles to maintain tongue to palate pressure. Thus, the increase in sEMG amplitude 
observed within a trial may be the result of increased power output of the submental muscles 
rather than submental muscle fatigue.  
Although it was not the purpose of the study, gender and age effects were investigated. There 
is debate in the literature regarding the presence of a gender effect on lingual endurance time. 
Studies in English and Portuguese speaking participants have found no differences between 
males and females in lingual endurance time at 50% MIP (Stierwalt & Youmans, 2007; 
Vitorino, 2010) and a study in Belgian participants demonstrated longer lingual endurance in 
males than females (Vanderwegen et al., 2013). In the current study, there was a significant 
difference in lingual endurance between genders with females producing a longer lingual 
endurance time than males. The current sample size was much smaller than that of previous 
studies and therefore may not be representative of the population. The finding that lingual 
endurance did not vary in response to age mirrors many previous studies that have also 
demonstrated no significant effect of age on lingual endurance time (Stierwalt & Youmans, 
2007; Vanderwegen et al., 2013; Vitorino, 2010).  
9.4.1 Limitations and future research 
This study relied on the assumption that fatigue would increase over trials. Lingual endurance 
time decreased significantly between the first and last trials, with gradual decline over 
sequential trials. This may indicate fatigue over trials; however, this cannot be confirmed 
with the current research methods. Further research to develop a clinically friendly method of 
quantifying fatigue of bulbar muscles would be beneficial for patients with dysphagia. In 
future research it would be useful to simultaneously collect sEMG frequency data as this is 
the gold standard for non-invasive assessment of muscle fatigue, and would therefore help to 
determine if muscle fatigue is occurring and validate the average sEMG amplitude data.  
It was observed in the current study that sEMG output increased within a trial; however, there 
was no change between trials. There was a 15 sec rest period between each of the trials, 
which may have been sufficient for some degree of recovery from fatigue. If participants had 
time to recover between trials, then it is unsurprising that there was no significant changes in 
fatigue levels measured by sEMG. Further research investigating changes within a trial or 
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without significant rest time between trials may be beneficial at determining the use of this 
method of detecting fatigue.  
A further limitation of this study is that many muscles are recruited to produce tongue to 
palate pressure but sEMG in the position used during this study primarily provides 
information regarding activity of the submental muscles. If using surface electromyography 
in the position used in this study, it would be of benefit to assess submental muscle activity 




10. Skill training for swallowing and quality of life in patients 
with MND 
10.1 Introduction 
Dysphagia is a symptom experienced by between 73% and 98% of patients with MND (A. 
Chen & Garrett, 2005; Kühnlein et al., 2008; Onesti et al., 2017). The cause of dysphagia in 
this population is likely a combination of both UMN and LMN degeneration leading to 
weakness of pharyngeal muscles as a result of spasticity and flaccidity. Any and all phases of 
swallowing can be affected over the course of MND. Oropharyngeal dysphagia can result in 
malnutrition and aspiration pneumonia, which can lead to death (Corcia et al., 2008; Yang et 
al., 2011). It is also one of the largest contributors to reduced quality of life in this population 
(Paris et al., 2013).  Despite this, exercise to prevent or improve dysphagia is not often 
recommended (Plowman et al., 2017). This is likely due to a historical belief that exercise 
results in muscular fatigue leading to worse outcomes for patients. However, recent literature 
demonstrates that exercise at a mild to moderate intensity may have positive outcomes 
(Carreras et al., 2010; Plowman et al., 2019; Plowman, Watts, Tabor, et al., 2016).  
A series of publications by Plowman and colleagues investigated the impact of expiratory 
muscle strength training (EMST) for patients with MND (Plowman, 2015; Plowman et al., 
2019; Plowman, Watts, Tabor, et al., 2016). Following a training period, patients in the 
treatment groups demonstrated an increase in maximum expiratory pressure. However, 
despite the authors reporting significant results, differences in swallowing outcomes between 
the treatment and control groups were not as compelling. Although strengthening of 
submental muscles is a benefit of EMST, the task is not specific to swallowing. It is possible 
that the lack of specificity in conjunction with decreased task intensity contributed to the 
limited improvement observed in swallowing outcomes despite increase in maximum 
expiratory pressure. 
Skill training for swallowing is a novel, swallowing specific treatment approach that has the 
potential to increase neuroplasticity and cortical excitability. To increase the likelihood of 
neuroplasticity, it is important to practice a task that is specific to the skill that it is intended 
to improve, with maximised intensity, repetition and long continuous bursts of training 
(Kitago & Krakauer, 2013; Robbins, Butler, et al., 2008). However, for patients with this 
rapidly neurodegenerative disease, the potential for skill training to induce neuroplasticity has 
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not been investigated. Importantly, there is evidence of early cortical reorganisation during 
swallowing in patients with a diagnosis of MND, but this is not associated with functional 
swallowing changes (Li et al., 2009). However, as the disease progresses and functional 
changes to swallowing become evident, a progressive reduction in cortical activation has 
been observed (Li et al., 2009; Teismann et al., 2009). These data suggest spontaneous 
neuroplasticity compensates for functional changes early in the disease, with disease 
progression presenting as both neural decline and progressive dysphagia. 
SEMG has been used as a swallowing biofeedback modality for decades (Crary & Baldwin, 
1997; Huckabee & Cannito, 1999). However, the investigation regarding its use for skill-
based training is much more recent. A skill training protocol has been investigated in patients 
with Parkinson’s Disease and was found to have significant beneficial effects on both 
functional swallowing outcomes and quality of life following two weeks of daily treatment 
(Athukorala et al., 2014). The authors hypothesised that these changes may be a result of 
greater voluntary control of swallowing, with increased cortical activation allowing patients 
to partially bypass the defective basal ganglia. As dysphagia is also progressive and 
neurological in origin for patients with MND, it is reasonable to hypothesise that a similar 
pattern of change will be observed in this patient group with MND.  
This research programme consisted of a pilot and a treatment study. The pilot study aimed to 
determine if it was feasible to complete skill training using the BiSSkiT software in a 
population of patients with MND and to determine if it was feasible to recruit an adequate 
sample size for the study within Christchurch, NZ. Following completion of the pilot study, 
the treatment study was initiated with methods that were adapted in response to results of the 
pilot study. The aim of the treatment study was to investigate the effects of skill training for 
swallowing on swallowing outcomes and quality of life in a larger patient cohort. As this was 
early exploratory research, a large number of outcome measures investigating swallowing 
function, biomechanics and quality of life were probed in an attempt to determine which 
areas of swallowing may be improved through this skill training protocol.  
10.2 Methods 
10.2.1 Participants  
The pilot study aimed to recruit ten patients with a diagnosis of MND within Christchurch in 
a one-year period. Participants were recruited through the support worker and specialist nurse 
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within the Motor Neurone Disease Association or the SLT. Participants received continued 
usual care from their SLT throughout the protocol; this did not, by report, include any active 
swallowing treatment. An explanation of the study protocol was given and written informed 
consent was obtained from all participants prior to participation. As methods were adapted 
for the treatment study, data from the initial five patients were not included in the final 
analysis. The initial participant in the pilot study was seen as a clinical patient at the Rose 
Centre for Stroke Recovery and Research and his results were included retrospectively. He 
therefore did not complete all of the assessments and some of his treatment sessions were 
conducted in his home without a researcher present. This study was approved by the 
University of Canterbury Human Ethics Committee. 
The subsequent treatment study aimed to recruit 24 participants with complete data sets from 
Auckland (NZ), Christchurch (NZ) and New York City (USA). Patients aged 18 or over with 
a diagnosis of MND made by a neurologist, and no history of any other neurological, 
structural or muscular conditions that may influence swallowing outcomes were recruited 
through the NZ MND Registry, the National ALS Registry (USA), SLTs and the Canterbury 
MND nurse specialist. At the initial meeting, patients were assessed using the EAT-10 
(Belafsky et al., 2008). A score greater than three, indicating self-perceived presence of 
dysphagia, was the final inclusion criteria. If a patient fit the inclusion criteria, demographic 
information was collected at the initial screening session. This demographic information 
consisted of MoCA and ALSFRS-R score as well as patient reported information about date 
of diagnosis, date of initial symptoms, medications and age. The treatment study was 
approved by the Health and Disability Ethics Committee for participants in NZ and the 
Teachers College, Columbia University Institutional Review Board for participants in New 
York City. 
10.2.2 Study design 
Given the degenerative nature of the disease and small population size, a within- subject 
treatment design was employed with an A-B-A approach to account for natural decline over a 
period of no treatment. Within the A-B-A approach, participants completed four assessment 
sessions with daily treatment sessions, five days per week, between assessments two and 
three and usual care alone between assessment one and two and between assessments three 





Figure 10.1. Study design. 
At the time the pilot study was conducted, the plan for the treatment study was to compare 
skill training to strength training using expiratory muscle strength training (EMST). In the 
pilot study, assessments were four weeks apart with four weeks of daily treatment sessions 
between assessments two and four to align with a protocol for EMST. Time commitment was 
reported to be a limiting factor for participation in the pilot study and including the EMST 
protocol as a comparison condition was determined to not be feasible for the treatment study. 
Because of these factors, assessments were two weeks apart for the treatment study with two 
weeks of treatment between assessment two and three, effectively halving total participation 
time from twelve weeks to six weeks, and aligning participation time with a prior study of 
swallowing skill training using the BiSSKiT software in Parkinson’s disease (Athukorala et 
al., 2014).    
Data was collected by three researchers to facilitate this multi-site study. The primary 
researcher collected data at all three sites, with data collection completed by the secondary 
and tertiary researchers if the primary researcher was at an alternate site. The primary 
researcher completed training with the secondary and tertiary researchers, including joint 
assessment and treatment sessions to ensure that all researchers were completing the protocol 
in the same manner. Assessment and treatment sessions were completed with one of the 
researchers at either the Rose Centre for Stroke Recovery and Research (University of 
Canterbury) in Christchurch, North Shore Hospital in Auckland, or the Upper Airway 
Dysfunction Lab (Teacher’s College Columbia University) in New York City. If a participant 
was unable to attend sessions at the centre in their region due to mobility issues or distance, 
treatment sessions were conducted in their home. All assessments in Christchurch and 
Auckland were completed at the University of Canterbury Rose Centre for Stroke Recovery 
and Research and North Shore Hospital respectively. Assessments in New York City, were 
completed either in the participants’ homes or at the Upper Airway Dysfunction Lab at 
















For the pilot study, a Siemens Acuson AntaresTM ultrasound system (Siemens Medical 
Solutions, USA) was utilised, with a CH6-2 curved array transducer for hyoid excursion and 
a VF13-5 linear transducer to measure the CSA of the submental muscles.  
For the treatment study, ClariusTM ultrasound scanners and software (Clarius, Burnaby CA) 
were utilised to allow for portability, accompanied by increased researcher training to 
facilitate optimal image quality. The ClariusTM linear scanner with a frequency range of 4-13 
MHz and depth of 1-7 cm was used to collect images of the CSA of the submental muscles. 
The ClariusTM curvilinear scanner with a frequency range of 2-6 MHz and depth of 3-30 cm 
was used to collect images of hyoid excursion. Image depth and gain were set as per the pre-
set exam type within the ClariusTM scanner; these were pre-determined to provide the best 
image quality. For hyoid images the ‘Abdomen’ setting was selected (depth of 7-10 cm, 
frequency of 4 MHz, single focus, dynamic range of 52dB). However, depth, gain and screen 
brightness were manually adjusted by the researcher to enhance the images. The scanners 
wirelessly connected with an iPad (Apple, CA) through Wi-Fi to allow visualisation and 
recording of videos and images within the ClariusTM  app. Recordings were each 20 seconds 
long and saved at 20 frames per sec on a web-based cloud.  
For all ultrasound data acquisition, aquasonic transmission gel was used to reduce reflection 
between the air and skin surface and enhance the image. Data acquisition was performed with 
a handheld transducer, without a stand to allow for optimal positioning and image quality (S. 
E. Perry, Winkelman, & Huckabee, 2016). 
10.2.2.2 Videofluoroscopic swallowing study 
At the Rose Centre for Stroke Recovery and Research, VFSS images were captured and 
recorded at 25 frames per seconds using an OEC FluoroStar 7900 series scanner (GE 
Healthcare,USA). At North Shore Hospital, VFSS images were captured and recorded at 30 
frames per sec using a Toshiba Ultimax Fluoroscopy unit and a Medi-capture USB 170 
recorder (USB 170 Medicap). Low dose continuous screening modes were used in both 
locations. Videofluoroscopy was not available for patients seen in New York City. 
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Liquid and puree boluses were prepared with a 40% w/v ratio of barium sulfate concentration 
using X-OPAQUE_HD Barim Sulfate Suspension formation (MCI (Aust) PTY LTD, Vic) 
mixed with water for liquid or Watties for BabyTM apple or apple and peach for pureed 
consistency. ARNOTT’S SaladaTM original crackers were spread with a thin layer of E-Z-
PASTE Barium sulfate oesophageal cream (60%w/w) (E-Z-EM Canada Inc., Canada) for the 
standard consistency. 
10.2.2.3 Pharyngeal manometry  
A ManoScan™ ESO Z catheter (Medtronic, Minneapolis) was used. It consisted of 36 
circumferential pressure sensors and 18 impedance sensors spaced 1 cm apart and housed in a 
4.2 mm diameter catheter. Each sensor consisted of 12 circumferential elements; the readings 
from each of these elements were averaged to derive the reading for a given sensor. This 
catheter was connected to a ManoScan 360TM (Model A120) (Medtronic, Minneapolis) 
system which uses the inbuilt ManoViewTM software to display the data. 
10.2.2.4 SEMG hardware and BiSSkiT software 
Treatment sessions and skill assessments utilised single channel sEMG hardware 
(NeurotracTM Simplex, Verity Medical Ltd., UK) and the Biofeedback in Strength and Skill 
Training (BiSSkiT) software (Huckabee, Sella, Jones & Han, 2016). Triode silver-silver 
chloride electrodes, with 2 cm spacing between electrodes and contained on an adhesive 
patch (TriodeTM Electrode, Thought Technology Ltd., Canada) were connected to the sEMG 
device. Information was sent from the sEMG device to the software via fibreoptic cable 
plugged into the computer’s USB port. A laptop computer was used when the treatment or 
assessment occurred at a participant’s home, North Shore Hospital or the Upper Airway 
Dysfunction Lab and a desktop computer for the participants who completed treatment at the 
Rose Centre for Stroke Recovery and Research. The computer used for each participant was 
kept consistent across all treatment and assessment sessions. The sEMG data were displayed 
through the BiSSkiT software as a time by amplitude waveform, with time in seconds on the 
x-axis and amplitude of muscle activity in µV on the y-axis. The BiSSkiT software has 




10.2.2.5 Data extraction and analysis 
A desktop computer with QuicktimeTM player (version 7.7.9, 1680.95.84, Apple Inc.) was 
used to review Ultrasound, VFSS, TOMASS and TWST videos. Timing measures were 
extracted from Quicktime player using the movie inspector function. For all distance 
measurements, still images were extracted from Quicktime player and opened in ImageJ 
(version 1.50i, National Institutes of Health, Bethesda, MD) (Schneider, Rasband, & Eliceiri, 
2012). GNU Image Manipulation Program (GIMP, version 2.10.14, Spencer Kimball, Peter 
Mattis and the GIMP Development Team) was used to align VFSS images for hyoid 
excursion, which were then measured using ImageJ. All statistical analyses were completed 
using RStudio software (version 1.2.5033) with R (version 3.6.2 for windows). 
10.2.3 Experimental Procedure:  
10.2.3.1 Pilot study assessment sessions 
10.2.3.1.1 EAT-10 and Swallowing Quality of Life   
In the pilot study, participants completed the EAT-10 and Swal-QOL questionnaires at the 
beginning of each assessment session. Participants would do this independently when 
possible; however, if assistance was required for physically completing the form, the 
researcher or a family member would provide assistance by reading the questions and circling 
the answer that the participant provided.   
10.2.3.1.2 The Timed Water Swallowing Test and the Test of Masticating and Swallowing 
Solids  
Following completion of the surveys the participants completed the TWST. Participants were 
instructed to drink 150 mL of water “as quickly as is comfortably possible” (Hughes & 
Wiles, 1996). If a participant was unable to complete the 150mL of water due to coughing or 
discomfort then the assessment was terminated and the amount of water that was left was 
recorded and calculation titrated to the ingested amount. If a participant was unable to hold a 
cup to their mouth and was comfortable using a straw, then a straw was used with the 
researcher holding the cup in place for the participant. The use of a straw was kept consistent 
across assessment sessions. The TOMASS was completed after the TWST as there is less 
likelihood of oral-pharyngeal residue from liquid than solid bolus ingestion, which might 
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have influenced the subsequent assessment. To complete the TOMASS, participants were 
instructed to eat one portion of an Arnott’s SALADATM cracker “as quickly as is comfortably 
possible” and say their name when they had finished (Huckabee et al., 2017). If a participant 
nibbled small amounts of cracker rather than biting, they were stopped and instructed to 
begin again without nibbling. 
Clinical judgement was used to determine if it was unsafe for a participant to proceed with 
these assessments; amount of coughing, number of swallows and participant discomfort were 
taken into account. Both the TOMASS and TWST were video recorded with an Apple iPad. 
The iPad was held by the researcher to view the participant in a lateral view and allow for 
optimal visualisation of movement of the thyroid cartilage when swallowing. The eyes were 
not included in video recordings to increase participant confidentiality. Following completion 
of the TOMASS, participants were offered a sip of water to clear any sensation of pharyngeal 
residue before proceeding. 
10.2.3.1.3 Speech assessments 
Vowel prolongation, alternating motion (/pa/, /ta/, /ka/) and sequential motion rate (/pataka/) 
tasks were completed by participants. For vowel prolongation, participants were instructed to 
sustain /ah/ for as long as possible three times with a one-minute break between trials to 
avoid fatigue. For alternating and sequential motion rates, participants were instructed to 
repeat the given sound as quickly and clearly as possible for five seconds. Each sound (/pa/, 
/ta/, /ka/ and /pataka/) was repeated three times. All speech assessments were recorded on a 
voice recorder.  
10.2.3.1.4 Ultrasound 
For collection of ultrasound data, participants sat comfortably in a chair or their own 
wheelchair with their head in a neutral position and their back against the back of the chair. 
Ample gel was applied to the transducer for coupling. Imaging of hyoid excursion was 
completed first. For these measures the transducer was placed in the midsagittal plane, as 
seen in Figure 10.4. This allowed for visualisation of the acoustic shadows produced by the 
hyoid and mandible bones. Minimal pressure was applied to avoid depression of soft tissue, 
which results in distorted images (Stone, 2005).  
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Participants performed three dry swallows, three 5 mL puree swallows from a spoon and 
three 5 mL thin water swallows from a 20 mL medicine cup in sequential order. The 5 mL 
bolus size was selected for puree and water swallows as patients with neurological disorders 
resulting in dysphagia are often unable to consume large boluses in one swallow (Ertekin, 
Aydoğdu, & Yüceyar, 1996). Participants were instructed to hold the bolus in their mouth 
until the transducer was positioned to achieve a clear image, then the instruction was given to 
swallow when they were ready. For consistency, the image was orientated with the skin 
surface at the top, lingual surface at the bottom, the mandible on the left side of the screen 
and the hyoid on the right. If a participant coughed, swallowed multiple times or continued to 
move following the initial swallow, this would be noted and the transducer held in place to 
obtain a rest image once the participant’s muscles relaxed. If the participant was unable to 
stop moving (e.g. severe coughing) so that a rest image could not be obtained within the 20 
sec video limit the trial was repeated after the movement subsided.  
 
Figure 10.4. ClariusTM handheld transducer placed in the midsaggital plane to measure hyoid 
excursion. 
Following the acquisition of data for hyoid excursion, videos of the CSA of the submental 
muscles were collected. Participants were instructed to sit as still as possible with their lower 
back against the back of the chair and without hyperextending their neck. The Clarius linear 
transducer was placed on the coronal plane under the chin (Figure 10.5) with minimal 
pressure applied to ensure the images were not distorted. The pre-selected setting for 
submental muscle CSA was the ‘Breast’ setting on the ClariusTM scanner (depth of 3-5 cm, 
frequency 10 MHz, dual focus, dynamic range of 65dB). Depth, gain and screen brightness 
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were manually adjusted by the researcher as necessary to ensure optimal image quality. A 20 
sec video was acquired as the transducer was slowly moved anteriorly to posteriorly over the 
muscles (left anterior belly of the digastric, right anterior belly of the digastric and GH+).  To 
ensure that there was an image that could be accurately measured, each muscle was imaged 
separately. Videos of the CSA of submental muscles were acquired without a bolus.  
 
Figure 10.5 ClariusTM handheld transducer placed in the coronal plane to measure cross 
sectional area of submental muscles. 
10.2.3.2 Treatment study assessment sessions 
Treatment study assessment sessions began with filling in the Swal-QOL survey, followed by 
the TWST, the TOMASS and US using the same methods as described for the pilot study 
with one adaptation. During Ultrasound, measurements were made by the researcher between 
boluses using the software within the ClariusTM app on the iPad. This gave participants 
approximately one minute of rest between each swallow. As they were not blinded, these 
measurements were not included in the final analysis; this process was completed to ensure 
adequate quality of videos for later analysis. Details of the measurements made are in the data 
extraction section (section 7.2.5.4). If a video and the reviewed images were deemed not of 
adequate quality measurement, the bolus trial was repeated and measured. Following these 
assessments, further instrumental analyses were completed as outlined below.  
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10.2.3.2.1 Swallowing skill 
In assessment sessions three and four, following ultrasound data acquisition, a measure of 
swallowing skill was collected. This information was then compared to the first ten swallows 
of the initial treatment session to determine change in swallowing-skill over time. 
Participants completed ten swallows using the skill training aspect of the BiSSKiT software 
on the same computer that was used for a patient’s treatment sessions. The sEMG electrodes 
were attached and calibrated as per treatment sessions. Ten saliva swallows were performed 
using the skill training aspect of the BiSSkiT software with the instruction to aim for the 
centre of the target box. Visual feedback of success was displayed on the screen as in the 
treatment sessions. If a participant was unable, or did not attempt, to initiate a swallow on a 
trial, the trial would be repeated on the following screen.  
10.2.3.2.2 Videofluoroscopic swallowing study 
VFSSs were completed by two trained researchers or SLTs; an additional radiographer 
assisted with all VFSSs at North Shore Hospital. A radiopaque coin of either 18 mm or 20 
mm (dependent on VFSS location) was adhered under the participant’s chin that was used for 
image calibration. Participants sat in either their own wheelchair or a chair with a back and 
arm rests for comfort.  
Prior to video recording, still images were taken to ensure the correct positioning. It was 
ensured that the nasal cavity and velopharyngeal port, anterior aspect of the mandible, the 
cervical spine and the superior portion of the oesophagus could be visualised. Once 
positioning was confirmed, a bolus hold video was acquired to obtain an image of structural 
position at rest. To acquire the hold position participants held a 1 cc puree bolus (no barium) 
in the oral cavity and were instructed not to swallow, this was recorded for approximately 
two seconds. Participants then performed three non-cued swallows of 5 cc boluses of thin 
liquid mixed with barium followed by three 5 cc boluses of puree mixed with barium. 
Boluses were measured with a syringe; liquid boluses were given to the participant in a 20 
mL medicine cup and puree boluses on a spoon. If the participant was not able to 
independently bring the cup or spoon to their mouth, the researcher would assist with feeding. 
Screening began when the spoon or cup reached the participants lips and continued until 
structures returned to an approximate rest position following the initial swallow. At the Rose 
Centre for Stroke Recovery and Research the researcher was able to start and stop screening 
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independently; at North Shore Hospital, the researcher indicated to the radiographer when to 
start and stop screening. Following the puree boluses, the participant completed three 
swallows, each of a bite of SALADA cracker lightly coated with barium paste. Bite size and 
mastication time were determined by the participant. To minimise radiation exposure during 
mastication, participants were instructed to chew the bite of cracker for as long as they 
needed and to indicate to the researcher just before they were ready to swallow by raising a 
finger or nodding, dependent on the participant’s range of movement. The researcher or 
radiographer would then begin screening and the researcher would instruct the participant to 
swallow when they were ready. If the participant had pharyngeal residue following a bolus 
they were instructed to perform dry swallows or ingest sips of water taken from a cup until 
the residue was cleared.  
10.2.3.2.3 Pharyngeal manometry  
In the treatment study, participants in Christchurch underwent high resolution impedance 
manometry (HRIM). HRIM was not used at North Shore Hospital or the Upper Airway 
Dysfunction Lab due to resource limitations. Routine in-vivo calibration as well as standard 
calibration were performed prior to use, using the calibration protocol within the ManoScan 
system according to the manufacturer recommendations. The participant was seated in a 
comfortable chair or wheelchair with a high back to prevent the participant leaning away 
from the researcher during catheter insertion. To determine which nasal passage was more 
open the participant was asked to cover one nare and inhale and then to repeat with the other 
nare covered. The nasal passage deemed to be more open was used for catheter placement. 
Topical nasal anaesthetic was not used as in healthy participants it has been found to not 
reduce discomfort but it may alter swallowing pressures (Guiu Hernandez et al., 2018; 
Kwong, 2018). A lubricating gel was applied to the end of the catheter to facilitate insertion 
(Omari et al., 2019). The catheter was placed through the selected nare and inserted using a 
standard procedure (Knigge, Thibeault, & McCulloch, 2014; Omari et al., 2019). Once the 
catheter reached the pharynx, as indicated by resistance at the pharyngeal wall, participants 
were instructed to look up so the catheter could be manoeuvred around the nasopharyngeal 
angle. Participants were then instructed to return their head to a neutral position and swallow 
sips of water at their own pace as the catheter was passed through the pharynx and into the 
proximal oesophagus. Once the catheter was inserted with the final sensor just inside the nare 
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and the lower sensors in the oesophagus, the catheter was taped securely to the participant’s 
nose to ensure that it remained in place throughout the assessment.  
Prior to bolus ingestion, participants were given five minutes to become accustomed to the 
catheter in situ (Omari et al., 2019). Participants then performed three dry swallows followed 
by three 5 mL swallows of saline from a 20 mL medicine cup and three 5 mL puree boluses 
(apple sauce mixed with saline) from a spoon. A bolus size of 5 mL was selected as it is 
consistent with other instrumental assessments in this study and it is the most commonly used 
bolus size for pharyngeal manometry (Omari et al., 2019). Three swallows of a consistency is 
considered the minimum number that is sufficient for internal consistency when using 
pharyngeal manometry (Omari et al., 2019). Each swallowing event was marked on the 
Manoscan system by the researcher.  
If at any point the participant experienced extreme discomfort (e.g. continued gag reflex) as a 
result of catheter placement, the study was terminated. If the participant could not tolerate 
catheter placement on the first assessment it was not repeated at subsequent assessments. 
10.2.3.3 Treatment sessions 
10.2.3.3.1 Calibration 
The computer and sEMG device were placed on a table within reach of the participant and 
researcher. Participants were seated in a comfortable chair or their wheelchair and 
encouraged to wear any corrective lenses necessary to ensure that they could view the 
computer screen. The area of skin over the submental muscles was prepared using an alcohol 
wipe. The electrode patch was adhered with the active electrodes placed over the submental 
muscles and the ground electrode placed laterally (figure 10.2), over the mandible. The wires 
were placed over the ears to reduce the chance of movement artefact and to prevent the 
electrode patch from being pulled off due to the weight of the wires. When necessary, the 
patch and electrodes were secured with medical tape to aid adherence. A sEMG reading at 
rest with noise less than 10µV was ensured prior to starting a session. This was achieved by 
turning off nearby electrical appliances that might have interfered and ensuring adequate 
connection between the sEMG electrodes and the skin’s surface. If turning off nearby 
appliances was not possible and noise could not be reduced when in a participant’s home, a 
new electrode patch with repeated skin preparation and/or a different area of the home were 





Figure 10.2. Placement of surface electromyography (sEMG) electrode patch. 
Once the noise was under 10 µV with the patient sitting at rest, the device was zeroed to 
ensure that the waveform represented only movement-related activity. To zero the device, the 
participant was instructed to sit as still as possible and not swallow for 10 seconds. The 
waveform was monitored by the researcher to ensure that no swallows or extraneous 
movement occurred. After 10 seconds, the “Remove DC offset” button on the BiSSkiT 
software was pressed and the waveform dropped to zero. Calibration was completed at the 
start of every session. To calibrate the device, participants were instructed to swallow their 
saliva “as hard as possible”. If this instruction was not sufficient, the researcher would tell the 
participant to “swallow hard as if you are swallowing a golf ball”. The researcher observed 
laryngeal movement of the patient to ensure that a peak in the waveform represented an 
observed swallow. When a swallow was identified, the researcher marked the peak of the 
waveform representing the swallow by placing a cursor with a right mouse click. Each screen 
sweep lasted 30 seconds, one effortful swallow was completed at any time on each 30 sec 
screen with rest between each swallow. If a participant was unable to elicit an effortful 
swallow within a screen sweep, they would be instructed to perform an effortful swallow in 
the following screen and this swallow would be marked; this was repeated until five swallows 
had been marked. The software then calculated the average value from the five calibration 
trials and this was set this as the maximum amplitude of the y-axis during the treatment task.  
The calibration method was adapted following the pilot study as in this study it was observed 
that some participants were unable to produce swallows with peaks within the calibrated 
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screen range. For the treatment study, if the participant was unable to perform effortful 
swallows during calibration, the maximum value on the y-axis was adjusted to be 140% of 
the average of the five swallows from the calibration task. A participant was deemed unable 
to perform effortful swallows if their peak swallowing amplitude when performing a normal 
swallow was consistently greater than or equal to that of the effortful calibration swallows. 
10.2.3.3.2 Treatment 
Following calibration, the treatment task began. During the skill training task, the BiSSkiT 
software provided visual feedback represented by a time by amplitude waveform associated 
with activation of proximal muscles (figure 10.3). Due to the electrodes’ position, a peak was 
observed in the waveform as the submental muscles contracted during swallowing. Increased 
swallowing effort resulted in increased muscle activity, and, in turn, a higher peak on the 
sEMG waveform (De Luca, 1997; Huckabee et al., 2005). The software produced a green 
target box randomly placed on the screen between 30% and 70% of the calibrated y-axis 
amplitude (i.e. between 30-70% of an individual’s effortful swallow amplitude). Participants 
were instructed to swallow their saliva such that the peak fell as close as possible to the 
centre of the target box. This required precision in timing and relative degree of muscle 
activation during swallowing. The researcher observed the participant to ensure that 
swallowing had occurred and provided verbal feedback to the participant if waveforms were 
the result of submental muscle activation that was not associated with swallowing. When 
swallowing was identified, the researcher marked the event by right clicking on the peak of 
the waveform. Each screen sweep lasted 30 seconds with one target box per screen; this gave 
participants time between swallowing to generate saliva and prepare for the following 
attempt. If the participant swallowed multiple times on a screen the swallow that was closest 
to the target box was selected.  
For each trial, success was defined by the peak of the waveform representing a swallow 
falling within the target box. Participants received immediate visual feedback to inform them 
of the accuracy of their performance. Following a swallow, a numerical figure representing 
the distance of the peak of the swallow from the centre of the target box and the word “hit” or 
“miss” would show, in green or red, respectively, depending on a participant’s success (figure 
10.3). The size of the target box was programmed to adapt dependent on success. The target 
decreased in size by 10% following three consecutive successful attempts; this made the task 
more challenging. Conversely, following three consecutive misses, the size of the target 
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increased by 10% to reduce task difficulty. The researcher provided verbal encouragement to 
ensure continued motivation to achieve success, and if a participant appeared to lose 
concentration during the task, the researcher would focus the participant, for example by 
asking “are you ready for the next swallow?” or stating “three more until the break”. 
Participants completed 10 swallows per block, and eight blocks per session for a total of 80 
swallows per session. The decision to use 80 swallows per session was made to limit the 
treatment sessions to one hour and reduce the risk of fatigue compared to 100 swallows per 
session used in previous skill training research (Athukorala et al., 2014). Each block of ten 
trials was separated by a 100-sec rest period during which the participant would be offered 
sips of water and given the chance to speak to the researcher. Conversation and drinking 
water was discouraged between swallows during the treatment task.  
 
 
Figure 10.3 screen that a participant views during treatment. The blue line represents muscle 
activity and the green box is the target. The blue peak within the target represents the 
submental muscle activation during swallowing. 
10.2.4 Data extraction 
During the pilot study, all data were extracted online, and therefore, no blinding was in place. 
When analysing data for the treatment study, the researcher was blinded to session number 
for all analyses and additionally blinded to participant for ultrasound measures. Blinding to 
participant was not possible for TOMASS, TWST or VFSS analysis due to identifying 




Symptom frequency scores from the Swal-QOL survey were analysed. These included the 
total symptom frequency score (all 14 items from section three) and subscores for oral, 
pharyngeal and salivary symptoms. The oral symptom frequency subscore was calculated 
from three factors (drooling, problems chewing and food/liquid dribbling from the mouth), 
pharyngeal symptom frequency from seven factors (coughing, choking on food, choking on 
liquids, gagging, clearing throat, food sticking in throat and coughing when food stuck) and 
salivary symptom frequency from two factors (thick saliva and excess saliva) (McHorney et 
al., 2002). This produced an overall score for each of these factors out of 100.  
10.2.4.2 TOMASS and TWST 
Videos were extracted from the iPad onto a desktop computer. Each video was watched as 
many times as necessary to ensure analysis was as accurate as possible. The number of bites, 
masticatory cycles, swallows and time (in sec) were tallied for the TOMASS (Huckabee et 
al., 2017). The number of bites was determined by the number of discrete segments of 
cracker that the participant placed in their mouth. The number of masticatory cycles was 
counted by observing jaw movement. One masticatory cycle consisted of jaw opening and 
closing. Time started when the cracker passed the bottom lip and stopped when the 
participant said their name. Swallows were counted through observation of the movement of 
the thyroid cartilage. For the TOMASS, the raw data of number of bites, swallows, 
masticatory cycles and the time taken for a participant to consume a cracker were extracted 
from the video recordings. 
The number of swallows and time taken were measured for the TWST. The number of 
swallows was counted through observation of movement of the thyroid cartilage. Time 
started when the cup was put to the lips and stopped when the thyroid cartilage returned to 
the rest position following the final swallow (Hughes & Wiles, 1996). Volume per swallow 
(mL consumed/number of swallows), time per swallow (number of swallows/ time taken) and 
volume per sec (amount consumed/time taken) were calculated in an excel spreadsheet.  
10.2.4.3 Ultrasound 
Videos were downloaded from the ClariusTM cloud onto a desktop computer. QuicktimeTM 
was used to scroll through videos of hyoid excursion frame by frame to select the frame in 
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which the hyoid was at rest and the frame in which it was at maximum excursion. The rest 
frame was always a frame following the swallow. The frame for maximum hyoid excursion 
was that in which the shadow of the hyoid was deemed to be most approximated to the 
shadow cast by the mandible. If piecemeal swallowing occurred, the first swallow would be 
measured and the rest frame taken following the final swallow.  
Measurements were made in a dark room using the straight line function in the image J 
software 1.50i developed by the National Institutes of Health (Schneider et al., 2012). The 
measurements were calibrated using reference points on the right of the image (figure 10.6), 
each of which were one centimetre apart. A best-fit reference line was placed along the 
anterior edge of the acoustic shadow cast by the hyoid bone, which extended past the end of 
the shadow, towards the skin surface.  This was done to help facilitate identification of the 
hyoid measurement point (figure 10.6, line D). The shadow cast by the mandible was used as 
a reference point from which to measure hyoid excursion (figure 10.6, point A) (Macrae et 
al., 2012). A line was drawn from the point on the shadow of the mandible at the posterior 
border where there was a sharp change in direction from vertical to horizontal to the point in 
which the line of best fit intersected the onset of the shadow cast by the hyoid bone (figure 
10.6, line E). The length of this line was measured in mm. This measurement was done first 
in the rest image to calculate Hrest, followed by Hmax using the maximally approximated 
image. The researcher was able to play or scroll through the video at any point in making 
measurements to track movement. Hyoid excursion was calculated as a percentage change of 
the total distance between the hyoid and mandible at rest  







Figure 10.6. A – acoustic shadow from the mandible, B – acoustic shadow from the hyoid 
bone, C- GH+ muscles, D- guideline at the anterior portion of hyoid shadow, E – distance 
measured between hyoid and mandible. 
For CSA of the submental muscles, the image selected was that in which the muscle was at 
its largest, yet still had clear borders. This was done by scrolling frame by frame through 
videos. The frame with the best image was selected for each muscle independently. The 
freehand measurement tool on the ImageJ software was used to outline the muscle borders. 
CSA of submental muscles were measured in mm2. The left (figure 10.7, A) and right (figure 
10.7, B) anterior belly of the digastric muscles were measured separately by tracing around 
the outer borders. The paired right and left geniohyoid muscles and part of the mylohyoid 
muscle (figure 10.7, C) were measured as one entity due to the inability to clearly and 
consistently identify boundaries between the muscles. This was consequently referred to as 
GH+. This measurement ran along the inferior border of the mylohyoid muscle with a vertical 
line drawn to the point where the mylohyoid met the lateral border of the geniohyoid on both 
sides; this line followed down the lateral borders and across the superior border of the 





Figure 10.7. Ultrasound image of CSA of submental muscles, A- left anterior belly of the 
digastric muscles, B-right anterior belly of the digastric muscles, C- GH+ muscles.  
 
Figure 10.8. Measure of GH+ muscle complex 
10.2.4.4 Swallowing skill  
Session statistics were extracted from the BiSSkiT software into an excel spreadsheet. Data 
indicating amplitude and temporal error from the first 10 swallows of the initial treatment 
session and the same data from the first 10 swallows during the third and fourth assessment 




Timing measures of oropharyngeal physiology calculated from the fluoroscopic recordings 
included: oropharyngeal, hypopharyngeal and total pharyngeal transit time, timing of 
supraglottic closure, duration of airway closure and UES opening duration. Spatial measures 
were upper oesophageal sphincter opening, pharyngeal constriction ratio and hyoid 
displacement (Leonard & Kendall, 2008). Additionally, the Penetration-aspiration Scale 
(PAS) was used to quantify depth of and reaction to airway invasion (Rosenbek, et. al. 1996). 
Objective measurements of swallowing from VFSS followed instructions set out in the 
Dynamic Swallow Study (DSS) guidelines (Leonard & Kendall, 2018). VFSS videos were 
saved on a password protected USB and transferred to a desktop computer. For all measures 
image contrast and brightness were adjusted to enhance the image for optimal viewing as 
determined by the researcher.  
The movie inspector function was used on Quicktime player to extract the time in the video 
that each of the following events occurred. B1 was the time in which the bolus passed the 
anterior portion of the nasal spine. BV1 was the time in which the head of the bolus reached 
the base of the valleculae. BV2 was the point in which the head of the bolus left the 
valleculae. BP1 was the time in which the head of the bolus entered the UES. BP2 was the 
time in which the tail of the bolus passed through the UES. AEstart was the time of the first 
superior movement of the arytenoid cartilage for airway protection. AEclose was the time in 
which the airway was fully closed. EM was the moment in which the epiglottis returned to its 
pre-swallow, upright position.  
Formulas were established in Microsoft Excel and the following timing measures were 
calculated  
 Oropharyngeal transit time (OPTT): BV2 -B1 
 Hypopharyngeal transit time (HPTT): BP2 - BV2 
 Total pharyngeal transit time (TPTT): BP2 - B1 
 Timing of supraglottic closure: BP1 - AEClose 
 Duration of airway closure: EM - AEClose 
 Duration of UES opening: BP2 - BP1 
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VFSS spatial measures also followed the DSS guidelines by Leonard and Kendal (2018), 
with some minor variations due to the chosen software. The bolus hold frame was selected 
from the 1 cc puree bolus hold video as the frame in which the participant appeared most at 
rest. To measure maximum hyoid displacement, the frame in which the hyoid was maximally 
displaced both anteriorly and superiorly was selected. The hold and maximum displacement 
images were aligned to allow visualisation of the hyoid bone at rest and during the bolus hold 
within one image (figure 10.9). To align these images, first the hold image was opened and a 
straight line drawn from the anterior inferior portion of the C2 vertebrae to the anterior 
inferior portion of the C4 vertebrae. Additionally, the anterior inferior border of the hyoid 
bone was traced with a freehand drawing tool. The maximum hyoid displacement image was 
then opened as a layer and the same lines drawn from C2 to C4 and around the hyoid. 
Opacity of the overlaid image was set to 50% so that the hold image could be viewed through 
the superimposed image. The two images were aligned by moving and adjusting the angle of 
the maximal excursion image and using the line between C2 and C4 as a guide. Once aligned, 
images were saved as a jpg file. The overlaid image was opened in ImageJ and calibration 
was completed using the known dimensions of the coin placed under the chin. Measurement 
was made between the anterior inferior portion of the hyoid at rest and at maximum 
excursion in mm using the straight line measurement tool. 
 
 
Figure 10.9. Rest and hyoid at max excursion images overlaid with measurement 
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The frame of maximal UES opening was selected by scrolling though the video to find the 
frame in which the UES was maximally distended. Calibration occurred prior to 
measurement using the known dimensions of the coin placed under a patients chin. The UES 
was selected as the narrowest point between C4 and C6 that was not the result of an 
osteophyte. Once the UES was located, the line drawing tool was used to measure in a 
straight line anterior to posterior across the shortest distance of the UES (figure 10.10).  
 
Figure 10.10. UES opening indicated by white line 
To calculate pharyngeal constriction ratio (PCR) the pharyngeal area at rest (PArest) was 
compared to the Pharyngeal area when maximally constricted (PAmax). The same hold image 
was used as the hyoid excursion rest frame. The frame used to measure PAmax was found by 
scrolling through frame by frame on the on Quicktime player. The frame in which the 
pharynx was maximally constricted was selected. Frames were selected on a desktop 
computer then transferred to a Surface laptop (Microsoft®, NM, USA). Calibration occurred 
prior to measurement, by drawing a straight line anterior to posterior on the coin under the 
chin and setting dimensions to the known measurement. An electronic Surface pen 
(Microsft®, NM, USA) was used to outline the structures with the freehand drawing tool on 
the ImageJ software. To measure PArest, an outline was drawn that started at the posterior 
nasal spine with a straight line to the tubercle of the atlas, the line followed down the 
posterior pharyngeal wall and outlined the pyriform sinuses. The outline then traced around 
the anterior superior portion of the arytenoid cartilages and straight across to the epiglottis at 
the point of the connection of the thyroepiglottic ligament. It then followed the epiglottis, into 
the vallecular space, around the base of tongue and the soft palate. If the soft palate was not 
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visible then the line would connect straight up to, but not anterior of, the posterior nasal spine 
(figure 10.11). This area was measured in mm2. PAmax
 was also measured using the freehand 
drawing tool and electronic pen. The area of bolus and any air that was visible in the pharynx 
at maximum constriction, but that was not connected to the body of the bolus, and not below 
the UES, was outlined and the area measured in mm2  (figure 10.12). A ratio of maximum 










Figure 10.12. Measurement of PAmax. 
10.2.4.6 Pharyngeal manometry 
De-identified studies were taken from the ManoScan using a USB and uploaded to the 
Swallow GatewayTM webpage. Studies were saved without identifying material, only the 
randomly generated number produced during blinding. Swallow GatewayTM was used for 
analysis of pharyngeal impedance manometry, following the instructions in the user manual 
(Omari, 2020). To complete this semi-automated data-extraction, the researcher identified six 
landmarks through the software. These are the point of UES relaxation, time of UES 
contraction, position of velopharynx upper margin, position of hypopharynx upper margin, 
position of UES apogee and the position of the UES distal margin (Omari, 2020). If 
piecemeal swallowing occurred, the swallow with the largest bolus volume was analysed as 
per the Swallow GatewayTM instruction manual (Omari, 2020). Data were then exported from 
the software to an excel spreadsheet using the “EXPORT DATA” function. Data for Whole 
Pharyngeal Contractile Integral (PhCI) (mmHg.cm.s), Hypopharyngeal Contractile Integral 
(HPCI) (mmHg.cm.s), UES Integrated Relaxation Pressure (UESIRP) (mmHg), UES 
Relaxation Time (UES Open Time) (s), Hypopharyngeal Peak Pressure (PeakP) (mmHg), 
Hypopharyngeal Bolus Presence Time (BPT) (s) and Velopharyngeal to Tongue Base 
Integral (VTI) (mmHg.cm.s) were extracted.  
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10.2.4.7 Inter- and intra-rater reliability  
Inter-rater and intra-rater reliability were completed on 20% of sessions which were 
randomly selected via a random number generator. Consensus-based training was completed 
with the primary researcher and secondary rater using data that were not selected for inter-
rater analysis. This training followed a guide that was used by both the primary and 
secondary rater to follow when completing the ratings. Inter-rater reliability was performed 
by two separate researchers, one completed inter-rater reliability of ultrasound measures and 
the other of VFSS, TOMASS and TWST measures. Both raters had extensive experience in 
the areas that they were assigned. Two weeks following initial data extraction, the primary 
researcher re-rated the selected sessions for intra-rater reliability.  
10.2.5 Statistical analysis 
Analyses were completed in a stepwise fashion. First, data were assessed for normality and 
equality of variances to determine if parametric tests could be used for analysis. For the data 
which met the assumptions of normality and equality of variance likelihood ratio tests were 
used to determine if there was an effect of session. To do this, the full model, which included 
session as a fixed effect, was compared to the reduced model which did not contain session. 
If there was a significant session effect, further analyses were completed using the full model 
to further evaluate the changes across specific sessions. If the session effect was not 
significant at the 0.1 level then it was concluded that there was no significant difference 
between sessions, and therefore, the treatment had no statistically significant effect. A p-
value of 0.1 level was selected a priori to ensure that post-hoc comparisons were completed 
to identify all potential significant differences between sessions. Comparisons were selected a 
priori and the differences between sessions 1 and 2, sessions 2 and 3 and sessions 3 and 4 
were investigated. These sessions were selected as the difference between sessions one and 
two indicated natural change with no intervention, between sessions two and three indicated 
an effect of the treatment and between three and four investigated the maintenance effect 
after treatment. An alpha level of 0.05 was selected to indicate significance in pairwise 
comparisons. No adjustments were made for multiple comparisons. The study has a small 
sample size and therefore limited power, which inherently results in a large risk of a type II 
error (Christley, 2010; A. Smith, 2018). As this is exploratory research, decreasing the chance 
of type I error and therefore further increasing the chance of type II error through adjustments 
would be detrimental as it could result in overlooking potential clinical benefits (Althouse, 
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2016; Perneger, 1998). Linear mixed effects models were used with session as the fixed 
effect and participant a random effect for all assessments. If multiple boluses were used e.g. 
in VFSS and US measures then each bolus type was analysed independently.  
If assumptions were not met, non-parametric tests were used. Again, these were done in a 
stepwise fashion, starting with Friedmans tests to determine if there was a difference between 
sessions. For boluses with multiple trials (e.g. VFSS and Ultrasound) the scores were 
averaged over these trials. If the p-value was significant at the 0.1 level, post-hoc analyses 
were completed using Wilcoxon signed ranked tests for the pairwise comparisons with the 
same comparisons as made in parametric testing. As with the parametric tests no adjustments 
were made for multiple comparisons and a p-value of .05 was accepted as a significant 
difference between sessions.  
Additionally, the degree of change between periods was compared to determine if the 
treatment hastened or slowed the rate of decline in swallowing ability for a patient. To do 
this, three new variables were created: change over the treatment period (assessment 3- 
assessment 2) change over the baseline period (assessment 2 – assessment 1) and change over 
the maintenance period (assessment 4 - assessment3). As with the previous analysis, 
assumptions were assessed. Comparisons for post-hoc analyses were selected a priori with 
comparisons made between the baseline period and treatment period to determine if the 
treatment alters the usual rate of decline for a patient and comparison between the baseline 
and maintenance periods to determine if the rate of change returns to that of natural decline 
following the offset of treatment. If assumptions were met, linear mixed effects models were 
used to assess for an effect of period with follow-up pairwise comparisons to compare the 
aforementioned periods. This was done in the same manner as the previous analyses with the 
full model, which included period as a fixed effect, compared to the reduced model which did 
not include period. If there was a significant effect of period determined at the 0.1 level of 
significance, post-hoc analyses were completed using the full model to evaluate the changes 
between baseline and treatment and baseline and maintenance periods. If the effect of period 
was not significant at the 0.1 level then it was concluded that there was no significant 
difference between periods. If assumptions were not met, non-parametric tests were 
completed. Friedman’s tests were used to determine if there was a significant difference 
between periods. Again, if there was no significant effect then no further analyses occurred. 
If there was a significant effect at the 0.1 level, post-hoc Wilcoxon signed rank tests were 
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used to complete pairwise comparisons of the aforementioned periods. The PAS is a 
categorical scale (Steele & Grace-Martin, 2017), therefore, descriptive statistics based on 
graphs of the raw data were used to describe the observed changes. 
Inter-rater and intra-rater reliability were calculated for all outcome measures using intraclass 
correlation coefficients (ICCs) derived from linear mixed effects model analyses. For 
assessments with multiple swallows, each swallow was considered independent. For inter-
rater reliability, a two-way random effects model based on single measures (ICC(2,1)) was 
used. Participant and rater were entered into the model as random effects, with bolus as a 
fixed effect if there were multiple consistencies trialled. If multiple boluses were not trialled 
(e.g. Swal-QOL and TOMASS) an intercept was the only fixed effect. Likelihood ratio tests 
were used to determine if there was a significant rater effect. For intra-rater reliability 
ICC(3,1) was used, derived from linear mixed effects model analyses. Bolus (when there 
were multiple consistencies trialled) and rating number were fixed effects with the 
measurement number as the random intercept. All models were tested for normality and 
equality of variance. An ICC value less than 0.5 was considered poor, between 0.5 and 0.75 
was considered moderate, between 0.75 and 0.9 was considered good and above 0.9 was 
considered excellent agreement (Koo & Li, 2016). 
As the PAS was considered a categorical variable, kappa statistics were used to calculate 




 where Pr(a) is the observed agreement and Pr(e) is the agreement expected by 
chance (McHugh, 2012). A Kappa of 0 - .2 was considered no agreement, .21 - .39 minimal  
agreement, .4 - .59 was considered weak agreement, .6 -.79 moderate agreement, .8 - .9 
represents strong agreement and above .9 was considered almost perfect agreement 
(McHugh, 2012). Additionally, the absolute agreement for PAS was calculated by dividing 
the number of trials in which the two raters gave the same rating for the swallow by the total 
number trials.  
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10.3 Results  
10.3.1 Pilot study descriptive results 
10.3.1.1 Participants 
Five participants were recruited for the pilot study. Three had a diagnosis of bulbar onset 
MND and two had a diagnosis of spinal onset MND. The average age was 59.8 with a range 
of 46 to 73. Gender ratio (M : F) was 4 : 1. All patients had an EAT-10 score > 3 (mean = 17, 
range = 4 to 28) at the time of the initial assessment, indicating abnormal swallowing 
(Belafsky et al., 2008; Plowman, Tabor, et al., 2016). Pt4 had a PEG tube in situ to 
supplement hydration but oral intake was his primary source of nutrition at the time of the 
initial assessment. Pt5 had a PEG tube inserted prior to the fourth assessment. Due to 
dysarthria, alternative communication using an iPad was Pt4’s main source of 
communication; all others used verbal communication. No participants dropped out and all 
participants were able to participate in the treatment protocol despite concomitant limb, 
respiratory and speech symptoms. 
Pt1 completed the final three weeks of sessions at home with once-weekly face-to-face 
check-in session to ensure correct procedure. The number of swallows completed per session 
by Pt1 ranged from 17 to 80, with an average of 67 swallows per session. Additionally, the 
participant reported that he would often complete the task sitting in front of the television.  
10.3.1.2 Outcome measures 
The data from TOMASS are detailed below in figures 8.13 - 8.16. For the three participants 
with mild to moderate dysphagia (Pt1, Pt2, Pt3), time taken to complete the TOMASS did not 
vary over the first three assessments (figure 10.13). However, following four weeks of no 
treatment, TOMASS time increased for two of these participants (Pt2 and Pt3) (Figure 
10.13). Number of bites also appeared to be stable or decrease over the treatment period for 
all participants (Figure 10.14). Number of swallows increased over the treatment period for 
all participants (Figure 10.15). There was no pattern of change across participants observed 
for number of masticatory cycles (Figure 10.16). Pt4 was unable to complete the TOMASS in 
the first assessment due to a gagging episode that he could not control; however, he was able 
to complete the TOMASS in subsequent assessments. Pt5 had a PEG tube placed prior to 




Figure 10.13. Time taken for patients to complete the TOMASS at the four assessment 
points. 
 










































Figure 10.15. Number of swallows for patients to complete the TOMASS at the four 
assessment points. 
 
Figure 10.16 Number of masticatory cycles taken for patients to complete the TOMASS at 
the four assessment points. 
Outcomes on liquid bolus ingestion measured by the TWST are displayed below in Figures 
















































per swallow (figure 10.19) increased or remained stable following treatment for the 
participants who were able to complete the test (Pt1, Pt2 and Pt3). This differed from the 
pattern seen over the baseline and follow-up periods of no treatment, during which decline in 
function was observed. Pt4 did not complete the TWST in any assessment due to drinking 
only thickened liquids with supplemental liquids that were delivered through his PEG tube. 
Pt5 was placed on thickened fluids prior to the post-treatment assessment and it was deemed 
unsafe for him to complete the TWST with thin liquids in the final two assessments. 
 









































Figure 10.18. Swallowing efficiency, volume of water consumed in each swallow when 
completing the TWST over the four assessment sessions. 
 
 
Figure 10.19. Time taken per swallow when completing the TWST in the four assessment 
sessions. 
Participant’s self-perception of dysphagia appeared to progressively decline for the 
participants with moderate-severe dysphagia (Pt4 and Pt5). Pt2 reported improved dysphagia 




















































the opposite with a reduction in score over the treatment period and improvement in the 
baseline and follow-up periods (Figure 10.20). Pt1 did not complete the Swal-QOL as this 
was not included in assessments at the time of his participation.  
 
Figure 10.20. Total symptom frequency of participants over the four assessment sessions. 
There was no consistent pattern of change in the EAT-10 over the assessments (figure 10.21). 
Of the two participants deemed to have severe dysphagia, Pt5 demonstrated improvement 
over assessments and Pt4 demonstrated decline. Pt2 and Pt3 demonstrated opposite patterns 
of improvement and decline over sessions (figure 10.21). Pt1 did not complete the EAT10 as 



































Figure 10.21. Self-reported dysphagia symptoms using the EAT-10 survey over the four 
assessment sessions. 
The three participants who completed their assessment sessions in Christchurch underwent 
ultrasound. The ultrasound instrumentation used during the pilot study was not portable and 
therefore, was not able to be used with Auckland participants. The US images obtained were 
deemed to be of insufficient quality for reliable analysis. Therefore, there were no ultrasound 
data extracted for the pilot study.  
Decline in measures of speech production appeared steady across all assessment points. 
Vowel prolongation declined for all participants except Pt2 who demonstrated a steady 
increase in length of prolonged “ah” (figure 10.22).  Alternating and sequential motion rate 
appeared to decline steadily over the course of the assessments for all participants, this 
pattern of change was similar with all sounds produced (figure 10.23). Pt1 did not complete 
vowel prolongation or alternating motion rates as these were not included in assessment 





























Figure 10.22. Vowel prolongation time over the four assessment sessions 
 
 
Figure 10.23. Alternating motion rate for “pa” over four assessment sessions 
10.3.2 Treatment study results 
10.3.2.1 Participants 
Twenty-seven patients with MND were recruited for the treatment study in Auckland (8), 
Christchurch (7) and New York City (12). Three of these participants were excluded because 


















































and the other reported that they obtained the majority of their nutrition through a PEG tube. 
Two participants withdrew from the study following screening but prior to the initial 
assessment. Three participants dropped out prior to or during treatment due to unrelated 
illness in two participants (kidney stones and influenza) and reported discomfort sitting 
during the treatment for one participant who usually remained supine. Nineteen participants 
completed the two-week treatment protocol; however, one of these participants was unable to 
be contacted for the final assessment due to reported hospitalisation for oral ulcers.  
The following data are from the 19 participants who completed the treatment aspect of the 
protocol (table 10.1). One participant was Spanish speaking and completed the Swal-QOL, 
EAT-10 and ALSFRS-R in Spanish with a Spanish speaking researcher (Burgos et al., 2012; 
Campos et al., 2010; Zaldibar-Barinaga et al., 2013). Three participants were unable to 
consistently complete 80 swallows per treatment session due to fatigue, these participants 
completed a minimum of 50 swallows in each session. No patient developed pneumonia 
during the study.  
Table 10.1. Demographic information 
 Christchurch 
(n = 4) 
Auckland      
(n = 7) 
New York City 
(n = 8) 
Total              
(n = 19) 
Age (years)      
Mean ± sd 66 ± 8 65 ± 9 66 ± 8 66 ± 8 
Gender      
Male 1 (25%) 6 (86%) 5 (63%) 10 (53%) 
Female 3 (75%) 1 (14%) 3 (38%) 9 (47%) 
Diagnosis     
ALS 4 4 8 16 




   
Mean ± sd 43 ± 51 66 ± 73 20 ± 21 38 ± 47 
Range 7 - 159 2 - 122 2 - 57 2 - 159 
Medications     
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Riluzole 1 3* 1 5 
Neudexta 0 0 2 2 
MoCA      
Mean ± sd 25 ± 2 27 ± 2 25 ± 2 26 ± 3 
EAT-10      
Mean ± sd 13 ± 7 8 ± 7 20 ± 6 14 ± 10 
ASLFRS-R      
Mean ± sd 36 ± 10 36 ± 10 31 ± 10 34 ± 12 
*One participant stopped taking Riluzole between assessments one and two due to nausea 
 
10.3.2.2 Reliability 
Inter-rater and intra-rater reliability is detailed in table 10.2. Measures of inter-rater and intra-
rater reliability were excellent for the TWST and TOMASS, except for the measures of inter-
rater reliability for the number of swallows for the TOMASS, which was moderate (table 
10.2). For measures of CSA of submental muscles measured via US, inter- and intra-rater 
reliability were moderate to good. Measures of inter-rater and intra-rater reliability of hyoid 
excursion measured by US were moderate. Hyoid displacement on VFSS was measured with 
excellent inter-rater reliability and moderate intra-rater reliability. Measures of inter-rater 
reliability of UES opening distance and pharyngeal constriction ratio were poor; but both 
measures had good intra-rater reliability. Measures of OPTT and TPTT had moderate inter-
rater and good intra-rater reliability. Good inter-rater reliability and excellent intra-rater 
reliability were found for measures of HPTT. Measures of supraglottic closure timing and 
UES opening duration had poor inter-rater and moderate intra-rater reliability. Measures of 
airway closure duration had moderate inter-rater reliability and good intra-rater reliability. 
For the PAS, 81% of values were scored the same by two separate raters, with a Kappa 
statistic of 0.044. When analysing the same videos twice by one rater, 89% of values were 





Table 10.2. Inter-rater and intra-rater reliability of all outcome measures.  








TWST volume per 
swallow 
94.83 (82.7-98.4) .13 98.96 (96.9-99.7) .315 
TWST time per 
swallow 
97.55 (92-99.2) .45 99.15 (97.6-99.7) .274 
TWST volume per 
second 
[99.77 (99.2-99.2)] .21 99.5 (98.6-99.8) .163 
TOMASS bites [99.43 (98.3-99.8)] .33 [100 (100-100)] 1 
TOMASS 
masticatory cycles 
97.6 (93.3-99.2) .35 99.78 (99.4-99.9) .203 
TOMASS swallows 73.6 (40.2-90.1) .164 [99.51 (98.6-99.8)] .757 
TOMASS time [97.98 (94-99.3)] .24 99.98 (99.9-100) .75 
CSA of LAB 66.61 (23.6-97.5) .25 55.92 (14-82.7) .174 
CSA of RAB 48.58 (1.7-78.9)  .028* 71.01 (31.3-91.1) .248 
CSA of GH+ 76.21 (44.7-90.8) .91  83.43 (60.4-94.2) .341 
Hyoid excursion 
(US) 
65.76 (51.6, 76.3)  .01* 70.45 (61.8-78.7) .103 
Hyoid excursion 
(VFSS) 
90.21 (83.8,94.3)  < .01* 73.47 (62.5-82.3) .351 
UES opening 
distance  
46.67 (27.9,64.6)  < .01* 78.07 (70.1,86.0)  .583 
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PCR 48.85(23.5,72.7)  < .01* 82.69 (74.7-89) < .01* 
OPTT [57.21 (40.9,70.3)] .47 [86.81 (80.5-91.8)]  .025* 
HPTT 81.36 (72.6,88.2) .10 90.13 (85.2-93.9)  < .01* 
TPTT [65.4(51.1,77)] .26 87.68 (81.6-92.2) .14 
Supraglottic closure 
timing 
[0.00 (0.00,21.0)]  < .01* 51.55 (35.7,66.4)  .04* 
Airway closure 
duration 
55.79 (38.9,71) .03* 84.25 (77-89.9)  < .01* 
UES opening 
duration 
45.31 (26.2,63.7) < .01* 60.41 (45.6-73)  < .01* 
ICC = intraclass correlation coefficient, CI = confidence interval, * = statistically significant 
at the .05 level, [ ] = assumptions not met – interpret results with caution. 
10.3.2.3 Skill learning 
There was no significant effect of trial on the model for temporal (χ2 [9] = 5.99, p = .741) or 
amplitude (χ2 [9] = 5.91, p = .75) error for the skill training task; therefore, trial was not 
included in the final models. As data for both error types did not meet the assumptions for 
parametric testing, non-parametric statistics were used. There was a significant difference 
between assessments for temporal error (χ2 [2] = 9.38, p < .01). Post-hoc analyses 
demonstrate that median temporal error decreased from 0.82 s in assessment two, to 0.55 s in 
assessment three (V = 180, p < .01), with no significant change to 0.53 s at assessment four 
(p = .77). Median amplitude error also decreased from 11.8 µV in assessment two to 7.28 µV 
in assessment three (V = 144, p = .05), with no significant change to 7.73 µV in assessment 
four (V = 61, p = .31). 
10.3.2.4 Swal-QOL 
The Swal-QOL was incomplete on two assessments of one participant and one assessment of 
a second participant; thus, data from these time points were not included in the analyses. Data 
136 
 
from all measures of the Swal-QOL met the assumptions for parametric testing. There were 
no significant effects of assessment session for oral, pharyngeal or secretion symptom 
frequency. There was a significant effect of assessment session for the Swal-QOL total 
symptom frequency score (χ2 [3] = 7.94, p = .047). The average total score was 5.59 points 
higher in assessment three than in assessment two (95% CI [-0.22, 11.4], p = .017). There 
was no significant difference between assessment one and assessment two (95% CI [-10.23, 
1.62], p = .068) or assessment three and assessment four (95% CI [-5.96, 5.85], p = .982). To 
further probe the data, an analysis was also completed investigating the amount of change in 
Swal-QOL score. There was a significant difference between the baseline, treatment and 
follow-up periods for amount of change in the total score (χ2 [2] = 7.125, p = .028). Change 
in Swal-QOL total score was significantly greater over the treatment period than over the 
baseline period (V = 29, p = .023; figure 10.24). The amount of change in Swal-QOL total 
score was not significantly different over the baseline and follow-up periods or over the 
treatment and follow-up periods (p > .05). 
 
 
Figure 10.24. Boxplots of the median change in Swal-QOL total score over the three periods. 
Centre line denotes the median, horizontal lines represent upper and lower quartiles of the 
data, vertical whiskers represent 1.5 times the interquartile range * = significant change 





























10.3.2.5 VFSS structural displacement measures 
For the evaluation of outcomes with VFSS, in 6% of swallows, at least one timing measure, 
and in 4% of swallows, one spatial measure, were unable to be analysed due to participant 
movement, positioning or the timing of onset of imaging.  
For VFSS measures, data met the assumptions for parametric testing for UES opening 
distance (water, puree and cracker), PCR (water and cracker), hyoid displacement (water, 
puree and cracker), supraglottic closure timing (water) and UES opening duration (water and 
puree). Data from other VFSS outcome measures did not meet the assumptions of normality 
and equality of variance. None of the data investigating difference in amount of change over 
the baseline, treatment and follow-up periods met the assumptions of normality and equality 
of variance. Therefore, data from these outcome measures were analysed using non-
parametric statistics. 
Pharyngeal constriction ratio. 
There was a significant effect of assessment on PCR with water boluses (χ2 [3] = 7.18, p = 
.066). However, post-hoc analyses showed no significant differences between any of the 
comparisons of interest (p > .05). There was a significant difference in amount of change in 
PCR between baseline, treatment and follow-up periods for cracker boluses (χ2 [2] = 5, p = 
.082). Post-hoc analyses demonstrated no significant differences in the amount of change in 
the comparisons of interest (p > .05).  
Hyoid excursion. 
There was no significant main effect of bolus on hyoid excursion (χ2 [2] = 0.704, p = .703). 
Hyoid displacement for puree boluses varied over assessment sessions (χ2 [3] = 21, p < .001). 
For puree boluses, mean hyoid displacement was 3.3 mm less in assessment one when 
compared to assessment two and 2.9 mm greater in assessment four compared to assessment 
three (table 10.3.). Hyoid displacement was 1.6 mm greater in assessment three than 
assessment two; however, this change was not statistically significant (table 10.3.). Over the 
baseline, treatment and follow-up periods, there was a significant difference in the amount of 
change of hyoid displacement for puree boluses (χ2 [2] = 5.091, p = .078). Over the baseline 
period, hyoid displacement reduced by a median of -5.73 mm. Over the follow-up period, 
median hyoid displacement increased by 2.5 mm; this was significantly greater than the 
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amount of change over the baseline period (V = 6, p = .014). There were no significant 
differences between the amount of change in hyoid excursion between the baseline and 
treatment periods or between the treatment and follow-up periods (p > .05).  
Table 10.3. Change in hyoid excursion across assessments with a puree bolus 
Assessments compared Average hyoid excursion 
2-1 -3.34 (95% CI [-5.97, -.71], p = .001) ** 
3-2 1.69 (95% CI [-0.93, 4.32], p = .1) 











Figure 10.25. Hyoid displacement measured by VFSS over assessment sessions for puree 
boluses. Vertical lines represent one standard deviation from the mean. * = significant change 
between assessments at the p = .05 level. 
There was a significant effect of assessment session on hyoid displacement for water boluses 
(χ2[3] = 8.42, p = .038). Hyoid displacement was 2.4 mm greater in assessment four than in 
assessment three; there were no significant changes between other assessments of interest 
* * 
Assessment 


























(table 10.4.). No significant differences were observed in the amount of change in hyoid 
displacement over the baseline, treatment and follow-up periods for water boluses (p > .1).  
Table 10.4. Change in hyoid excursion across assessments with a water bolus 
Assessments compared Average hyoid excursion 
2-1 -1.18 (95% CI [-4.1, 1.73], p = .301) 
3-2 .82 (95% CI [-2.12, 3.76], p = .476) 












Figure 10.26. Mean hyoid displacement between assessment sessions for water boluses. 
Vertical lines represent one standard deviation from the mean. * = significant change between 
assessments at the p = .05 level. 
10.3.2.6 VFSS timing measures 
A significant main effect of assessment session was observed for OPTT with a water bolus 
(χ2 [3] = 9.28, p = .026). Median OPTT was 0.32 s at baseline and increased significantly (V 






























= 7, p = .019) to 0.37 s in the assessment two. There were no significant differences in other 
comparisons of interest (p > .05). There was a significant difference in the amount of change 
in OPTT between baseline, treatment and follow-up periods (χ2[2] = 8.909, p = .012). The 
amount of change in OPTT for a water bolus was significantly greater during the treatment 
period than during the baseline (V = 10, p = .042) and follow-up periods (V = 61, p = .01). 
No significant difference was observed in the amount of change between the baseline and 
follow-up periods (V = 38,  p = .7).  
 
 
Figure 10.27. Boxplots of the median oropharyngeal transit time for water boluses. Centre 
line denotes the median, horizontal lines represent upper and lower quartiles of the data, 
vertical whiskers represent 1.5 times the interquartile range. * = significant change between 
assessments at the p = .05 level. 
There was a significant difference between assessment sessions for OPTT with a puree bolus 
(χ2 [3] = 9.33, p = .025). Median OPTT was 0.58 s at assessment one, increased to 1.03 s in 
assessment two (V = 58, p = .024), decreased to 0.37 s in assessment three (V = 61, p = .01) 
and had no significant change to 0.39 s at assessment four (V = 40, p = .01). There was a 
significant difference in the amount of change in OPTT over baseline, treatment and follow-
up sessions (χ2 [2] = 7.818, p = .078). Post-hoc analyses showed no significant difference in 

























Figure 10.28. Boxplots of the median oropharyngeal transit time for puree boluses. Centre 
line denotes the median, horizontal lines represent upper and lower quartiles of the data, 
vertical whiskers represent 1.5 times the interquartile range. * = significant change between 
assessments at the p = .05 level. 
A significant difference between assessments was observed for TPTT of a water bolus (χ2[3] 
= 7.08, p = .07). For water boluses, median TPTT decreased from 0.89 s at assessment one, 
to 0.85 s in assessment two but this change was not statistically significant (V = 37, p = 
.765). TPTT then increased to 0.96 s in assessment three (V = 6, p = .018) with a decline to 
0.88 s in assessment four (V = 40, p = .044). There was a significant difference in the amount 
of change in TPTT (water) over the baseline, treatment and follow-up condidtions (χ2[2] = 
5.628, p = .06). Post-hoc analyses demonstrated a significantly greater amount of change 
during the treatment period than during the follow-up period (p = .014). The amount of 
change was not statistically different between the baseline period and the treatment period (p 
> .278). 
There was a significant difference between assessments for TPTT of a puree bolus (χ2[3] = 
7.04, p = .071). Median TPTT (puree) was 1.35 s at assessment one, increased to 1.76 s in 
assessment two (V = 59, p = .019), decreased to 1.53 s in assessment three (V = 64, p = .003) 
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observed between baseline, treatment and follow-up periods for the amount of change in 
TPTT (puree) (χ2[2] = 5.091, p = .078); however, post-hoc analyses showed no significant 
differences in the comparisons of interest (p > .05). There were no significant effects of 
assessment session on other VFSS outcome measures (p > .1; see appendix for details). 
10.3.2.7 PAS 
All participants had a PAS below three on the initial assessment. There was little change 
observed in penetration aspiration scale scores over assessments for water, puree or cracker 
boluses (tables 10.5 - 10.7).  
Table 10.5. PAS scores for water boluses of all participants over the four assessment sessions 
PAS SCORE 
 NA 1 2 3 4 5+ 
Pre-tx 1 0 27 6 0 0 0 
Pre-tx 2 0 27 5 0 1 0 
Post-tx 0 29 4 0 0 0 
Follow-up 0 29 4 0 0 0 
 
Table 10.6. PAS scores for puree boluses of all participants over the four assessment sessions 
PAS SCORE 
 NA 1 2 3 4 5+ 
Pre-tx 1 0 30 3 0 0 0 
Pre-tx 2 2 27 4 0 0 0 
Post-tx 0 27 6 0 0 0 






Table 10.7. PAS scores for cracker boluses of all participants over the four assessment 
sessions 
PAS SCORE 
 NA 1 2 3 4 5+ 
Pre-tx 1 4 29 0 0 0 0 
Pre-tx 2 0 31 2 0 0 0 
Post-tx 2 30 1 0 0 0 
Follow-up 1 32 0 0 0 0 
 
10.3.2.8 Ultrasound 
Errors occurred in saving the videos for one session with one participant. For the evaluation 
of hyoid excursion using US, 1% of videos were unable to be analysed due to patient 
movement or poor positioning of the transducer. One participant was unable to complete the 
full assessment due to fatigue and therefore does not have a full dataset of US measures. US 
images of cross sectional area of at least one of the submental muscles were not of sufficient 
quality for analysis in 7% of assessments.  
Hyoid excursion and CSA of GH+ data met the assumptions required for parametric testing.  
CSA of LAB and CSA of RAB data did not meet the assumptions of normality and equality 
of variance, therefore, non-parametric testing was used for these variables. There were no 
significant effects of assessment session for any of the US data (p > .1; see appendix for 
details). There were no significant differences in the amount of change over the baseline, 
treatment and follow-up periods for any of the data obtained using US (p > .1). 
10.3.2.9 TWST and TOMASS 
Due to overt signs of aspiration, it was deemed unsafe for two participants to complete the 
TWST and for one participant to complete the TOMASS. Errors occurred with saving the 
videos for three assessments, and data could not be extracted offline. For these sessions, the 
data collected during the sessions were included in the analyses. 
Time per swallow data from the TWST met the assumptions for parametric testing. Data 
from all other TWST and TOMASS measures did not meet assumptions of normality and 
144 
 
equality of variance and were, therefore, analysed with non-parametric statistics. There were 
no significant differences between assessment sessions for any of the measures of the 
TOMASS or TWST (p > .1; see appendix for details).  
10.3.2.10 Pharyngeal manometry 
Pharyngeal manometry was attempted with the four Christchurch participants. None of these 
patients tolerated this assessment due to high levels of discomfort and/or vomiting. 
Consequently, no manometry data were analysed.    
10.4 Discussion for Treatment Studies 
This is the first research to evaluate the potential of skill training to improve, or maintain, 
swallowing outcomes for patients with MND. The studies showed that patients with mild to 
moderate dysphagia are able to successfully participate in this treatment. This was 
demonstrated by a low rate of drop out and few patients reporting significant fatigue as a 
result of the treatment. The patients who did experience difficulty were those in the later 
stages of the disease with limb and respiratory complications that limited comfortable sitting 
for prolonged times. Following four weeks of training during the pilot study, patients with 
mild to moderate dysphagia demonstrated evidence of functional swallowing improvement, 
indicating that further investigation was warranted. Therefore, the aims of the treatment study 
were to explore the functional and biomechanical changes to swallowing associated with skill 
training in patients with MND in a larger cohort. There was no evidence of functional change 
to swallowing after the shorter two-week training period in this treatment study. However, 
subtle signs of improvement in swallowing biomechanics and quality of life were identified 
(increase in hyoid excursion, decrease in oropharyngeal transit time and increase in reported 
total symptom frequency) that provide justification for further investigation. The information 
gleaned from this treatment study is a crucial early step in evaluating the effects of skill 
training for patients with MND. 
10.4.1 Pilot study  
All participants completed the four-week treatment protocol in the pilot study with no 
evidence of adverse effects, demonstrating that swallowing skill training is a suitable 
treatment approach for patients with MND. The study originally aimed to recruit 6 to 10 
participants in the Canterbury region. Recruitment of this number of participants was not 
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possible and the recruitment region was, therefore, expanded within the pilot study. Only two 
participants from Christchurch, two participants from Auckland and one participant from 
Wellington were recruited over the twelve months that recruitment was open, indicating that 
the recruitment area would need to be further expanded to conduct a study with a larger 
cohort. Inability to travel to the research clinic on a daily basis was reported to be one factor 
that limited an individual’s ability to enrol in the study. Previous research has also 
documented travel distance as a limiting factor for participation in multidisciplinary clinics 
for patients with MND (Stephens, Young, Felgoise, & Simmons, 2016). It is therefore crucial 
in developing treatment approaches for this population that they can be conducted in a 
patient’s home. This led to the decision to facilitate at home treatment as an option for 
patients in the treatment study. In the pilot study, Pt1 was the only participant to complete 
part of the treatment independently at home. All sessions were completed by this participant; 
however, number of swallows per session varied, resulting in an average adherence of 84%. 
Pt1 reported completing some treatment sessions whilst sitting in front of the television, it is 
assumed that levels of concentration on the task were less for this participant than other 
participants who did not have distractions in the room. Clinician presence has been reported 
as a factor that increases adherence to the treatment protocol and would help to reduce 
distraction during participation (Krekeler, Broadfoot, Johnson, Connor, & Rogus-Pulia, 2018; 
Smith-Tamaray, Wilson, & McAllister, 2011). The pilot study reinforced the importance of 
researcher presence when participants were completing the task, to reduce distractions and 
ensure that participants complete the required daily number of trials according to the 
treatment protocol. Therefore, a researcher was present for all sessions performed at home or 
in the research lab during the treatment study.  
Patients with MND demonstrate reduced functional swallowing as measured by the TWST 
(Hughes & Wiles, 1996). Scores outside normal limits were observed for all participants in 
assessment one of the pilot study. Functional swallowing outcomes, measured by the TWST, 
were expected to improve following treatment. The TWST indicated functional improvement 
in swallowing post-treatment for the three participants with mild to moderate dysphagia. 
These changes were clinically significant as Pt1 and Pt2 went from outside normal limits 
before treatment to within normal limits following treatment for at least one aspect of the 
TWST, and rate of decline appeared to stabilise for Pt3. Improvement in sequential liquid 
swallowing as a result of skill training with the BiSSKiT software has previously been 
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observed in patients with neurodegenerative diseases (Athukorala et al., 2014; S. E. Perry et 
al., 2018).  
Findings from the pilot study further shaped the treatment study as it assisted with selection 
of outcome measures. Previous research demonstrated that US is a valid method of measuring 
CSA of submental muscles (Macrae et al., 2013) with moderate to good intra-rater reliability 
and moderate intra-rater reliability (Winiker, 2019). Additionally, measures of hyoid 
excursion obtained using US have been shown to have good to excellent intra-rater reliability 
and moderate to good inter-rater reliability in healthy participants (Hsiao et al., 2012; Macrae 
et al., 2012) and patients with dysphagia (Y.-C. Chen, Hsiao, Wang, Fu, & Wang, 2017). 
During the pilot study, researchers did not gather US videos that were of high enough quality 
for reliable offline measurement, highlighting limitations with the methods and/or knowledge 
of the researchers obtaining the images. Poor reliability of measurement for ultrasound 
images in the pilot study suggested that further training to increase the quality of images was 
required before implementing the treatment study. It also encouraged the researchers to 
perform online measures during assessment sessions to ensure high quality videos were 
captured. Ultrasound was only utilised in three participants in the pilot study because the 
instrumentation was not portable, so could not be taken to patients outside of Christchurch. 
This highlighted the necessity of using portable ultrasound instrumentation in the treatment 
study that was conducted across three locations. 
When originally designed, this research series was going to be included as part of a larger 
study that included investigation of speech outcomes. Although we speculated a potential for 
transference across tasks (Kleim & Jones, 2008), there did not appear to be an effect of skill 
training for swallowing on measures of speech in patients with MND. The rate of decline in 
speech tasks remained stable across all participants, regardless of the presence or absence of 
treatment. It is likely that the speech assessments were too far removed from the trained skill 
for transference to these tasks to occur. Prior to commencement of the treatment study, it was 
revealed that the larger, collaborative study would no longer proceed. Therefore, as there was 
a lack of transference observed from the swallowing training to speech and voice tasks during 
the pilot study, the scope of the treatment study was refined and did not include investigation 
of speech production.  
Quality of life and patient perception of dysphagia were integral aspects of this research as it 
is known that dysphagia results in reduced quality of life in patients with MND (Paris et al., 
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2013). Both the Swal-QOL and EAT-10 surveys were included in the pilot study to align with 
the aforementioned collaborative study. Scores from the Swal-QOL and EAT-10 assessments 
varied in the same manner for most participants, and it was therefore concluded that both 
assessments were not necessary. The Swal-QOL is a validated measure of quality of life that 
has been shown to differentiate between dysphagic and non-dysphagic patients with ALS 
(Paris et al., 2013). The EAT-10 was designed as a screening measure for swallowing 
(Belafsky et al., 2008) and has been shown to have poor ability to detect small changes in 
swallowing ability (Cordier et al., 2017; Wilmskoetter et al., 2019). It was therefore decided 
that the Swal-QOL would be a more robust measure of patient-reported quality of life in the 
treatment study and the EAT-10 was removed.   
The TOMASS did not highlight functional changes to swallowing as a result of treatment 
during the pilot study. This was expected as the oral phase of swallowing contributes to all of 
the outcomes associated with the TOMASS. All participants in this study experienced oral 
phase dysphagia to varying degrees and oral phase dysphagia was not addressed by the skill 
training exercise. Assessment of functional swallowing of solids was an important aspect of 
this research and as there was no alternative simple and portable exam that could be used, the 
TOMASS was included in the treatment study. 
The pilot study also identified an issue with calibration of the sEMG equipment. Calibration 
during the pilot study set the skill training trials at 30-70% of a patient’s average muscle 
recruitment for effortful swallows. This was based on previous research that demonstrated 
that healthy participants performed low effort swallows at 29 - 34% of their maximum effort 
during effortful swallowing (Ng, 2018). The significant difference in muscle recruitment 
between regular and effortful swallowing in healthy participants indicates the presence of a 
functional reserve, a concept that has been frequently reported in the dysphagia literature 
(Yeates, Steele, & Pelletier, 2010; Youmans, Youmans, & Stierwalt, 2009). It was identified 
that not all participants in the current study were able to produce effortful swallows with 
greater submental muscle activation than their normal swallows. This meant that during the 
task, the target was placed at an amplitude that was lower than what was achievable, and they 
were consistently overshooting. EMG activity during a maximal voluntary muscle 
contraction has been demonstrated to be reduced in patients with MND, which may be due to 
loss of motor units or spasticity (Krarup, 2011). Further, patients with MND do not 
demonstrate differences in hyoid excursion between different consistencies, demonstrating 
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reduced ability to spontaneously adapt swallowing in response to bolus properties (Waito, 
2019), likely the result of a loss of functional reserve. Loss of functional reserve in patients 
with MND may have contributed to the patients’ inability to perform an effortful swallow at 
an amplitude that was significantly greater than their normal swallow. This meant that the 
calibration of the software was such that their normal swallows were often reaching the top of 
the screen, and individuals had difficulty modifying swallowing to achieve success with 
lower targets. As discussed in the methods section, for the treatment study, alterations were 
made to the calibration protocol to counteract this limitation. 
This pilot study played an integral role in establishing the treatment study as it highlighted 
adaptations that were necessary to accommodate this population, such as altering calibration 
methods and reducing participation time. This allowed greater consistency in treatment 
provision between participants in the treatment study. Importantly, the pilot study 
demonstrated functional improvement in the TWST for patients with mild-moderate 
dysphagia, justifying further research to evaluate potential physiologic and functional 
changes.  
10.4.2 Skill training for patients with MND 
For patients with MND, there was, historically, the belief that exercise would lead to 
increased rate of degeneration and negative health outcomes (Plowman, 2015). However, 
evidence is emerging that exercise completed at an appropriate intensity may be beneficial 
(Carreras et al., 2010; Plowman, 2015). No participants in either the treatment or pilot study 
developed negative swallowing related outcomes over the course of these studies. This 
suggests that skill-based swallowing training using the BiSSKiT software is a safe and well-
tolerated treatment for patients with MND. Over the treatment protocol, participants 
improved their accuracy at the skilled swallowing task, indicating that the skill training was 
at an appropriate level to facilitate task improvement. This improvement in accuracy was 
maintained over the follow-up period of no treatment. Although, the follow-up period was 
only two weeks post-treatment, maintenance of skill is an important factor that differentiates 
skill training from strength training. Due to the short time period between treatment and 
follow-up, this research is not directly comparable to previous research that demonstrated 
reductions in function 2-6 months following offset of strength training (Cheah et al., 2009; 
Drory et al., 2001). 
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10.4.2.1 Quality of life  
Quality of life is negatively affected in patients with dysphagia as a result of MND (Paris et 
al., 2013; Tabor et al., 2016). Changes in quality of life in response to treatment for 
dysphagia have not been previously investigated in this population. However, two studies 
investigating limb stretching exercises for patients with MND resulted in improvements in 
quality of life (Dal Bello-Haas et al., 2007; Drory et al., 2001). There were no significant 
changes in oral, secretion or pharyngeal Swal-QOL scores when analysed independently. 
There were high levels of variability observed between participants resulting in large standard 
deviations, which could have contributed to the lack of significant findings. However, the 
total symptom frequency as measured by the Swal-QOL demonstrated improvement in score 
following treatment. Further, in patients with MND, Swal-QOL scores have been 
demonstrated to be negatively correlated with the penetration aspiration scale as patients who 
demonstrate aspiration on VFSS score lower on the Swal-QOL (Tabor et al., 2016). The 
change in score over the treatment period was significantly different to the change in score 
over the baseline period, over which quality of life declined. This is in contrast to previous 
research investigating skill training in patients with Parkinson’s disease that demonstrated an 
improvement in quality of life over an initial baseline no treatment period as well as during 
treatment itself (Athukorala et al., 2014). The difference between direction of change over the 
baseline and treatment periods seen in the current research helps to reduce the likelihood of 
the observed change being a result of a placebo effect; however, as there was no control 
group this cannot be ruled out.  
10.4.2.2 Structural displacement 
Hyoid excursion is an important aspect of swallowing as it facilitates epiglottic deflection and 
UES opening. Over the no treatment baseline period in this study, the extent of hyoid 
excursion decreased but not to the level of statistical significance. This mirrors previous 
research in this population (Plowman, Watts, Tabor, et al., 2016) and is likely due to the 
rapidly degenerative nature of MND.  
Hyoid excursion increased following training, both in this study and in previous research 
investigating EMST (Plowman, Watts, Tabor, et al., 2016). The reasons for increased hyoid 
excursion in these studies are likely different due to the underlying nature of the treatments. 
An increase in hyoid excursion following EMST is hypothesised to be due to strengthening of 
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the submental muscles during treatment (Plowman, Watts, Tabor, et al., 2016). The current 
treatment focused on increasing swallowing skill and not strength. An increase in peripheral 
muscle strength occurs as a result of exercises that are conducted above the habitual level 
(Rasch & Morehouse, 1957; Zatsiorsky & Kraemer, 2006). During skill training sessions, 
participants swallowed at 40 – 70% of their maximum power output, which would be not be 
expected to above their habitual level (Ng, 2018). Further, as there was no evidence of 
hypertrophy of submental muscles as measured by US, we would not expect an increase in 
strength of submental muscle contraction to account for the observed changes in hyoid 
excursion.  
The relationship between muscle strength and structural displacement during swallowing is 
inconclusive in the literature. The submental muscles contribute to hyolaryngeal excursion as 
well as jaw opening, and therefore, it would be assumed that jaw opening strength would be 
correlated with hyoid excursion during swallowing. It has been demonstrated in healthy 
elderly men that jaw opening force is positively correlated with hyoid resting position but not 
hyoid position at maximum excursion (Shinozaki et al., 2017). In healthy elderly women, 
there were no significant correlations between submental muscle strength measured by jaw 
opening and any of the assessed measures of hyoid position (Shinozaki et al., 2017). The 
relationship between coordination and extent of movement of the hyoid bone has not been 
fully examined. Using 2D kinematic swallowing motion analysis, Paik et al. (2008) 
demonstrated different patterns of hyoid displacement between healthy controls, patients with 
myopathy and patients with supratentorial stroke. The authors hypothesised that they would 
observe weakness in patients with myopathy, whereas reduced coordination with or without 
weakness would be observed in patients following stroke. The stroke patients demonstrated 
irregular velocities and extraneous anterior and posterior movement of the hyoid bone, which 
were not observed in the other groups, suggesting the presence of incoordination contributing 
to a change in hyoid bone displacement. A further study investigated the relationship between 
hyoid trajectory and submental muscle strength and precision in seven patients with 
dysphagia following stroke (Ng, 2018). Hyoid trajectory was radiographically visualised, 
submental muscle strength was measured through sEMG of effortful swallowing and a 
maximum jaw opening task; submental muscle precision was measured through a skilled 
swallowing task, similar to that used for treatment in the current research and a skilled jaw 
opening task. Hyoid trajectory was not found to be significantly associated with either 
strength or skill of the submental muscles in the tasks assessed (Ng, 2018). Further research 
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investigating the effects of impaired skill on hyoid trajectory is necessary in advancing 
treatment options for patients with dysphagia. 
In the limb literature, skill learning has been shown to result in neuroplasticity (Pascual-
Leone et al., 2005; Tyč et al., 2005) and transference of the skill to similar behaviours (Kleim 
& Jones, 2008). Skill acquisition was evidenced in this swallowing task by a reduction in 
errors over the treatment period. It is, therefore, possible that this skill training task resulted 
in neuroplasticity, allowing greater cortical control of swallowing and increased coordination 
of recruitment of the muscles involved in hyolaryngeal excursion. However, neural imaging 
studies are required to confirm or deny this speculation.   
There was no significant improvement in hyoid displacement immediately following the 
treatment period. However, there was a trend towards improvement for both thin and puree 
bolus types. The sample size of patients who received VFSS was small (n = 11) and the 
standard deviation was large for this measure. A larger sample size and/or more 
homogeneous population may have increased the ability to detect a significant change in 
hyoid excursion immediately following treatment. Interestingly, significant improvements in 
hyoid displacement measures were observed over the follow-up period for both water and 
puree boluses. Improvements in swallowing outcomes over a non-contact period following 
swallowing skill training have previously been observed in patients with Parkinson’s disease 
(Athukorala et al., 2014). This may suggest that swallowing skill-learning occurs both online 
and offline, and neural adaptation continues to occur throughout the late stages of training 
and periods of skill consolidation and retention (Kida, Sakimoto, & Mitsushima, 2017; Luft 
& Buitrago, 2005; Spampinato & Celnik, 2017). Curtis and colleagues (2020) investigated 
the effects of respiratory swallow coordination training in a single patient with anoxic brain 
injury. The patient completed one treatment session per week for four weeks. Frequency of 
optimal respiratory swallow pattern was observed during the probe task and a generalisation 
task in which various consistencies were ingested. Improvement in frequency of optimal 
respiratory swallow pattern was found as a result of training, with further improvements 
observed following a one month retention period on the generalisation task. The same pattern 
of improvement was not seen for the trained task, with improvements demonstrated over the 
training period but not the follow-up (J. A. Curtis, Seikaly, et al., 2020). This indicates 
improvement in generalisation over a period of no treatment following a swallowing skill 
training protocol, as was observed in the current study. It is therefore possible that in the 
152 
 
current study improvement was demonstrated over the follow-up period due to increased time 
necessary for transference of the learned skill to untrained tasks such as bolus swallows 
during VFSS. This transference to the TWST, a functional swallowing task, was not observed 
in the treatment study. This may be due to the task being further removed from the trained 
task as sequential swallows are required during the TWST. Further discussion regarding 
functional swallowing outcomes is presented below.  
Transference to untrained tasks over the follow-up period may be contributed to by mental 
practice, defined as the cognitive rehearsal of physical movements. In the limb literature, 
mental practicw has been shown to facilitate cortical plasticity (Page, Szaflarski, Eliassen, 
Pan, & Cramer, 2009) and improve functional outcomes when compared to traditional 
treatment approaches alone (Page, Levine, & Leonard, 2005; Page et al., 2009). In an FMRI 
study, Page and colleagues (2009) demonstrated increased activation in the premotor area and 
primary motor cortex following 10 weeks of mental practice in patients with chronic stroke. 
The tasks were activities of daily living that involved the effected arm of the patients. In 
addition to increased cortical activation, the authors report anecdotal evidence of transference 
to tasks that were not included in the treatment programme. Motor imagery and mental 
practice results in activation of cortical areas associated with motor movements, including the 
primary motor cortex, premotor cortex and the posterior parietal lobe (Hanakawa et al., 2003; 
Kosslyn, Ganis, & Thompson, 2001). In the current study, many patients reported thinking 
about the skill training task when not in the treatment sessions and may, therefore, may have 
been subconsciously using this mental practice technique outside of the treatment sessions 
and in the two weeks of no treatment during the follow-up period. Continued mental practice 
during the follow-up period may have contributed to continued cortical adaptation, resulting 
in the observed significant changes over the final period of no treatment. Functional 
improvements resulting from mental practice have not been investigated in patients with 
MND; however, in chronic stroke patients, the addition of mental practice to physical 
practice of functional tasks using the hand resulted in improved outcomes that were not 
observed with physical practice alone (Page, Levine, & Leonard, 2007; Page et al., 2005). In 
healthy adults, mental imagery of swallowing has been shown to activate areas of the brain 
that are comparable to those activated during swallowing, including the precentral gyrus and 
inferior frontal gyrus (Kober, Grössinger, & Wood, 2019). A recent study investigated the 
use of mental practice to increase lingual strength in a small cohort of healthy older 
individuals (Szynkiewicz et al., 2020). Improvements in maximum isometric press and 
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pressure during regular effort saliva swallowing were observed for the group who underwent 
physical exercise and mental practice but not the control group, a group who did mental 
practice alone or the group who did physical exercise alone. Although this is early research in 
healthy individuals, it highlights the potential benefits associated with mental imagery for 
swallowing.  
Another possible explanation for the observed increase in hyoid excursion is a reduction in 
tone of the submental muscles. Spasticity in MND is a result of UMN damage and can affect 
bulbar muscles as demonstrated by spastic dysarthria (Darley et al., 1969; R. M. Miller & 
Britton, 2011). SEMG as biofeedback has been used as a method for reducing spasticity and 
improving function through targeted relaxation of specific muscles (Dursun, Dursun, & 
Alican, 2004; Marchant, McAuliffe, & Huckabee, 2008; Nash, Neilson, & O'Dwyer, 1989). 
In the current research, many participants anecdotally reported that the most difficult targets 
to hit were the lower targets, as they had difficulty down-regulating the effort involved in the 
swallowing task. Participants often had to attempt to relax the submental muscles during 
swallowing to achieve success at the lower targets. Additionally, participants were asked to 
hold the muscles still between swallowing trials, with the line from the sEMG remaining at 
the bottom of the screen. This was not monitored and no verbal feedback was given to 
participants regarding their success; however sEMG feedback of the submental muscles was 
provided. It is therefore possible that although it was not a direct target of this treatment, 
there was an element of relaxation training of the submental muscles, resulting in reduced 
underlying tone. The presence of muscle spasticity was not assessed in these patients; this 
may explain why there was not consistent improvement over all individuals. As previously 
discussed, there was no immediate change in response to treatment. It would therefore be 
hypothesised that spasticity continued to decrease over the non-contact period or that the 
reduction in spasticity was better incorporated into bolus swallowing over this time. As 
spasticity was not assessed it is difficult to conclude whether this contributed to the 
outcomes. 
As well as VFSS, hyoid displacement was also measured using US; however, a significant 
increase was not identified using this technique. There was a difference in the number of 
participants in each group, as only the participants in NZ underwent VFSS, but all 
participants underwent US. If both measurements were equal and there was a true effect it is 
more likely that this would be statistically significant with a larger sample size, due to the 
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positive relationship between sample size and statistical power (Dupont & Plummer, 1990; 
VanVoorhis & Morgan, 2007). However, this was not the case, indicating that the differences 
in significance between the two modalities were likely due to the imaging techniques 
themselves. Intra-rater reliability of hyoid displacement was higher with images obtained 
using VFSS than with US. Higher reliability implies that variance is lower and the effect 
sizes are increased, thereby increasing the power to detect a significant difference 
(Humphreys, 1993; Kanyongo, Brook, Kyei-Blankson, & Gocmen, 2007).  
In healthy individuals, almost complete obliteration of the pharynx would be expected during 
swallowing (Kendall et al., 2000). Increased pharyngeal constriction ratio (PCR) is common 
in patients with MND and has been shown to be associated with pharyngeal residue (Waito et 
al., 2018). As in previous research, pharyngeal constriction was impaired in most individuals 
who participated in this study. There was no significant change in pharyngeal constriction 
ratio as a result of the skill training protocol. PCR has been previously investigated pre- and 
post-treatment in this patient population with no significant differences found as a result of 
five weeks of EMST (Plowman, Watts, Tabor, et al., 2016). The differences between 
outcomes for PCR and hyoid excursion in this study may be due to the fact that the muscles 
targeted in treatment are not directly involved in pharyngeal closure. This would imply a lack 
of transference to associated biomechanics following the short training period. Alternatively, 
the lack of detection of change may be due to the high standard deviations observed within 
the current study; standard deviations were not reported by Plowman, Watts, Tabor, et al. 
(2016). Further research with a more heterogeneous sample may help to determine if 
significant changes to PCR are possible as a result of these treatment modalities.  
No significant differences were observed for cracker boluses across any of the outcome 
measures on VFSS. Bolus size can have a significant effect on swallowing kinematics 
(Dantas et al., 1990; Nagy, Molfenter, Péladeau-Pigeon, Stokely, & Steele, 2014; Ryu, Park, 
Oh, Lee, & Kang, 2016). In this study, during VFSS, participants self-selected their bite size 
of crackers and this was not controlled across assessments. If the size of the bite of cracker 
had been predetermined and consistent between assessments, it may have allowed more 
information to be gleaned from these assessments.  
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10.4.2.3 Swallowing timing 
In healthy individuals, swallowing transit time is impacted by bolus consistency, with more 
viscous consistencies such as puree resulting in a longer pharyngeal transit time than thin 
liquids (Taniguchi, Tsukada, Ootaki, Yamada, & Inoue, 2008). In patients with MND, the 
speed of bolus transit through the pharynx is reduced, with progressive decline throughout the 
disease process (J. Tomik et al., 2017). To date, research has not highlighted treatment 
options that are effective for increasing pharyngeal transit speed.  
Normative data for bolus transit timing have not been established for the 5 cc boluses used in 
this study. Prior research has documented a significant effect of bolus size on OPTT, but no 
significant effect of bolus size on TPTT (Kendall et al., 2000). This suggests that referencing 
existing 1 cc norms is appropriate for liquid boluses for TPTT but not for OPTT. 
Interestingly, in this cohort, median TPTT was within the range of normal for 1 cc water 
boluses at baseline and across all subsequent assessments. No normative data have been 
established for pharyngeal transit times of puree or solid boluses and as pharyngeal transit 
time is dependent on bolus consistency it is not appropriate to compare puree boluses to 
normative data for thin liquids. 
The direction of change in OPTT and TPTT were the same over the baseline, treatment and 
follow-up periods, with the same comparisons reaching significance. This is to be expected as 
OPTT and HPTT make up TPTT. Surprisingly, the direction of change varied between thin 
liquid and puree boluses, with an increase in OPTT and TPTT following treatment for thin 
liquid and a decrease for puree. The observed changes in water boluses were contrary to what 
was hypothesised. Although the oropharyngeal phase of swallowing was significantly slower 
following treatment for water boluses, the change was only 0.05 s, or approximately one 
frame. A change of 0.05 s is likely not clinically significant as it did not result in an increase 
in airway invasion. Further, when many hypotheses are tested within a study it increases the 
probability of a finding being statistically significant by chance alone (Streiner, 2015). As the 
patterns of change were not predictive of functional changes, and the direction of change 
differed between bolus types, it is possible that these findings were spurious. It was 
determined a priori that adjustments would not be made for multiple comparisons. The reason 
for this decision was that due to the exploratory nature of this research, the risk of missing a 
significant finding due to overcorrection would likely be more detrimental than the 
alternative risk of type I error. If Bonferroni corrections were made for multiple comparisons, 
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only the decrease in OPTT over the treatment period and increase in OPTT over the follow-
up period for puree boluses would remain significant. There is no definition of what would be 
considered normal transit time for 5 cc puree boluses. However, patients with MND often 
demonstrate an increase in pharyngeal transit time, which increases over the course of the 
disease (J. Tomik et al., 2017). Therefore, a reduction in OPTT was considered an 
improvement in swallowing timing. The significant reduction in OPTT over the treatment 
period that was observed for puree boluses could be explained by an increase in swallowing 
skill resulting in increased speed of pharyngeal swallowing initiation. The significant increase 
during the follow-up period would indicate that these changes were not maintained following 
the offset of treatment, in patients with this rapidly progressive neurodegenerative disease. 
10.4.2.4 Swallowing safety 
In this study, PAS did not improve significantly over the course of the treatment; however, 
the scores were all within normal limits at the time of the initial assessment, likely producing 
a ceiling effect. Previous research concluded that for patients with MND, an EAT-10 score 
greater than three had good discriminant ability to identify patients who exhibit penetration 
and an EAT-10 score greater than eight to identify patients who aspirate (Plowman, Tabor, et 
al., 2016). This finding was not replicated in this study. There was no evidence of penetration 
or aspiration during the initial assessment despite all participants having an EAT-10 score ≥ 3 
and 13 participants having an EAT-10 score ≥ 8. Further, the only participant who 
demonstrated trace penetration in the second assessment had a comparatively low EAT-10 
score of four. The difference in findings may be due to the bolus sizes that were trialled. In 
patients with MND, aspiration is more common with thin fluids than puree or solid boluses 
(D’Ottaviano et al., 2013). In the previous research, participants had thin liquid boluses of 
varying amounts including a 20 cc bolus and a 90 cc sequential sips task, with analysis of the 
worst PAS score (Plowman, Tabor, et al., 2016). In the current study, bolus size was limited 
to 5 cc on VFSS. Therefore, if larger bolus sizes of thin fluid were used we may not have 
observed this ceiling effect for PAS.  
Kappa statistics were used to determine inter- and intra-rater reliability of the PAS. These 
kappa statistics demonstrated no agreement and weak agreement, respectively, indicating that 
reliability of the PAS scale may be a limitation of this study. However, the kappa statistic 
becomes less reliable when one or more of the categories contains occurrences which are rare 
(Viera & Garrett, 2005). In this study, most participants had a PAS score of 1, leaving the 
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other categories to be only rarely observed. Therefore, it is important to consider the high 
percentage agreement of both inter- and intra-rater reliability, 81% agreement and 90% 
agreement respectively. Inter-rater and intra-rater reliability are therefore likely sufficient for 
measures of the PAS.  
10.4.2.5 Functional swallowing  
Although total pharyngeal transit time for a single sip of water was within normal limits, 
mean scores for all TWST and TOMASS measures were outside normal limits at all 
assessment points. This inconsistency may be due to the differences in demand between 
single and sequential sips. In addition to pharyngeal transit time, the TWST and TOMASS 
are impacted by oral transit time and an increased demand on the respiratory system due to 
sequential swallowing (Hegland, Huber, Pitts, Davenport, & Sapienza, 2011). As patients 
with MND often have reduced respiratory capacity, this could have contributed to increased 
time taken to complete the TWST due to an increased number of pauses between swallows 
for respiration than would be expected in healthy participants. This irregular pattern of 
breathing and swallowing has been previously recorded in the literature (Aydogdu, 
Tanriverdi, & Ertekin, 2011) and would contribute to both the time taken and number of 
swallows to complete the TWST. Sequential swallowing was not completed under 
instrumental evaluation so it cannot be confirmed if a similar pattern of disorganised 
swallowing was present in the individuals who participated in this study.  
The degree of change in functional outcomes for participants in the treatment study was not 
as compelling as what was observed in the pilot study for these assessments. Of the 18 
participants who completed the TWST pre- and post-treatment, nine demonstrated 
improvement in volume per swallow following treatment. However, this change was not 
statistically significant and there does not appear to be a pattern that predicted improvement, 
unlike in the pilot study, in which all participants who had mild to moderate dysphagia 
improved following treatment. One major difference between the pilot study and the 
treatment study that could have contributed to this variation is the treatment dosage. The pilot 
study consisted of 20 sessions of skill training compared to 10 in the treatment study. The 
reason for reducing participation time was feasibility for patient participation and to align this 
study with previous research that demonstrated significant differences in patient outcomes 
after two weeks of skill training for patients with Parkinson’s disease (Athukorala et al., 
2014). However, compared to the study by Athukorala et al. (2014), the number of trials per 
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session in this study were reduced from 100 to 80. This was to ensure that the intensity of the 
exercise was not high enough to potentially result in fatigue and negative outcomes that have 
been associated with higher intensity exercise for patients with MND (Carreras et al., 2010). 
As sequential swallowing was not directly trained during this task, 10 skill training sessions 
may not have been sufficient for transference to the TWST. However, it is possible that there 
are potential benefits for this treatment that were not observed within the treatment study due 
to the intensity limitations for the MND population.  
There were no observed changes in TOMASS outcomes for either the pilot or treatment 
study. This finding is not surprising, as although pharyngeal swallowing is assessed during 
the TOMASS, the oral phase of swallowing is an integral aspect. During the TOMASS, the 
cracker must be manipulated in the oral cavity prior to pharyngeal transfer. This requires 
adequate strength and range of motion of the muscles required for jaw closing and lingual 
movement (Huckabee et al., 2017; Morita et al., 2018; Stierwalt & Youmans, 2007). Lingual 
strength and range of motion as well as bite strength are often some of the first signs of 
dysphagia in patients with MND (Briani et al., 1998; Higo et al., 2004; Riera-Punet et al., 
2018). Some participants in this research had significant oral phase difficulties, and therefore, 
used their hands to break the cracker as they could not bite it, used their hand to press on their 
jaw to bite the cracker or softened the cracker in their mouth by sucking it prior to 
mastication. The skill training protocol used in this research focuses on the onset, timing and 
amplitude of pharyngeal swallowing and changes in masticatory efficiency would not be 
expected. It is, therefore, likely that the TOMASS was not specific enough to the trained task 
to detect functional changes.  
10.4.2.6 Pharyngeal manometry 
Of the four participants in Christchurch who attempted to complete manometry, none 
tolerated catheter placement. The observed reduced tolerance is likely due to an increased gag 
reflex in patients with MND as a result of UMN dysfunction, which has also been observed 
in studies that implement FEES (Aviv et al., 2002; Brooks, 1994; Cohen et al., 2003; Domer 
et al., 2013; Leder et al., 2004). The successful use of HRM without impedance has been 
reported previously in the literature in patients with MND (Suh et al., 2019). In this study 
limited information was provided about placement methods; however, it was noted that ten 
percent lidocaine spray was used (Suh et al., 2019). Recent research has demonstrated that 
topical nasal anaesthetic does not have an effect on comfort during HRM with or without 
159 
 
impedance in healthy participants (Guiu Hernandez et al., 2018; Kwong, 2018). It is therefore 
unlikely that this was the cause of increased discomfort in the current study population. The 
diameter of the catheter used in the study by Suh et al. (2019) was not reported; however, as 
the catheter did not measure impedance, it is likely that the diameter was smaller than in the 
current study.  Healthy individuals tolerate a catheter with a smaller diameter better than a 
large diameter the first time they undergo HRM (Kwong, 2018). When using the same 
catheter as in the current research, previous research found that 19% of healthy participants 
were unable to tolerate catheter placement (Kwong, 2018). It is therefore likely that the large 
catheter size in conjunction with UMN pathology contributed to the inability to tolerate 
catheter placement in the four individuals who participated in the current study.  
10.4.2.7 Medications 
Neudexta is a medication used for patients with MND that contains an antitussive agent (C. 
P. Taylor et al., 2016). Two participants were taking Neudexta at the time of the study. 
Neither of these participants underwent VFSS as they were in New York City, so silent 
aspiration cannot be ruled out. Although it does not guarantee the absence of aspiration, it is 
important to consider that there was no evidence of aspiration pneumonia throughout the 
protocol. There was one participant whose medication was altered during the baseline period 
as Riluzole was discontinued due to the side effect of severe nausea. There is little evidence 
to suggest significant improvements in swallowing as a result of Riluzole for patients with 
MND (R. G. Miller et al., 2012) and this participant was not deemed to be an outlier in the 
amount of change over the period for which he stopped taking the drug, he was therefore, 
included in the final analysis. For all other participants, medication remained stable, and as a 
result, the observed effects are not likely due to medication. 
10.4.2.8 Cognition 
Almost half of all patients with MND have some degree of cognitive impairment, and 10-
15% meet the criteria for frontotemporal dementia (Gordon et al., 2011; Ringholz et al., 
2005). In this study, seven participants scored outside the normal range (< 26) on the 
cognitive screening test. However, two participants were unable to complete the full 
assessment due to impaired hand function inhibiting their ability to use a pen, and therefore, 
the lower score is not truly reflective of poor cognition. This highlights the need for the 
development of a cognitive screening tool that is appropriate for patients with MND who 
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have impaired motor function. Importantly, none of the participants had difficulty following 
instructions to participate in the treatment sessions, indicating that skill training with a 
clinician present is feasible for patients with cognitive abilities outside the normal range.  
10.4.3 Limitations and future directions 
When considering the outcomes of these studies, it is important to acknowledge the 
limitations. Although some changes in swallowing biomechanics and quality of life were 
observed, these changes were not compelling, as many outcome measures were investigated 
in this study without correction for multiple comparisons. It is, therefore, possible that falsely 
significant changes were observed, given the absence of functional correlation. This was 
expected due to the exploratory nature of this research; however, further research with a 
larger sample size would be beneficial to determine whether the observed effects are 
replicable.  
The sample size included in this study was small: 11 participants for VFSS measures, 19 
participants in total, and the standard deviations were large. The large standard deviations are 
likely a result of the heterogeneity of the population and contribute to a reduced ability to 
detect statistically significant changes. The inclusion criteria for this study were broad to 
increase the number of potential participants. This would have contributed to the observed 
large standard deviations. Further, due to the limited sample size, participants acted as their 
own controls during a baseline no treatment period. There was no control group that 
underwent a sham treatment to rule out the possibility of a placebo effect. However, as 
participants in this study have a rapidly degenerative disease, this method did allow for 
comparison of treatment results to the natural decline seen during the baseline period. This 
method also allowed a greater number of participants to compete the treatment arm of the 
study. A sham group would have reduced participants completing the treatment by half, 
which would have been a greater limitation on the study. 
All participants underwent skill training regardless of differences in swallowing 
biomechanics observed during instrumental assessment. Research has begun to investigate a 
method of determining if a patient’s dysphagia is the result of strength or skill deficit (Ng, 
2018). Further developments of this assessment would be beneficial for all patients to ensure 
that they are receiving the most appropriate treatment approach. It was discovered that many 
participants lacked the ability to achieve greater activation of the submental muscles during 
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an effortful swallow compared to normal swallowing. This may be due to a reduced 
functional reserve resulting in maximal muscle activation during normal swallowing. 
Participants in this category may have benefitted from a period of strength training prior to 
skill training to increase strength of submental muscles and allow for greater muscle 
recruitment during swallowing. Strength training using EMST has been shown to have some 
potential benefits for patients with MND (Plowman et al., 2019; Plowman, Watts, Tabor, et 
al., 2016). As there is a large amount of heterogeneity in patients with MND due to the 
combination of UMN and LMN symptoms, it remains plausible that some individuals with 
MND would benefit from skill training, whereas strength training or a combined approach 
may be a better for others. Collapsing all patients into one group based solely on their 
diagnosis limits potential findings across many areas of research.  
The skill that was trained during this treatment was a single saliva swallow every thirty 
seconds. The task trained did not involve a bolus, and was therefore, not specific to the bolus 
swallowing outcome measures that were assessed. Patients with MND frequently report 
anterior loss of saliva as indicated by the ALSFRS-R (Cedarbaum et al., 1999). Excess saliva 
is due to a reduction in frequency and efficiency of saliva swallowing, and therefore, may 
have been improved by the treatment task (Bongioanni, 2012; Garuti, Rao, Ribuffo, & 
Sansone, 2019). The only outcome measure that addressed saliva swallowing was the 
secretions symptom frequency subscale of the Swal-QOL. This was reported by participants 
to be the most severely affected aspect of the Swal-QOL; however, there was no significant 
change as a result of treatment. This measure is made up of the outcomes from only two 
questions – the presence of thick saliva and the presence of excess saliva. Thick saliva is a 
common complaint in patients with MND (Newall, Orser, & Hunt, 1996), and would not 
have been addressed by the current treatment. It is therefore, not surprising that no changes 
were observed in this outcome measure. Future investigation about saliva swallowing 
frequency and drooling before and after treatment may be beneficial in determining the 
effects of the trained task.    
Immediately after every trial, feedback was provided to participants regarding the distance 
from the centre of the target and whether the attempt was successful. Research investigating 
skill learning in patients following stroke has demonstrated that a delaying feedback for a few 
seconds and not providing feedback for all trials, instead giving a summary, may enhance 
learning (Van Vliet & Wulf, 2006; Zimmerman, Carnaby, Lazarus, & Malandraki, 2020). An 
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alternative feedback schedule may have facilitated greater learning in patients. A potential 
example of this within the swallowing literature is that used by Martin-Harris and colleagues 
(2015) when training respiratory swallow coordination in patients with head and neck cancer. 
In the initial acquisition phase, feedback was provided following all trials; however, when 
participants moved to the mastery phase they aimed to complete the task without the visual or 
verbal feedback. In the current research, although the task did become more difficult with 
skill improvement, the feedback frequency did not change. Further research investigating 
skill training with a delayed and or less frequent feedback approach may result in improved 
awareness and therefore control of swallowing during untrained tasks.  
Due to the differences in outcomes between participants in the four-week pilot study and the 
two-week treatment study, further investigation into the effects of a longer period of skill 
training would be beneficial. As previously discussed, a four-week treatment protocol using 
the current methods was not feasible in this population. However, if a participant is able to 
complete the treatment task in their own home and at their own time then four weeks of daily 
treatment may not seem such a daunting task. Investigation of methods to improve adherence 
and engagement when completing the task at home would be beneficial to help facilitate 
longer treatment protocols. More research is required regarding the amount of therapist 
intervention that is necessary to ensure that participants not only complete the task correctly 
but are engaged whilst doing so.  
Maintenance of swallowing function would be considered a beneficial outcome in this 
degenerative disease and many previous studies have reported reduced rate of decline as a 
measure of improvement. There was no significant deterioration observed in any of the 
outcome measures assessed. It is likely that the two-week period between assessments was 
not sufficient for significant disease progression and it cannot be concluded that the lack of 
deterioration was due to a maintenance effect. However, if treatment and/or monitoring had 
continued for a longer period of time, with a control group, then it is possible that a 
maintenance effect would have been observed in response to the skill training. 
Although reliability was high for many of the outcome measures, there were some of 
concern. Measures of intra-rater reliability were good for UES opening distance and PCR; 
however, inter-rater reliability of these measures were poor. There was also a significant rater 
effect for both of these outcome measures, indicating a systematic difference between raters. 
For PCR and UES opening distance, the primary rater consistently rated lower than the 
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secondary rater. As there was a significant rater effect, it is likely that the raters differed in 
their interpretations of the instructions for measurement. Increasing the specificity of the 
instructions for completing the measurements may have increased the consistency of 
interpretation and therefore measurement reliability. Rater-effects were also demonstrated for 
CSA of the RAB, hyoid excursion measured with VFSS and US, supraglottic closure timing, 
airway closure timing and UES opening duration. Again, indicating the need for increased 
specificity of instructions for measurement. A significant effect of rating was also observed 
for measures of intra-rater reliability of timing aspects measured by VFSS. A rating effect 
indicates that these measurements were performed systematically differently the first time 
compared to the second time that they were measured. This could have an effect on the data 
as data that were extracted later may have been extracted differently to that which was 
performed earlier in the process. The order that data were extracted was random as a result of 
blinding, so systematic differences in analysis should not have led to falsely significant 
findings during data analysis.  
Many of the hypotheses of this research hinged on the assumption that increased 
neuroplasticity as a result of swallowing skill training is possible in individuals with MND. 
Although there is evidence of increased neural activation during swallowing in the absence of 
functional swallowing changes (Li et al., 2009), more information is needed about the 
potential for neuroplasticity as a result of swallowing skill training. Neuroimaging that 
evaluates the areas of neural activation during swallowing before and after skill training at 
different stages of the disease process would help to inform us if and when neuroplasticity 






For patients with MND, dysphagia is detrimental to quality and length of life. There is 
increasing evidence supporting the use of behavioural treatment to prolong function for 
individuals suffering from this degenerative disease. An important consideration when 
developing treatment options is optimising intensity to ensure patients benefit, whilst 
minimising the risk of adverse effects. Current guidelines suggest that exercises should be 
performed at a mild to moderate intensity to avoid fatigue, yet there are currently no 
clinically accessible means to identify fatigue of bulbar muscles. This research contributed to 
the literature by assessing one potential method of recognising fatigue. Measurement of 
submental sEMG amplitude during a lingual press task was not deemed a successful method, 
but potential explanations for this were identified. The limitations identified during this study 
will assist in developing future trials, as the ability to quantify fatigue in a clinically 
accessible manner remains an important objective. 
Investigation of treatment options for relief from bulbar symptoms of MND has not 
progressed at the same rate as is observed in the limb literature. This research series 
investigated a novel approach to dysphagia treatment, focusing on training precision in 
movement patterns rather than muscle strength. This approach was investigated as an 
alternative to traditional strength training, due to the adverse effects that have been previously 
associated with muscle strengthening. The skill training protocol through the BiSSkiT 
software was well tolerated and easily followed by the individuals in this study, who varied in 
dysphagia severity and level of cognitive function. Importantly, there was no evidence of 
swallowing decline associated with the treatment or disease progression over the course of 
the protocol. Further, there was some evidence of improvement in quality of life and 
swallowing biomechanics following two weeks of treatment; however, these changes did not 
transfer to functional swallowing. Following four weeks of skill training during the pilot 
study, functional improvements were observed for the three patients with mild-moderate 
dysphagia, indicating potential transference as a result of a longer exposure to the protocol. 
This exploratory investigation did not reach a convincing conclusion regarding whether skill 
training with sEMG biofeedback is an effective treatment in this population. However, it 
highlighted potential positive outcomes that motivate further research and identified 
limitations of the current methodology that may guide future studies. Continued research 
investigating treatment options for improving or maintaining swallowing ability is necessary. 
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Due to the heterogeneity of the disease it is unlikely that there will be one treatment that is 
appropriate for all patients. Therefore, it is crucial to continue the investigation of novel 
treatment approaches that may be recommended to patients to reduce the significant burden 
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Appendix A:  Tables from study one results 
Table A1. Median lingual press endurance time by trial 










Table A2. Post hoc comparisons of endurance time between sessions using Wilcoxon signed 
rank tests.  
Trials compared V p-value 
1-2 196 0.0802 
2-3 210 0.02767 
3-4 124 0.6869 
4-5 145 0.8433 
5-6 141 0.9406 
6-7 187 0.1424 
7-8 145 0.8462 
1-8 255 0.0001066** 















Table A4. Post-hoc pair-wise comparisons of submental average sEMG amplitude  
Trials compared V p-value 
1-2 97 .2226 
2-3 189 .1262 
3-4 93 .1796 
4-5 99 .2467 
5-6 147 .7998 
6-7 198 .06982 
7-8 51 .006711* 
1-8 57 .01229 




Appendix B: Tables from study three results 
Table B1. Means and standard deviations of outcome measures over assessments 








TWST volume per 
swallow 
N/A 12.2(6.51) 11.2(6.18) 11(7.1) 11.4(7.4) 
TWST time per 
swallow 
N/A 3.19(2.08) 3.34(2.07) 3.53(2.13) 3.47(1.97) 
TWST volume per 
second 
N/A 6.22(5.58) 5.21(4.74) 4.82(4.80) 5.27(5.36) 
TOMASS bites N/A 5.74(6.87) 5.42(5.27) 5(3.62) 5.24(3.38) 
TOMASS chews N/A 96.5(101) 91.2(76.4) 84.3(48.8) 83.8(53.8) 
TOMASS swallows N/A 5.37(5.57) 4.53(2.84) 4.74(2.88) 4.18(2.65) 
TOMASS time N/A 135(152) 117(78.9) 113(58.4) 105(60.8) 
CSA of LAB N/A 76.4(21.3) 71.5(13.3) 75.7(19.1) 71.8(17) 
CSA of RAB N/A 70.6(19.7) 73.8(12.4) 66.9(21.6) 65.7(13.6) 
CSA of GH+ N/A 182(36.1) 171(32.6) 165(49.1) 176(40.8) 
Swal-QOL total N/A 58.1(16.8) 53(18.6) 58.6(19.1) 59(19.4) 
Swal-QOL oral  N/A 53.9(28.4) 55.3(23.4) 56.3(23.6) 59.4(26.9) 
Swal-QOL 
pharyngeal 
N/A 60.4(14.2) 54.9(17.2) 60(14.1) 57.6(18.6) 
Swal-QOL 
secretions 
N/A 47.4(26.6) 39.9(26.2) 42(31.3) 45.3(31.2) 
Hyoid excursion (%) 
(US) 
Dry 25(7.53) 22.1(10.2) 23.8(10.5) 25.6(8.63) 
Puree 25.1(8.95) 23.9(8.23) 24.9(8.94) 26.6(7.85) 
 Water 26.6(9.12) 24.8(7.47) 24.9(8.67) 25.4(8.43) 
Hyoid excursion 
(mm) (VFSS) 
Cracker 21.6(4.27) 19.5(6.35) 18.1(8.19) 20.1(6.58) 
Puree 20.2(4.72) 16.9(6.45) 18.5(8.24) 21.4(7.55) 
 Water 19.1(6.22) 18(6.09) 18.5(8.07) 20.9(8.39) 
UES opening 
distance 
Cracker 4.63(2.19) 5.16(1.93) 4.4(2.24) 4.86(2.11) 
Puree 4.64(1.89) 4.94(1.51) 5.21(1.83) 4.74(1.59 
 Water 4.45(2.06) 4.67(1.33) 4.57(1.58) 4.65(1.36) 
 
 
PCR Cracker 0.09(0.06) 0.09(0.06) 0.08(0.04) 0.08(0.06) 
 Puree 0.08(0.05) 0.07(0.06) 0.07(0.05) 0.09(0.05) 
 Water 0.06(0.05) 0.07(0.06) 0.07(0.05) 0.06(0.05) 
OPTT Cracker 1.3(1.08) 1.32(1.27) 1.07(1.22) 1.15(1.78) 
Puree 0.702(0.53) 1.21(1.14) 1.17(1.06) 1.41(1.36) 
 Water 0.582(0.76) 0.39(0.26) 0.74(0.88) 0.493(0.5) 
HPTT Cracker 0.474(0.13) 0.49(0.18) 0.44(0.1) 0.51(0.16) 
Puree 0.652(0.31) 0.61(0.18) 0.67(0.45) 0.6(0.15) 
 Water 0.58(0.26) 0.54(0.24) 0.6(0.38) 0.58(0.27) 
TPTT Cracker 1.77(1.16) 1.81(1.38) 1.51(1.25) 1.66(1.83) 
Puree 1.36(0.72) 1.82(1.19) 1.83(1.13) 2.01(1.41) 
 Water 1.15(0.83) 0.94(0.37) 1.35(0.95) 1.08(0.62) 
Supraglottic closure 
timing 
Cracker 0.03(0.12) 0.074(0.1) 0.024(0.081) 0.043(0.11) 
Puree -0.001(0.12) -0.011(0.082) -0.037(0.068) -0.018(0.10) 
 Water -0.13(0.115) -0.11(0.12) -0.11(0.11) -0.12(0.12) 
Airway closure 
duration 
Cracker 0.81(0.25) 0.92(0.39) 0.81(0.3) 0.9(0.43) 
Puree 0.93(0.34) 0.96(0.6) 0.93(0.36) 1(0.67) 
 Water 0.21(0.29) 0.84(0.28) 0.92(0.33) 0.9(0.49) 
UES opening 
duration 
Cracker 0.34(0.14) 0.34(0.1) 0.32(0.083) 0.38(0.15) 
Puree 0.45(0.11) 0.46(0.079) 0.45(0.066) 0.48(0.091 
 Water 0.42(0.093) 0.43(0.11) 0.44(0.089) 0.44(0.095) 
 
Table B2. Outcomes of likelihood ratio test 
Measure Bolus Chi-sq (df) p-value 
TWST time per swallow N/A 1.318 (3) .725 
TWST volume per swallow N/A 2.35(3) .503† 
TWST volume per second N/A 2.1(3) .552† 
TOMASS bites N/A 1.71(3) .635† 
TOMASS masticatory cycles N/A 0.56(3) .906† 
TOMASS swallows N/A 1.23(3) .746† 
TOMASS time N/A 0.33(3) .953† 
Swal-QOL total N/A 7.94(3) .047** 
Swal-QOL pharyngeal  N/A 3.76(3) .289  
 
 
Swal-QOL oral  N/A 0.68(3) .878 
Swal-QOL secretions N/A 2.83(3) .418 
CSA of GH+ N/A 3.06(3) .383  
CSA of LAB N/A 5.06(3) .998† 
CSA of RAB N/A .04(3) .168† 
Hyoid excursion (US) Water 1.04(3) .790 
 Puree 0.66(3) .882 
 Dry 5.60(3) .133 
Hyoid excursion (VFSS) Water 8.42(3) .038 ** 
Puree 21.0(3) < .001 ** 
 Cracker 5.71(3) .127 
UES opening distance (VFSS) Water 0.65(3) .885 
Puree 4.89(3) .18 
 
Pharyngeal constriction ratio 
(VFSS) 
Cracker 4.66(3) .200 
Water 7.18(3) .066 * 
Puree 3.45(3) .327† 
 Cracker 3.31(3) .346 
OPTT Water 9.28(3) .026 †** 
 Puree 9.33(3) .025† ** 
 Cracker 2.03(3) .566† 
HPTT Water 3.06(3) .383† 
 Puree .36(3) .949† 
 Cracker 6.03(3) .11† 
TPTT Water 7.08(3) .07† * 
 Puree 7.04(3) .071 †* 
 Cracker 1.2(3) .735† 
Supraglottic closure timing Water 1.0(3) .800 
 Puree 0.78(3) .854† 
 Cracker 1.18(3) .754† 
Airway closure duration Water 2.69(3) .441† 
 Puree 0.27(3) .965† 
 Cracker 1.44(3) .696† 
UES opening duration Water 0.65(3) .885 
 
 
 Puree 5.09(3) .165 
 Cracker 5.94(3) .114† 
Note: †= did not meet assumptions - non-parametric statistics used, * = p-value is significant 
at the .1 level, ** = p-value is significant at the .05 level 
 
 
Table B3. Outcomes from post-hoc analyses investigating between assessment differences of 




Swal-QOL total 2-1 -4.31 (95% CI [-10.23, 1.62],  p = .068) * 
 3-2 5.59 (95% CI [-0.22, 11.4], p = .017) ** 
 4-3 -0.05 (95%CI [-5.96, 5.85], p = .982) 
Pharyngeal constriction 
ratio (water) 
2-1 0.007 (95% CI [-0.01, 0.02], p = .297) 
3-2 -0.007 (95% CI [-0.02, 0.01], p = .3) 
 4-3 -0.01 (95% CI [-0.03, 0.006], p = .103) 
Hyoid displacement 
(water) 
2-1 -1.18 (95% CI [-4.1,1.73], p = .301) 
3-2 .82 (95% CI [-2.12, 3.76], p = .476) 
 4-3 2.4 (95% CI [-0.56, 5.36], p = .04)** 
Hyoid displacement 
(puree) 
2-1 -3.34 (95% CI [-5.97, -.71], p = .001) ** 
3-2 1.69 (95% CI [-0.93, 4.32], p = .1) 
 4-3 2.84 (95% CI [.26, 5.43], p = .006) ** 
Note: * = p-value is significant at the .1 level, ** = p-value is significant at the .05 level 
 
 
Table B4. Outcome of Friedman’s tests for data that did not meet the assumptions required 
for parametric testing.  
Measure Bolus Chi-sq (df) p-value 
TWST volume per swallow N/A 2.35(3) .503† 
TWST volume per second N/A 2.1(3) .552† 
TOMASS bites N/A 1.71(3) .635† 
TOMASS masticatory 
cycles 
N/A 0.56(3) .906† 
 
 
TOMASS swallows N/A 1.23(3) .746† 
TOMASS time N/A 0.33(3) .953 
CSA of LAB N/A 5.06(3) .998† 
CSA of RAB N/A .04(3) .168† 
PCR Puree 3.45(3) .327† 
OPTT Water 9.28(3) .026 †** 
 Puree 9.33(3) .025† ** 
 Cracker 2.03(3) .566† 
HPTT Water 3.06(3) .383† 
 Puree .36(3) .949† 
 Cracker 6.03(3) .11† 
TPTT Water 7.08(3) .07† * 
 Puree 7.04(3) .071 †* 
 Cracker 1.2(3) .735† 
SGCT Puree 0.78(3) .854† 
 Cracker 1.18(3) .754† 
ACD Water 2.69(3) .441† 
 Puree 0.27(3) .965† 
 Cracker 1.44(3) .696† 
UES opening duration Cracker 5.94(3) .114† 
Note: * = p-value is significant at the .1 level, ** = p-value is significant at the .05 level 
 
Table B5. Median scores by assessment session of outcome measures with significant effect 
of assessment session.  
Outcome measure Assessment Median 
OPTT (water) Baseline 0.36 
 Pre-tx 0.315 
 Post-tx 0.37 
 Follow-up  0.385 
OPTT (puree) Baseline 0.58 
 Pre-tx 1.03 
 Post-tx 0.9 
 Follow-up  1.045 
 
 
TPTT (water) Baseline 0.885 
 Pre-tx 0.845 
 Post-tx 0.965 
 Follow-up  0.875 
TPTT (puree) Baseline 1.345 
 Pre-tx 1.76 
 Post-tx 1.53 
 Follow-up  1.8 
 
 
Table B6. Post-hoc analyses investigating outcome measures with a significant effect of 
assessment session: 
Measure Assessment V p-value 
OPTT (water) 2-1 38.5 .657 
OPTT (water) 3-2 7 .019 ** 
OPTT (water) 4-3 55 .054 * 
OPTT (puree) 2-1 58 .024 ** 
OPTT (puree) 3-2 61 .01 ** 
OPTT (puree) 4-3 61 .01 ** 
TPTT (water) 2-1 37 .765 
TPTT (water) 3-2 6 .0184 ** 
TPTT (water) 4-3 40 .044 ** 
TPTT (puree) 2-1 59 .019 ** 
TPTT (puree) 3-2 64 .003 ** 
TPTT (puree) 4-3 60 .014  ** 
Note: * = p-value is significant at the .1 level, ** = p-value is significant at the .05 level 
 
Table B7. Outcome of Friedman’s tests investigating a difference in the amount of change in 
outcome measures over the baseline, treatment and follow-up periods.  
Measure Bolus Chi-sq (df) p-value 
TWST volume per swallow N/A 0.585 (2) 0.747 
TWST time per swallow N/A 0.875 (2) 0.646 
TWST volume per second  1.125 (2) 0.57 
 
 
TOMASS bites N/A 0.037 (2) 0.982 
TOMASS masticatory 
cycles 
N/A 0.394 (2) 0.821 
TOMASS swallows N/A 0.375 (2) 0.829 
TOMASS time N/A 0.118 (2) 0.943 
CSA of LAB N/A 0.133 (2) 0.936 
CSA of RAB N/A 3.857 (2) .145 
CSA of GH+ N/A 1.412 (2) .494 
Swal-QOL total N/A 7.125 (2) .028 ** 
Swal-QOL oral N/A 0.613 (2) .736 
Swal-QOL pharyngeal N/A 1.58 (2) .454 
Swal-QOL secretions N/A 0.47 (2) .47 
UES opening distance Water 0.727 (2) .695 
 Puree 1.273(2) .529 
 Cracker 0.727 (2) .695 
Pharyngeal Constriction 
Ratio 
Water 0.326 (2) .85 
Puree 1.256 (2) .534 
 Cracker 5 (2) .082* 
Hyoid Excursion(VFSS) Water 2.909 (2) .234 
Puree 5.091 (2) .078* 
 Cracker 4.222 (2) .121 
OPTT Water 8.909 (2) .012 ** 
 Puree 7.818 (2) .02 ** 
 Cracker 3.2 (2) .202 
HPTT Water 1.273 (2) .529 
 Puree 0.727 (2) .695 
 Cracker 4.546 (2) .103 
TPTT Water 5.628 (2) .06* 
 Puree 5.091 (2) .078* 
 Cracker 1.4 (2) .497 
SGCT Water 0.545 (2) .761 
 Puree 0.545 (2) .761 
 Cracker 3.436 (2) .179 
 
 
ACD Water 0.182 (2) .913 
 Puree 1.273 (2) .529 
 Cracker 2.6 (2) .273 
UES opening duration Water 0.182 (2) .913 
 Puree 1.636 (2) .441 
 Cracker 3.818 (2) .148 
Note: * = p-value is significant at the .1 level, ** = p-value is significant at the .05 level 
 
Table B8. Post-hoc comparisons of the outcome measures that were identified as significant  
Measure Periods compared V p-value 
Swal-QOL total Baseline - treatment 29 .023 ** 
 Treatment – follow-
up 
111 .107 
 Baseline-follow-up 43 .205 
PCR(cracker) Baseline - treatment 39 .275 
 Treatment – follow-
up 
11 .106 
 Baseline-follow-up 21 .557 
Hyoid excursion 
(puree, VFSS) 




 Baseline-follow-up 6 .014** 
OPTT (water) Baseline - treatment 10 .042** 
 Treatment – follow-
up 
61 .01** 
 Baseline-follow-up 38 .7 
OPTT(puree) Baseline - treatment 51 .123 
 Treatment – follow-
up 
21 .32 
 Baseline-follow-up 51 .123 
TPTT (water) Baseline - treatment 17 .175 





 Baseline-follow-up 55 .054* 
TPTT(puree) Baseline - treatment 46 .278 
 Treatment – follow-
up 
54 .067* 
 Baseline-follow-up 28 .7 
Note: * = p-value is significant at the .1 level, ** = p-value is significant at the .05 level 
 
Table B9. Median amount of change over baseline, treatment and follow-up periods of the 
outcome measures with significant difference between periods.  
Outcome measure Period Median 
Swal-QOL total Baseline -3.57 
 Treatment 5.36 
 Follow-up 0 
PCR(cracker) Baseline 0.00436 
 Treatment -0.0186 





 Follow-up 2.5 
OPTT (water) Baseline -2.08 
 Treatment -0.147 
 Follow-up -2.02 
OPTT(puree) Baseline 0.39 
 Treatment -0.203 
 Follow-up 0.103 
TPTT (water) Baseline 0.0233 
 Treatment 0.167 
 Follow-up -0.14 
TPTT(puree) Baseline 0.353 
 Treatment -0.13 




Appendix C: Information sheets and consent forms 
 
 
INFORMATION SHEET  
Department of Communication Disorders  
Telephone: +64 3 369 2385   
Email: paige.thomas@pg.canterbury.ac.nz  
19 May 2016  
  
Strength and endurance of submental and lingual muscles  
in healthy individuals 
I am a PhD student in the Department of Communication Disorders performing a research 
project in conjunction with two students from Lincoln High School. You are invited to take 
part in a study investigating the effects of fatigue on the strength and endurance of muscles in 
your tongue.  Results from this study will help us to design effective assessment and 
treatment for people with swallowing disorders.  
  
You can join this study if you are 20 years or older, have no medical problems that may 
affect your swallowing and are clean shaven under your chin (to allow the sensors to detect 
muscle activity). Your involvement in this project will be to attend one session in which you 
will be asked to press a soft plastic sensor between your tongue and the roof of your mouth 
and hold it there as hard as you can for 45 seconds. This sensor will measure how much force 
you can apply with your tongue. There will also be a small adhesive patch placed under your 
chin which contains sensors that will measure the activity of muscles as you perform the task. 
This task will be repeated 10 times with small breaks between trials. This will help us 
determine when and how much the muscle of the tongue get tired over time. The electrodes 
and tongue bulb can be easily removed at the completion of the study. The session will take 
approximately 30 minutes including the set-up of equipment.   
  
Information about your tongue strength and endurance will be stored on the computer as a 
waveform and analysed at another time. The only data recorded will be the lines that 
represent your tongue strength and muscle activity. To ensure anonymity and confidentiality, 
no material which could personally identify you will be used on the computer that stores the 
data, or in any reports. All hard-copy information will be kept in a locked filing cabinet 
which will be kept at the Rose Centre for Stroke Recovery and Research or stored on a 
password protected computer. The only people that will have access to the data are the 
    
 
 
researcher, the research assistants from Lincoln High School and the supervisor. Data will be 
kept for a period of 10 years following which time it will be destroyed.  
  
Unfortunately due to the limited funding for this project we cannot offer you any further 
token of appreciation for participation. The only benefit to you is that your participation gives 
important information about swallowing in healthy adults. There are no known risks of using 
small sensors to monitor muscle activity. Participation is voluntary and you are free to 
withdraw at any time, without having to give a reason. This will in no way affect any future 
care or treatment, or academic participation if you are a student. However, as there will be no 
identifying information stored alongside your data, following completion of the session it will 
become difficult to identify and remove your data from the study. You will be offered copies 
of the final manuscript of this project or a basic summary. However, you should be aware 
that a significant delay may occur between completion of data collection and the final report. 
Alternatively, or in addition, you can choose to have the results of the study discussed with 
you personally by the principal investigator.   
  
Results from this project may be included in the researcher’s PhD thesis and may be 
submitted for publication in a peer-reviewed journal. A thesis is a public document and will 
be available through the UC Library. Please use the consent form to indicate to the researcher 
if you would like to receive a copy of the final manuscript or a basic summary of the results. 
However, please be aware that there may be a long delay between data collection and 
completing the final report.   
  
I am carrying out this project as a requirement of a doctoral degree under the supervision of 
Professor Maggie-Lee Huckabee.  You can contact the principal investigator if you require 
any further information about the study during work hours at (03) 364 2307 or via email: 
paige.thomas@pg.canterbury.ac.nz. Prof Huckabee can be contacted at maggie-
lee.huckabee@canterbury.ac.nz.   
  
This project has been reviewed and approved by the University of Canterbury Human Ethics 
Committee, and participants should address any complaints to The Chair, Human Ethics 
Committee, University of Canterbury, Private Bag 4800, Christchurch (human-
ethics@canterbury.ac.nz).  
  
If you agree to participate in the study, you are asked to complete the consent form and return 
to the researcher.  
  
Paige Thomas  
Department of Communication Disorders  
Telephone: + 64 3 369 2385  




    
CONSENT FORM  
  
Department of Communication Disorders  
Telephone: +64 3 364 2307  
Email: paige.thomas@pg.canterbury.ac.nz  
19 May 2016  
  
Strength and endurance of submental and lingual muscles in 
healthy individuals  
  
I have been given a full explanation of this project and have had the opportunity to ask 
questions. I understand what will be required of me if I agree to take part in this research. I 
understand that my participation is voluntary and that I may withdraw at any stage without 
penalty. Withdrawal of participation will also include the withdrawal of any information I 
have provided should this remain practically achievable.  
I understand that any information or opinions I provide will be kept confidential to the 
researchers and two Lincoln High School Students and that any published or reported results 
will not identify me. I understand that all data collected for this study will be kept in locked 
and secure facilities or on password protected electronic form at the Rose Centre for Stroke 
Recovery & Research and will be destroyed after ten years.   
I understand the risks associated with taking part and how they will be managed. I understand 
that I am able to receive a report on the findings of the study at the conclusion of the project 
by checking the box below. I understand that if I require further information I can contact the 
researcher, Paige Thomas (paige.thomas@pg.canterbury.ac.nz) for further information, or her 
supervisor Professor Maggie-Lee Huckabee (maggie-lee.huckabee@canterbury.ac.nz). If I 
have any complaints about the research, I can contact the University of Canterbury Human 
Ethics Committee Private Bag 4800, Christchurch (human-ethics@canterbury.ac.nz).   
  
        I would like to receive a summary of the results of the project.   
Email: _________________________________________   
By signing below, I agree to participate in this research project.  
 Date          ____________________________________________   
 Print Name of Participant     ____________________________________________   
 Signature of Participant     ____________________________________________  
 
Please return this consent form to Paige Thomas (paige.thomas@pg.canterbury.ac.nz
 
 
Information Sheet for Participants   
  
  
Department of Communication Disorders  
The Rose Centre for Stroke Recovery and Research  
+64 3 364 2042  
maggie-lee.huckabee@canterbury.ac.nz   
  
07 January 2016  
  
An exploratory study of skill-based swallowing 
training in patients with motor neurone disease.  
  
I am a Professor in the Department of Communication Disorders and Director of the Rose 
Centre for Stroke Recovery and Research and am leading this project in conjunction with 
clinical director Sara Moore, PhD student Paige Thomas and honours student Michelle 
Westley. The purpose of this research is to evaluate if a novel skill-based swallowing therapy 
has the potential to improve health and quality of life in patients with motor neurone disease.  
This first study will help us decide if we should proceed to a larger clinical trial.    
If you choose to take part in this study, your involvement in this project will be commitment 
to four evaluation sessions and 20 treatments sessions across three months. During the 
evaluation sessions, you will complete two questionnaires about your swallowing, will be 
asked to drink water and eat a dry cracker and will have the muscles under your chin 
measured during swallowing with a non-invasive test called ultrasound.  Evaluation sessions 
will require video recording, however we will shield your upper face and eyes to reduce 
potential for recognition. These tasks will be completed during all four assessment sessions.  
The treatment sessions will involve placing a small adhesive disc containing electrodes on the 
underside of your chin to measure electrical activity from your muscles during swallowing. 
You will be instructed to swallow and will view a feedback graph on the computer screen that 
 
 
shows you when and how hard you swallow. Your task is to swallow so that the peak of the 
waveform falls in a target on the screen. See the figure below.  
Each treatment session will last  
approximately one hour in duration including 
rest periods, plus an additional 5 or 10 minutes 
of set-up time.  Treatment sessions will be 
completed every work day for one month. At 
least 10 of these sessions must be completed 
with the researcher; however there may be an 
option of doing some of the treatment sessions 
individually if you have an appropriate computer 
to run the software.   
The only identified risk associated with this  
research is the possibility that you may get food or fluid in your lungs when you eat or drink 
the cracker for assessment.   The researchers conducting the study and supervising the student 
have clinical backgrounds in managing swallowing disorders and recognising signs and 
symptoms of aspiration. We can and will adapt data collection to minimise risk if we feel that 
you are not safe in your swallowing. We understand that a diagnosis of motor neurone 
disease can be quite upsetting to you and your family.  We encourage you to involve your 
family/whanau or other people who support you in any or all session appointments. With 
consent, referrals to the Motor Neuron Disease Association can be made for additional 
support for you if you are not already involved with this organisation.  
Participation is voluntary and you have the right to withdraw at any stage without penalty. 
You may ask for your raw data to be returned to you or destroyed at any point. If you 
withdraw,  we will remove information relating to you.   
The results of the project may be published, but you can be assured of the complete 
confidentiality of data gathered in this investigation: your identity will not be made public.  
To ensure anonymity and confidentiality, documentation will be recorded using participant 
numbers and will be kept in locked filing cabinets for the duration of the study. Data from 
questionnaires will be coded using participant numbers and original copies will be shredded.  
 
 
Hard copies and digital data will be stored for a period of ten years at the University of 
Canterbury Rose Centre for Stroke Recovery and Research, at which time they will be 
destroyed by the primary researcher.  Please indicate to the researcher on the consent form if 
you would like to receive a copy of the summary of results of the project.  
  
This project has been reviewed and approved by the University of Canterbury Human Ethics  
Committee, and participants should address any complaints to The Chair, Human Ethics 
Committee, University of Canterbury, Private Bag 4800, Christchurch 
(humanethics@canterbury.ac.nz).  
If you agree to participate in the study, you are asked to complete the consent form and return 




     
 
 
Information Sheet for Participants   
  
Department of Communication Disorders  
The Rose Centre for Stroke Recovery and Research  
+64 3 364 2042  
maggie-lee.huckabee@canterbury.ac.nz   
07 January 2016   
An exploratory study of skill-based swallowing training  
in patients with motor neurone disease. 
 I have been given a full explanation of this project and have had the opportunity to ask 
questions.  
 I understand what is required of me if I agree to take part in the research.  
 I understand that participation is voluntary and I may withdraw at any time without penalty. 
Withdrawal of participation will also include the withdrawal of any information I have provided 
should this remain practically achievable.  
 I understand that any information or opinions I provide will be kept confidential to the 
researcher and supervisor and that any published or reported results will not identify the 
participants.   
 I understand that all data collected for the study will be kept in locked and secure facilities 
and/or in password protected electronic form and will be destroyed after ten years.   
 I understand the risks associated with taking part and how they will be managed.  
 I understand that I am able to receive a report on the findings of the study by contacting the 
researcher at the conclusion of the project.  
 I understand that I can contact the primary researcher Maggie-Lee Huckabee 
(maggielee.huckabee@canterbury.ac.nz ), Paige Thomas (paige.thomas@pg.canterbury.ac.nz) or 
Sara Moore (sara.moore@canterbury.ac.nz) for further information. If I have any complaints, I 
can contact the Chair of the University of Canterbury Human Ethics Committee, Private Bag 
4800, Christchurch (human-ethics@canterbury.ac.nz)  
  I would like a summary of the results of the project.   
 By signing below, I agree to participate in this research project. 
Name:________________________Signed________________________Date________________ 
Email (for report of findings if applicable:________________________________________________ 







PARTICIPANT INFORMATION SHEET 
Department of Communication Disorders 
Email: paige.thomas@pg.canterbury.ac.nz, emma.burnip@pg.canterbury.ac.nz 
6th December 2017 
 
Study title: Skill-based swallowing training for patients with Motor Neurone Disease 
Lead investigators: Paige Thomas and Emma Burnip   
Contact phone number: 03 369 2385 Locality: Canterbury    
Ethics Committee ref: 17/NTB/214 
 
You are invited to take part in a study on an intervention for swallowing difficulties in Motor 
Neurone Disease (MND).  Whether or not you take part is your choice.  If you don’t want to 
take part, you don’t have to give a reason, and it won’t affect the care you receive.  If you do 
want to take part now, but change your mind later, you can pull out of the study at any time.   
 
This Participant Information Sheet will help you decide if you’d like to take part.  It sets out 
why we are doing the study, what your participation would involve, what the benefits and risks 
to you might be, and what would happen after the study ends.  We will go through this 
information with you and answer any questions you may have.    You do not have to decide 
today whether or not you will participate in this study. Before you decide you may want to talk 
about the study with other people, such as family, whānau, friends, or healthcare providers.  
Feel free to do this. 
If you agree to take part in this study, you will be asked to sign the Consent Form on the last 
page of this document.  You will be given a copy of both the Participant Information Sheet and 
the Consent Form to keep. 
 
This document is 6 pages long, including the Consent Form.  Please make sure you have read 
and understood all the pages. 
 
WHAT IS THE PURPOSE OF THE STUDY? 
 I am Paige Thomas, a Speech-Language Therapist and PhD student. With a fellow 
PhD student, Emma Burnip, we are researching a skill-based swallowing therapy.  
 At the moment, there are no options to treat people with swallowing problems caused 
by MND.  
 We want to find out whether this new intervention can help swallowing and quality of 
life in people with MND. 
 This intervention uses ideas of skill training and biofeedback to see if people with MND 
can control their own swallowing when they can visualise it on a screen.  
 All volunteers will receive the intervention. We will compare measures of swallowing 
before and after therapy to see if there are any changes. 
 
 
 This study is being funded by the University of Canterbury Rose Centre for Stroke 
Recovery and Research as part of our PhD projects. 
 This study has been approved by Northern B HDEC. 
 
WHAT WILL MY PARTICIPATION IN THE STUDY INVOLVE? 
 You can join this study if you are 18 years or older and have been diagnosed with the 
Amyotrophic Lateral Sclerosis type of MND. You must have noticed some changes in 
how you are swallowing but still be eating and drinking.  
 You cannot take part if you have another condition that affects your swallowing, if you 
are pregnant, or if you have had a facial trauma. 
 If you choose to take part in this research, you will complete 4 assessment sessions 
and 10 intervention sessions over 6 weeks.  
 If you sign the consent form, there will be a short questionnaire about swallowing to 
ensure that you can take part in this study. We will also request general information 
such as your age, weight, height and stage of MND. You will be asked to do a short 
assessment of thinking skills, this will be recorded once as part of the general 
information before we start the study. 
 
In assessment sessions you will:  
 Fill in a questionnaire about your swallowing. 
 Eat a cracker and drink some water. 
 Have the muscles under your chin measured with an ultrasound device when you 
swallow. Ultrasound is a safe procedure which uses high frequency sound waves (like 
those that a bat uses to navigate dark caves) to produce an image of your swallowing 
muscles. 
If you are able to travel to the clinic you may also: 
 Have the pressures in your throat measured when you swallow - a small catheter the 
size of a piece of spaghetti will be inserted into your nose which you will swallow down. 
 Have an x-ray study of your swallowing.  
One part of the assessment session will need to be video-taped. This video will only be used 
by the researcher to analyse your chewing and swallowing. 
 
In the intervention sessions: 
 A small sticky patch will be placed over the muscles under your chin. This patch will 
be used to measure the activity of your muscles when you swallow. Your swallowing 
muscle activity will be displayed on a 
computer screen (see image). There 
will be a target box on the screen, 
your task will be to swallow so that 
the peak of the line lands in this box.  
 Each intervention session will last 
one hour including rest periods.  
 Intervention sessions will be five 
days per week for two weeks.  
 If you are in Christchurch and able to travel, intervention and assessment sessions 
will be carried out at the UC Rose Centre located in at St George’s Medical Centre.  
 
 
 If you are not in Christchurch or are unable to travel to the Rose Centre, intervention 
sessions and aspects of the assessment may be completed in your home 
 
WHAT ARE THE POSSIBLE BENEFITS AND RISKS OF THIS STUDY? 
 There are no known risks of this intervention, but, there are risks that you should be 
aware of in the assessment sessions. The researchers with you during the study are 
trained Speech Therapists and are able to manage these risks. 
 There is a slight risk that during assessment you may get food or fluid in your lungs, 
however, the risk here is no more than when you eat and drink at home.  
 The x-ray of your swallowing will involve exposure to radiation. The level of radiation 
required for this assessment is very low (it is about half of the radiation exposure you 
would have on a long haul flight) and is not likely to cause any negative effects. Please 
inform the researcher if you think you may be pregnant, as this radiation exposure is 
not recommended for the developing baby. 
 You may find that placement of the catheter to measure throat pressures is 
uncomfortable. There is a small risk of a nose bleed or fainting during this assessment. 
We will work with you to ensure that you are comfortable during assessments and alter 
them if needed.  
 We encourage you to involve your family or support network in any/all appointments.  
 These assessments will give us very detailed measurements of your swallowing. This 
means we can detect any changes as a result of the intervention. 
 
WHO PAYS FOR THE STUDY? 
 For participating in this research, we will offer you petrol vouchers to cover travel costs 
(based on the IRD Mileage Rate of $0.73 per km).  
 You do not need to pay any other costs to take part in this study. 
 The study is funded by the University of Canterbury Rose Centre for Stroke Recovery 
and Research as part of my PhD project. We have applied for a project grant from the 
Neurological Foundation of New Zealand. We are expecting to hear the outcome of 
this application in December 2018. 
 
WHAT IF SOMETHING GOES WRONG? 
If you were injured in this study, which is unlikely, you would be eligible to apply for 
compensation from ACC just as you would be if you were injured in an accident at work or at 
home. This does not mean that your claim will automatically be accepted. You will have to 
lodge a claim with ACC, which may take some time to assess. If your claim is accepted, you 
will receive funding to assist in your recovery. If you have private health or life insurance, you 
may wish to check with your insurer that taking part in this study won’t affect your cover. 
If you have private health or life insurance, you may wish to check with your insurer that taking 
part in this study won’t affect your cover. 
 
WHAT ARE MY RIGHTS? 
 Whether or not you take part is your choice. If you do not want to take part, you do not 
have to give a reason. This will not affect your future care or intervention.  
 
 
 You will be told of any new information about adverse or beneficial effects related to 
the study that becomes available during the study that may have an impact on your 
health. 
 If you find the intervention helpful, there may be an option to access the intervention 
at home after the study. This is dependent on the equipment that is available at that 
time. Please talk to the researcher at any time if you would like to discuss this option.  
 
WHAT HAPPENS AFTER THE STUDY OR IF I CHANGE MY MIND? 
 Nothing that could identify you will be stored with your results. All hard-copy data will 
be kept in a locked filing cabinet at the Rose Centre for Stroke Recovery and Research 
or stored on a password protected computer. The only people who will have access to 
the data are the researchers and their supervisor. Data will be kept for 10 years 
following which time it will be destroyed. 
 Results from this project will be included in my PhD thesis and may be published in a 
peer-reviewed journal. A thesis is public and will be available through the UC Library, 
but your identity will not be made public.  
 If you do want to take part now, but change your mind later, you can pull out of the 
study at any time.  
 You may ask for your data to be returned to you or destroyed at any time up to the 
point when analysis of raw data begins. 
 Please use the consent form to indicate if you would like to receive a summary of the 
results. Please be aware that there may be a delay between data collection and 
completing the final report in early 2020.  
 If you agree to participate in the study, you are asked to complete the consent form 
and return to the researcher. 
 
WHO DO I CONTACT FOR MORE INFORMATION OR IF I HAVE CONCERNS? 
If you have any questions, concerns or complaints about the study at any stage, you can 
contact:  
Name: Paige Thomas or Emma Burnip, PhD Candidates,  
Department of Communication Disorders, University of Canterbury 
Telephone number: 03 369 2385  
Email: emma.burnip@pg.canterbury.ac.nz, paige.thomas@pg.canterbury.ac.nz 
Name: Professor Maggie-Lee Huckabee, PhD Supervisor,  
Department of Communication Disorders, University of Canterbury  
Telephone number: 03 369 5124 Email:  maggie-lee.huckabee@canterbury.ac.nz.  
 
If you want to talk to someone who isn’t involved with the study, you can contact an 
independent health and disability advocate on:        Phone: 0800 555 050 
Fax:  0800 2 SUPPORT (0800 2787 7678) Email:  advocacy@hdc.org.nz 
For Maori Heath support please contact : 
Name: Catherine Grant, Administrator for He Kamaka Waiora (Māori Health Team) 
Telephone number: 09 486 8324 ext 2324 Email: catherine.grant@cdhb.health.nz 
 
You can also contact the health and disability ethics committee (HDEC) that approved this 









Department of Communication Disorders 
Telephone: +64 3 369 2385 
Email: paige.thomas@pg.canterbury.ac.nz  
6th December 2017 
 
Skill-based swallowing training for patients with Motor Neurone Disease 
If you need an INTERPRETER, please tell us. 
 
I have read, or have had read to me in my first language, and I 
understand the Participant Information Sheet.   
  
I have been given sufficient time to consider whether or not to 
participate in this study. 
  
I have had the opportunity to use a legal representative, whanau/ 
family support or a friend to help me ask questions and understand 
the study. 
  
I am satisfied with the answers I have been given regarding the 
study and I have a copy of this consent form and information sheet. 
  
I understand that taking part in this study is voluntary (my choice) 
and that I may withdraw from the study at any time without this 
affecting my medical care. 
  
I consent to the research staff collecting and processing my 
information, including information about my health. 
  
If I decide to withdraw from the study, I agree that the information 
collected about me up to the point when I withdraw may continue to 
be processed. 
  
I consent to my GP or current provider being informed about my 
participation in the study and of any significant abnormal results 
obtained during the study. 
  
I understand that there may be risks associated with the 
assessment in the event of myself becoming pregnant. I take 
responsibility to inform the investigator if there is any chance that I 








I agree to an approved auditor appointed by the New Zealand 
Health and Disability Ethic Committees, or any relevant regulatory 
authority or their approved representative reviewing my relevant 
medical records for the sole purpose of checking the accuracy of 
the information recorded for the study. 
I understand that my participation in this study is confidential and 
that no material, which could identify me personally, will be used in 
any reports on this study. 
  
I understand the compensation provisions in case of injury during 
the study.   
I know who to contact if I have any questions about the study in 
general.   
I understand my responsibilities as a study participant. 
  
I wish to receive a summary of the results from the study. Yes  No  
If yes to the above- email: _________________________________________ 
 
 
Declaration by participant: 
 







Declaration by member of research team: 
 
I have given a verbal explanation of the research project to the participant, and have 
answered the participant’s questions about it.   
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Protocol Title: Skill-based dysphagia therapy as an intervention for individuals with 
Neurodegenerative disease. 
 
Principal Investigators:  
Paige Thomas, MSLP: 212-678-3072; pat2151@tc.columbia.edu 




You are invited to participate in research to test if skill-based swallowing therapy has the 
potential to improve swallowing and quality of life in patients with neurodegenerative 
disease. You may qualify to participate in this study because you have a diagnosis of 
Amyotrophic Lateral Sclerosis (ALS) OR Huntington’s Disease (HD). Approximately 24 people 
will participate in this study. The therapy portion of this research will run over two weeks with 
five one-hour sessions per week. Additionally, there will be a total of four assessment sessions 
to monitor your swallowing changes, each of these assessment sessions will take 
approximately 40 minutes.  
To be included in this study you must be over 18 years of age and have a diagnosis of ALS or 
over 30 years of age and have a diagnosis of HD. You must have noticed some changes to your 
swallowing as a result of ALS or HD, these may be minor. Despite these changes, oral intake 
must continue to be your main source of nutrition. You will be excluded from study 
participation if you have another condition that may affect your swallowing.  
Audio and video recording is part of this study.  If you do not wish to be audio/video-
recorded, you will not be able to participate. 
WHY IS THIS STUDY BEING DONE?  
Swallowing impairments are common in people with ALS and HD.  However, there is currently 
no therapy which is commonly used to slow swallowing decline. We know very little about 
swallowing therapy for those with ALS or HD and this study will increase knowledge about the 
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WHAT WILL I BE ASKED TO DO IF I AGREE TO TAKE PART IN THIS STUDY?  
First, we will need to make sure you are eligible for study participation.  We will briefly test 
your cognition and your opinion of your swallowing ability.  
 
If we find that you are able to participate, you will need to come to our research labs at 
Teachers College Columbia University for a total of 13 visits. This will consist of 9 treatment 
sessions, 3 assessment sessions and one session in which both assessment and treatment can 
be done on the same day.  
 
At each of these visits, you will be working with either the principal investigator or one of the 
research staff.  If you choose to participate, you will be asked to participate in the following 
tasks: 
 
Assessment visits (Approximately 30 minutes). 
In each assessment session you will: 
1. Fill in a questionnaire about your swallowing and how this effects your quality of life.  
2. Fill in a questionnaire about your functional ability. 
3. Eat a saltine cracker as quickly as you can do so comfortably. 
4. Drink a glass of water as quickly as you can do so comfortably.  
5. Have the muscles under your chin measured both while sitting still and while 
swallowing using ultrasound. This is a non-invasive assessment that uses high 
frequency sound waves to produce an image of muscles and various other structures 
which are important for swallowing. 
 
As previously mentioned, portions of this assessment will require video recording. We will try 
to record only from your nose down as this will help to reduce the potential for recognition.  
 
Therapy visits (Approximately 1 hour). 
Therapy will take place at the Upper Airway Dysfunction Lab five days per week for two weeks. 
The treatment sessions will use skill training and aim to improve the precision of your 
swallowing. This will involve placing a small self-adhesive patch which contains electrodes 
(surface electromyography) on the underside of your chin. This patch will be used to measure 
and display the activity of your swallowing 
muscles as a waveform on the computer 
screen. There will also be a box displayed on 
the screen, your task will be to swallow so 
that the peak of the waveform falls within 
this target box. Each treatment session will 
last approximately one hour including rest 
periods.  
Teachers College, Columbia University 
525 West 120th Street 
New York NY 10027 






There will be a total of four assessment and ten therapy sessions over the course of six weeks. 
Assessments will be every two weeks with therapy for the two weeks between assessment 
two and assessment three. The four assessment sessions allows us to monitor natural changes 
to your swallowing when you are not receiving therapy, any changes as a result of the therapy, 
and to assess whether any effects seen as a result of therapy continue after therapy finishes. 
 
WHAT POSSIBLE RISKS OR DISCOMFORTS CAN I EXPECT FROM TAKING PART IN THIS STUDY?  
This is a minimal risk study, which means the harms or discomforts that you may experience 
are not greater than you would ordinarily encounter in daily life while taking routine physical 
or psychological examinations or tests. You will be eating and drinking foods and liquids of 
different consistencies. As you have swallowing difficulties, there is the risk of food or liquid 
going into your lungs during assessment. However, this risk is no more than when you are 
eating or drinking at home. If there is evidence of food or fluid going into your lungs we will 
stop testing immediately. As some of the sessions are long it is possible that they will make 
you feel tired. If you start to feel tired you will have an opportunity to rest prior to continuing 
with further treatment or assessment.  
 
There are no known risks associated with the therapy task. You will be given breaks 
throughout the therapy sessions and offered sips of water during these breaks. 
 
The investigators and research staff are taking precautions to keep your information 
confidential and prevent anyone from discovering or guessing your identity, such as using a 
randomized ID number instead of your name next to all data and keeping all information on 
a password protected computer or locked in a file drawer at Teachers College.  
 
WHAT POSSIBLE BENEFITS CAN I EXPECT FROM TAKING PART IN THIS STUDY?  
There are not direct benefits associated with taking part in this research. In a previous study, 
skill training for swallowing had beneficial effects on swallowing outcomes for individuals with 
Parkinson’s disease, another neurodegenerative disease. However, the effects of this therapy 
for individuals with ALS or HD are currently unknown.  
WILL I BE PAID FOR BEING IN THIS STUDY?  
You will not be paid to participate; however, we will give you a $75 Walgreens voucher to 
thank you for volunteering. There are no costs to you for taking part in this study.  
WHEN IS THE STUDY OVER? CAN I LEAVE THE STUDY BEFORE IT ENDS?  
The study is over when you have completed the final assessment session. However, you can 
leave the study at any time even if you haven’t finished.  
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PROTECTION OF YOUR CONFIDENTIALITY 
The investigators will keep all written materials locked in a desk drawer in a locked office. Any 
electronic or digital information (including video and audio recordings) will be stored on a 
computer that is password protected.  A master list matching your identifying information 
with your assigned de-identified code will be kept in a locked and separated from the 
documents with your de-identified code and visit (non-identifying) data. As part of our 
practice, we will hold onto all de-identified data for 10 years before securely discarding. 
HOW WILL THE RESULTS BE USED?  
Results from this research will be included in the researcher’s PhD thesis and may be 
submitted for publication in a peer-reviewed journal or as a presentation at a conference. 
Your name or any identifying information about you will not be published. A thesis is a public 
document and will be available online, but you can be assured that you identity will not be 
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CONSENT FOR VIDEO RECORDING  
Video recording is part of this research study. You can choose whether to give permission to 
be recorded. If you decide that you do not wish to be recorded, you will not be able to 
participate in this research study.  
 
 








WHO MAY VIEW MY PARTICIPATION IN THIS STUDY 
 
 
___I consent to allow written, video and/or audio taped materials viewed at an educational 
setting or at a conference outside of Teachers College________________________________ 




___I do not consent to allow written, video and/or audio taped materials viewed outside of 
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OPTIONAL CONSENT FOR FUTURE CONTACT  
 
The investigator may wish to contact you in the future. Please initial the appropriate 
statements to indicate whether or not you give permission for future contact.  
 
I give permission to be contacted in the future for research purposes: 
 
  Yes ________________________   No_______________________ 
           Initial                                                  Initial 
 
I give permission to be contacted in the future for information relating to this study:  
 
Yes ________________________   No_______________________ 
           Initial                                                  Initial 
 
WHO CAN ANSWER MY QUESTIONS ABOUT THIS STUDY? 
If you have any questions about taking part in this research study, you should contact the 
principal investigator, Paige Thomas, at 212-678-3072 or at pat2151@tc.columbia.edu You 
can also contact her academic supervisor, Dr. Troche at 212-678-3953 or at 
mst2139@tc.columbia.edu  
If you have questions or concerns about your rights as a research subject, you should 
contact the Institutional Review Board (IRB) (the human research ethics committee) at 212-
678-4105 or email IRB@tc.edu. Or you can write to the IRB at Teachers College, Columbia 
University, 525 W. 120th Street, New York, NY 1002.  The IRB is the committee that oversees 
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 I have read and discussed the informed consent with the researcher. I have had 
ample opportunity to ask questions about the purposes, procedures, risks and 
benefits regarding this research study.  
 I understand that my participation is voluntary. I may refuse to participate or 
withdraw participation at any time without penalty.  
 The researcher may withdraw me from the research at his or her professional 
discretion.  
 If, during the course of the study, significant new information that has been 
developed becomes available which may relate to my willingness to continue my 
participation, the investigator will provide this information to me.  
 Any information derived from the research study that personally identifies me will 
not be voluntarily released or disclosed without my separate consent, except as 
specifically required by law.  
 I should receive a copy of the Informed Consent document.  
 
My signature means that I agree to participate in this study 
 
 








HIPAA RESEARCH AUTHORIZATION 
 
Authorization for the Creation, Use, and Disclosure of Protected Health Information for 
Institutional Review Board Approved Research 
 
Instructions:   This authorization should be attached to each Informed Consent Form.   
Investigators:  Please complete information fields below and questions 2-8.  Leave the name 
of research subject and signature areas blank.   
 
Title of Study: Skill-based dysphagia therapy as an intervention for individuals with 
Neurodegenerative disease.  
Name of Principal Investigator: Paige Thomas, MSLP 
Phone Number: 212-678-3072   Sponsor:  
IRB Protocol Number: _______________________ Protocol Approval Date: 
 
This form authorizes Teachers College, Columbia University (TC) to use and disclose certain protected 
health information about _________________________(Name of research subject) that we will collect and create 
in this research study.     
 






1. If you sign this form, you are agreeing that TC may use and disclose protected health information 
collected and created in this research study.   
2. The specific health information and purpose of each use and disclosure are: 
 
                                                                         
Health Information               Purpose(s)             
(Check as applicable)                    (Enter matching letter(s) from  
                                                       Purpose Categories) 
√   Medical  records           ____A, E, J   
√   X-ray/MRI/CT/Diagnostic  ____A, C, D, F, I, J 
    Images 
√   Photographs, videotapes, or 
   digital or other images          ____ A, C, D, F, I, J  
√   Questionnaires, interview  
    results, focus group survey,  
    psychology survey, behavioral  
    performance tests  
    (e.g., memory & attention)   ___ A, C, D, F, I, J 









This authorization is voluntary, and you may refuse to sign this authorization.  If you refuse to sign 
this authorization, your health care and relationship with your provider and with TC will not be 
affected; however, you will not be able to enter this research study. 
Note: We will use this information for research purposes only.  Any information we get from you or your 




a. To learn more about the condition/disease being 
studied 
b. To learn more about the costs of treating the 
condition/disease being studied 
c. To improve health care for persons with the 
condition/disease being studied 
d. To analyze research results 
e. To facilitate treatment, payment, and operations 
related to the study 
f. To complete research obligations in this study 
g. To comply with federal or other governmental 
agency regulations 
h. To monitor for adverse events/side effects  
i. To determine the safety and effectiveness of the 
treatment(s) 
j. To perform quality assessments related to research 
at TC 
k. To teach TC students 
l. To place in a repository or “bank” for future 
research purposes  




3. If the information to be used or disclosed contains any of the types of records or information listed 
below, additional laws relating to use and disclosures of the information may apply.  You 
understand and agree that this information will be used and disclosed only if you place your 
initials in the applicable space next to the type of information.  (Investigators please type N/A in 
irrelevant fields). 
_N/A AIDS or HIV infection information 
_N/A Drug/alcohol diagnosis, treatment, or referral information 
_N/A Mental or behavioral health or psychiatric care 
_N/A Genetic testing information 
4. The persons who are authorized to use and disclose this information are: 
√ All the investigators listed on page one of the Research Consent Form 
√ Others at TC who are participating in the conduct of this research protocol: 
√ The TC Institutional Review Board 
5. The persons who are authorized to receive this information are: 
N/A The sponsor of this study:  
N/A_  Federal or other governmental agencies responsible for research oversight:    
N/A_  Others:   
6. Protected health information that we collect from you in this study will be kept by us until:  
√  The study is completed 
___  Indefinitely 
__    Other:   
7. You have the right to revoke this authorization and can withdraw your permission for us to use 
your information for this research by sending a written request to the Principal Investigator listed 
on page one of the research consent form.  If you do send a letter to the Principal Investigator, the 
use and disclosure of your protected health information will stop as of the date he/she receives 
your request.  However, the Principal Investigator is allowed to use information collected before 
the date of the letter or collected in good faith before your letter arrives.  Revoking this 
authorization will not affect your health care or your relationship with TC.  
8. If we have disclosed your protected health information outside of TC, to persons or agencies 
identified in item #5 above, it is possible that this information could be released again without 
your permission.  TC tries to protect against this by being very careful in releasing your 
information.  The ways in which we will limit the further release of your protected health 
information are: 
__    Contractual agreements with those who may not receive the information 
√_    Not releasing your information in a way that could identify you 
__    Other:  We will use this information for research purposes only.  Any information we 
get from you or your health records will be identified by a number only, not by your name.   
 
   
 
____________________________________________________________________________________ 
Printed name of research subject or subject’s representative 
 
__________________________________________                      _______________________________ 
Signature of subject or subject’s representative                                                             Date 
 
Description of Relationship to subject:  ____________________________________________________ 
 
This HIPAA Research authorization form must be used exactly as it is presented here.  Any 
alteration or editing of the form will render it unapproved for research use at TC.  The use of an 
unapproved research consent /authorization form will require that any data collected from subjects 
who received such a form, must be excluded.   
You will receive a copy of this authorization form after you sign it. 
